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Background: While early outcomes of paediatric cardiac surgery have improved, less attention has been
given to later outcomes including post-discharge mortality and emergency readmissions.
Objectives: Our objectives were to use a mixed-methods approach to build an evidenced-based guideline
for postdischarge management of infants undergoing interventions for congenital heart disease (CHD).
Methods: Systematic reviews of the literature – databases used: MEDLINE (1980 to 1 February 2013),
EMBASE (1980 to 1 February 2013), Cumulative Index to Nursing and Allied Health Literature (CINAHL;
1981 to 1 February 2013), The Cochrane Library (1999 to 1 February 2013), Web of Knowledge (1980 to
1 February 2013) and PsycINFO (1980 to 1 February 2013). Analysis of audit data from the National
Congenital Heart Disease Audit and Paediatric Intensive Care Audit Network databases pertaining to
records of infants undergoing interventions for CHD between 1 January 2005 and 31 December 2010.
Qualitative analyses of online discussion posted by 73 parents, interviews with 10 helpline staff based at
user groups, interviews with 20 families whose infant either died after discharge or was readmitted
urgently to intensive care, and interviews with 25 professionals from tertiary care and 13 professionals
from primary and secondary care. Iterative multidisciplinary review and discussion of evidence incorporating
the views of parents on suggestions for improvement.
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Results: Despite a wide search strategy, the studies identified for inclusion in reviews related only to
patients with complex CHD, for whom adverse outcome was linked to non-white ethnicity, lower
socioeconomic status, comorbidity, age, complexity and feeding difficulties. There was evidence to suggest
that home monitoring programmes (HMPs) are beneficial. Of 7976 included infants, 333 (4.2%) died
postoperatively, leaving 7634 infants, of whom 246 (3.2%) experienced outcome 1 (postdischarge death)
and 514 (6.7%) experienced outcome 2 (postdischarge death plus emergency intensive care readmissions).
Multiple logistic regression models for risk of outcomes 1 and 2 had areas under the receiver operator
curve of 0.78 [95% confidence interval (CI) 0.75 to 0.82] and 0.78 (95% CI 0.75 to 0.80), respectively.
Six patient groups were identified using classification and regression tree analysis to stratify by outcome 2
(range 3–24%), which were defined in terms of neurodevelopmental conditions, high-risk cardiac
diagnosis (hypoplastic left heart, single ventricle or pulmonary atresia), congenital anomalies and length of
stay (LOS) > 1 month. Deficiencies and national variability were noted for predischarge training and
information, the process of discharge to non-specialist services including documentation, paediatric
cardiology follow-up including HMP, psychosocial support post discharge and the processes for accessing
help when an infant becomes unwell.
Conclusions: National standardisation may improve discharge documents, training and guidance on ‘what
is normal’ and ‘signs and symptoms to look for’, including how to respond. Infants with high-risk cardiac
diagnoses, neurodevelopmental conditions or LOS > 1 month may benefit from discharge via their local
hospital. HMP is suggested for infants with hypoplastic left heart, single ventricle or pulmonary atresia.
Discussion of postdischarge deaths for infant CHD should occur at a network-based multidisciplinary
meeting. Audit is required of outcomes for this stage of the patient journey.
Future work: Further research may determine the optimal protocol for HMPs, evaluate the use of traffic
light tools for monitoring infants post discharge and develop the analytical steps and processes required
for audit of postdischarge metrics.
Study registration: This study is registered as PROSPERO CRD42013003483 and CRD42013003484.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
The National Congenital Heart Diseases Audit (NCHDA) and Paediatric Intensive Care Audit Network
(PICANet) are funded by the National Clinical Audit and Patient Outcomes Programme, administered
by the Healthcare Quality Improvement Partnership (HQIP). PICAnet is also funded by Welsh Health
Specialised Services Committee; NHS Lothian/National Service Division NHS Scotland, the Royal Belfast
Hospital for Sick Children, National Office of Clinical Audit Ireland, and HCA International. The study was
supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond
Street Hospital for Children NHS Foundation Trust and University College London. Sonya Crowe was
supported by the Health Foundation, an independent charity working to continuously improve the quality
of health care in the UK.
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Plain English summary
In recent years the outcomes of children’s heart surgery have greatly improved, largely because of bettermanagement in hospital. However, after hospital discharge some babies die unexpectedly or require
emergency readmission to intensive care. The Infant Heart Study aimed to explore risk factors for poor
outcomes after hospital discharge for infants undergoing heart surgery, to understand how the health
system works for them after discharge and to propose interventions to improve outcomes. We used a
range of different methods to collect data: we identified relevant published literature, analysed national
audit data routinely collected about UK babies undergoing heart surgery or admitted to intensive care and
conducted interviews with parents of children who had died or been readmitted unexpectedly after
hospital discharge, health professionals who work with these babies in hospitals or the community, and
charity helpline staff. A group of people from different backgrounds was convened to suggest effective
interventions. Results indicate the need for improved discharge planning and communication between
professionals in specialist hospital, local hospital and community settings that care for infants discharged
after heart surgery; for infants identified as being at high risk to be discharged from the specialist hospital
to their local hospital before going home; for a home-monitoring programme for infants at high risk; for
clear guidance to families and health professionals about spotting early warning signs in a baby who has
had heart surgery; for standardised training and information for families prior to discharge; and for the
opportunity for families to seek peer support from other families through charity-based groups or
social media.
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Scientific summary
Background
Early postoperative outcomes for children undergoing paediatric cardiac surgery have improved over the
last decade because of many small incremental adjustments to the patient journey. Furthermore, such early
postoperative outcomes for paediatric cardiac operations are subject to considerable scrutiny, especially in
the UK. In contrast, postdischarge outcomes for infants with congenital heart disease (CHD) have to date
been much less well understood, as has the performance of health services and postdischarge processes
that contribute to longer-term survival. The motivation for this project was to explore and understand both
the risk factors for poor postdischarge outcome for infants undergoing cardiac interventions and the
health-care processes underpinning them, and hence to make a series of recommendations for
improvement, the original study questions being:
1. Can a suitable surveillance programme or complex intervention be designed with the objective of
decreasing mortality associated with infant cardiac surgery, by averting unexpected deaths in the
community, subsequent to discharge after ‘successful’ surgery?
2. Can linkage of individual data from existing routine sources including both clinical and social
information, from National Congenital Heart Diseases Audit (NCHDA) and Paediatric Intensive Care
Audit Network (PICANet), improve our understanding of why some infants die or collapse at home
following cardiac surgery?
3. Can the parents of infants with heart disease and professionals involved in postdischarge care better
inform the follow-up and surveillance processes for infants in the community who have undergone
cardiac surgery and help to identify barriers that may be impairing their access to health care?
Methods
Systematic reviews
The following two systematic reviews of the literature were undertaken.
1. Unexpected deaths and unplanned readmissions in infants discharged home after major surgery for
congenital anomalies: a systematic review of potential risk factors: protocol registration
PROSPERO CRD42013003483.
2. A systematic review of non-invasive interventions for infants discharged from hospital after major
surgery for congenital anomalies: protocol registration PROSPERO CRD42013003484.
Quantitative analysis of national audit data
Records for all UK infants undergoing intervention for CHD between 1 January 2005 and 31 December
2010 were identified from NCHDA and linked to those individuals’ intensive care admission records in
PICANet. The procedure- and admission-based data sets from the two national audits were converted into
a patient-based data set. A total of 115 children who had an excluded catheter procedure only,
765 premature babies who had ligation of patent ductus arteriosus only and 24 transplant patients were
excluded from the analysis. A further 505 patients with unknown life status were removed, leaving 7976
remaining patients.
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Logistic regression was used to develop risk models for:
Outcome 1: out-of-hospital death or death following emergency admission within 1 year
following discharge.
Outcome 2: the combination of out-of-hospital death within 1 year following discharge and emergency
readmission to intensive care ending in either survival or death.
Classification and regression tree (CART) analysis was used to identify patient groups differentiated by
outcome 2.
Qualitative analysis
Helpline staff interviews (HLIs): semistructured interviews were conducted with 10 congenital heart
charity staff.
Online discussion forum (OF): 73 participants joined an OF hosted by the user group Children’s
Heart Federation.
Family interviews (FIs): semistructured interviews were conducted with 20 families that had either lost an
infant post discharge following paediatric cardiac surgery or had an infant readmitted to intensive care as
an emergency.
Health professional interviews (HPIs): semistructured interviews were conducted with 25 tertiary health
professionals (HPs) and 13 primary and secondary care HPs.
Qualitative analysis of these study data was performed using the Framework approach.
Intervention development
An expert advisory group was established to review evidence and propose interventions for improving
services. It comprised professionals from three tertiary cardiac centres, representatives from primary care,
secondary care and patient groups, as well as academics from the disciplines of psychology, statistics,
epidemiology and operational research. Three members are trained in quality improvement methodologies.
The group met on five occasions (each for 2–3 hours) between March 2013 and June 2014. The
suggestions for service improvement were discussed at a workshop consisting of parents that participated
in the FIs.
Through a facilitated process at the final meeting, the group generated a list of evidence-based
interventions for future implementation or evaluation.
Results
Systematic reviews
Despite a broad search strategy for both reviews, studies meeting inclusion criteria pertained only to
patients with CHD, in particular complex single ventricle conditions. Studies were predominantly from
the USA.
Systematic review 1
Fifteen studies were eligible for inclusion. Risk factors identified as having a significant association with
higher mortality or unplanned readmission were non-white ethnicity, lower socioeconomic status,
comorbid conditions, age at surgery, operative complexity and procedure type, and postoperative
feeding difficulties.
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Systematic review 2
Eight studies were eligible for inclusion. The interventions of interest were home monitoring programmes
(HMPs). Control patients were based on historic patient data in all studies. A range of clinical outcome
measures (1-year outcome, interstage mortality, detection of clinical deterioration) showed improvement
with HMPs in different studies.
Quantitative data
Of the 7976 patients meeting inclusion criteria, 333 [4.2%, 95% confidence interval (CI) 3.7 to 4.6] died
within their index admission period and were excluded from our analyses, leaving a final data set
comprising 7643 infants discharged alive from their index admission for paediatric cardiac surgery.
Of these, 246 (3.2%, 95% CI 2.8 to 3.6) experienced outcome 1 and 514 (6.7%, 95% CI 6.2 to 7.3)
experienced outcome 2.
Using multiple logistic regression analysis, risk factors for death within 1 year following discharge (outcome 1)
were identified as age at procedure, weight z-score, cardiac procedure, cardiac diagnosis, non-cardiac
congenital anomaly, clinical deterioration, prematurity (< 37 weeks’ gestation), ethnicity and length of stay
(LOS) in specialist centre.
When additionally including emergency readmissions to intensive care (outcome 2), preprocedure clinical
deterioration was not significant, whereas neurodevelopmental conditions and acquired diagnoses were.
Model discriminations for outcomes 1 and 2 were very similar, with area under the receiver operating
characteristic curves of 0.78 (95% CI 0.75 to 0.82) and 0.78 (95% CI 0.75 to 0.80), respectively.
The CART analysis identified six patient groups differentiated by outcome 2 and defined in terms of the
following patient characteristics:
1. neurodevelopmental conditions (24% outcome 2)
2. no neurodevelopmental conditions; low-risk cardiac diagnosis [ventricular septal defect (VSD)/other];
congenital anomalies; LOS in specialist centre > 1 month (24% outcome 2)
3. no neurodevelopmental conditions; high-risk cardiac diagnosis [hypoplastic left heart syndrome (HLHS),
other types of functionally univentricular heart (UVH) or pulmonary atresia (PA)] (15% outcome 2)
4. no neurodevelopmental conditions; low-risk cardiac diagnosis (VSD/other); no congenital anomalies;
LOS > 1 month (9% outcome 2)
5. no neurodevelopmental conditions; low-risk cardiac diagnosis (VSD/other); congenital anomalies;
LOS < 1 month (8% outcome 2)
6. no neurodevelopmental conditions; low-risk cardiac diagnosis (VSD/other); no congenital anomalies;
LOS < 1 month (3% outcome 2).
Qualitative data
This information is presented as a synthesis of the four qualitative data sources listed in the methods.
Training and information for families predischarge
Information overload: it is difficult for families to understand and absorb all of the information they are
given (FI and OF).
Poor timing: information is often rushed before discharge (FI and HPI).
Insufficient training on ‘signs, symptoms, responses’: these are often missed, vague or unstructured, and
no written material is given to take away (FI and HPI).
Barriers for non-English speakers: there is limited access to interpreters and most resources are only
available in English (HPI).
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Some families miss out: limits to the availability of resources may influence the content of training and
information provided (HPI).
Discharge and transferring to non-specialist services
Poor access to local support services: it is difficult for specialist centres to know what local and community
services are available and how to contact them, particularly when links are not well established.
Community teams are often short of resources (HPI).
Inadequate planning: discharge may occur at short notice and the content of a discharge package may be
strongly influenced by the availability and accessibility of local resources, leading to variation across the
country in terms of who is offered what follow-up care (HPI).
Poor-quality discharge letters/summaries: these are often very delayed, do not reach all HPs, contain too
much specialist information and terminology and often do not include basic information, what to look out
for and how to respond (HPI).
Ad-hoc planning for high-risk patients: in some centres there is no protocol in place for identifying
high-risk babies and the (extra) care that is offered to them (HPI).
Medical follow-up services
Problems with clinics: clinics are often full and running late. Outreach clinics may not incorporate
paediatricians and specialist nurses (FI and HPI).
Inconsistent specialist support between clinics: many families (particularly high-risk ones) get regular calls
from cardiac liaison nurses, but some do not and can find it hard to get in touch with them (FI and HPI).
Variability and resource challenges: there are not enough paediatricians with expertise in cardiology (PEC)
and often newly trained or less-experienced community nurses/health visitors (HVs) attend visits. Infants
must have a medical need to get a community nurse but it can be difficult to maintain regular home visits
from HVs, as the baby may not be considered high priority (HPI).
No protocol for HMPs: there is a large variation between centres in the provision of HMPs and the content
thereof. Community professionals may not know how to respond to changes in the infant’s condition.
Some families find HMPs to be helpful, others find them to be a distraction or too complicated (FI and HPI).
Feeding/weight gain: many families find this a very stressful aspect of care. Lack of support and conflicting
advice between HPs and difficulty in using nasogastric tubes were cited as reasons. (FI.)
Non-medical support
Practical difficulties: families sometimes experience practical difficulties in the community that may not
have been identified prior to discharge. These include child care for siblings, access to transport, financial
difficulties due to long hospital stays, debts, loss of earnings and inability to return to work. Some families
struggle to adhere to medication regimes and can experience difficultly getting prescriptions because
general practitioners are not always clear as to what has been prescribed or what to do about off-licence
medications (FI, HLI and OF).
Fear and isolation: parents often live in fear of an emergency and the worry of infection isolates them from
other parents and support groups in their community (FI and OF).
Families lack confidence: some families lack the confidence to approach or challenge HPs, fail to ask
questions during appointments for fear of appearing ignorant or incapable or lack the ability to articulate
their concerns (particularly non-English speakers) (HLI, HPI and OF).
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The strain of ‘expert parenting’/lack of confidence in local services: many families have to pass on
information about their child’s condition to HPs that do not have specialist knowledge and sometimes
(as the holders of knowledge) feel they are battling with local services. Many families take on an ‘expert
parent’ role, which can be alienating and frightening (OF, FI and HPI).
Insufficient psychosocial support: support offered to families is often purely related to the medical needs of
their child with no specific protocol for assessing their psychosocial needs and resources harder to get for
social support unless they meet criteria for safeguarding (FI, HPI and OF).
Patient information
Poor sharing of patient information: there are very few shared electronic patient record systems across
services. Information is often relayed through the families, although there is inconsistency in the extent to
which HPs use red books, hand-held records, health booklets, etc. (FI and HPI).
Not flagged or fast-tracked: there is often no formal system for flagging (high-risk) babies or for enabling
them to have quick access to services (FI and HP).
Accessing support when a baby is sick
Not knowing ‘signs, symptoms, response’: parents and all local HPs are often unclear on what signs and
symptoms to look for and how to respond, with insufficient guidance from specialist centres (FI and HPI).
Families not taken seriously: families sometimes find it difficult to verbalise their concerns, lack the
confidence to seek help or do not feel listened to by HPs when they do (FI and OF).
Failing to seek specialist advice: sometimes local HPs fail to notify the PEC or specialist centre of an
incident (deterioration) or contact them when there is a concern (FI and HPI).
Conclusions: suggestions for health care improvement
The following are recommended by the working group.
l All infants may benefit from a nationally standardised structured discharge document available to HPs
involved in their care.
l Infants in high-risk groups, with HLHS, UVH or PA, neurodevelopmental conditions and/or
LOS > 1 month, would benefit from ‘step-down’ care, that is discharge via their local hospital.
l Home monitoring may be beneficial for all infants with a primary diagnosis of HLHS, UVH or PA.
l All families and HPs are likely to benefit from the same clear guidance on ‘what is normal’ for that
child, signs and symptoms to look for, how to respond and important contact numbers, for example in
the form of a traffic-light tool.
l A nationally standardised checklist in order to plan, deliver and audit the provision of training and
information for all families prior to discharge may be helpful to HPs.
l Review of all postdischarge deaths of infants outside a specialist centre may be best placed at a
mortality and morbidity conference held within the relevant network.
l Peer support with other families, for example through social media or charity support groups, is
suggested for those being discharged with their infant.
l The wider report provides detail of proposed metrics for processes and outcomes for use on the care
quality dashboard, including additional clinical outcome measures for national audit.
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Conclusions: recommendations for research
These include:
l further research and national consensus building is required to establish the optimal protocol,
components and inclusion criteria for HMPs (if beyond those proposed above), including an assessment
of resource implications
l additional health-care evaluation is required of the best format, applications and effectiveness of the
proposed traffic-light tool, as well as an evaluation of the proposed structured discharge document,
discharge checklist and step-down care. Cultural and language barriers should form part of
this evaluation
l further research to establish the statistical and analytical steps required for routine audit of relevant
outcome measures for this population, in particular postdischarge mortality rates, which should
incorporate adjustment for case mix.
Study registration
This study is registered as PROSPERO CRD42013003483 and CRD42013003484.
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Funding for this study was provided by the Health Services and Delivery of the Research programme
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Chapter 1 Introduction
Major technological advances in paediatric surgical and intensive care in recent decades, particularly forneonates, have resulted in the survival of children with previously life-threatening congenital heart
defects,1 yet congenital heart disease (CHD) remains the most common cause of infant death because of
congenital anomalies in the UK.2,3 Although many of the deaths that do occur early are in association with
surgery, the outcomes for this immediate phase of in hospital care have improved overall in recent years4
with current 30-day mortality rates at historically low levels. The scope of audit beyond 30 days after
operation is limited; however, UK National Congenital Heart Diseases Audit (NCHDA) data indicate that
significant numbers of deaths do occur more than 30 days after neonatal cardiac surgery but within the
first postoperative year.5 Moreover, analysis of 1018 neonates undergoing all types of cardiac surgery in
two London hospitals from 2000 to 2009 found that of 176 deaths during the first year of life, 116 (66%)
occurred during the initial postsurgical hospital stay and 37 (21%) were unexpected late deaths in infants
who had been discharged home after apparently successful cardiac surgery.6 Thus, cardiac infants remain
vulnerable even after surgery; one reason previously proposed for this is that certain CHD types necessitate
a series of staged procedures within the first few months of life.7 It is also important to note that babies
with CHDs who survive past their first birthday are subsequently at a lower mortality risk during childhood.3,8
Although considerable emphasis has been placed on quantifying and exploring what risk factors impact on
early postoperative and in-hospital mortality9–12 and on improving treatment strategies for within hospital
care, including surgical techniques13 and postoperative management approaches,14 resulting in net benefit
to patients, less attention has been paid to the risks and care pathways post discharge. An exception to
this is the case of hypoplastic left heart syndrome (HLHS), for which teams from the USA have reported the
benefits of enhanced surveillance known as home monitoring programmes (HMPs).15 However, despite
the obvious importance to patients and families of this phase in the patient journey, uncertainty has
previously existed around which diagnostic groups across the spectrum of infant CHD are at risk of adverse
postdischarge outcomes and what can be done to improve upon them, while considering various elements
and stages of relevant care pathways. Guidance on hospital discharge for high-risk neonates from the
American Academy of Pediatrics is informed by a robust evidence base describing the specific needs of
vulnerable neonates at the time of hospital discharge and hence what should be put into place.16 Although
neonates with complex congenital anomalies are highlighted as a vulnerable population, specific guidance
for the postdischarge care of neonates with CHD is not provided. In the UK, the management of children
with CHD, including infants after being discharged home, falls within the responsibility of ‘congenital
heart networks of care’, including designated ‘outreach’ services provided or supported by the specialist
centres.17 These services have been subject to several reviews, including the ‘Safe and Sustainable Review’18
and most recently the ‘New Review of Congenital Heart Services’, which delivered its final report on
2 March 2015.19 We hope that our study findings may be taken forwards within the context of this
evolving service provision for children with CHD.
The original aims and objectives for the Infant Heart Study (IHS) were as follows.
Aims
To use a mixed-methods approach including quantitative analyses of national audit data and qualitative
approaches to gather information from key individuals, in order to establish an evidence-based and realistic
guideline for community-based surveillance of fragile infants with CHD.
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Objectives
1. To perform a literature review exploring risk factors for death in infancy following cardiac surgery
(rather than early postoperative death in hospital), to identify examples of successful surveillance or
intervention programmes for infants with CHD and to explore evidence for social, ethnic and economic
factors that may reduce access to health care for children with complex medical disorders.
2. To perform a quantitative analysis of risk factors, including both medical and social variables available
from routine data sources, that may be related to the outcome measures: late death or unplanned
readmission to intensive care, in infants that have undergone surgery for CHD. This analysis used
national audit data from NCHDA and the Paediatric Intensive Care Audit Network (PICANet).
3. To perform a qualitative study drawing on a series of sources for information, including an online
discussion forum (OF) through a patient and user group’s Facebook web page (www.facebook.com;
Facebook, Inc., Menlo Park, CA, USA), the user group’s helpline staff, professionals caring for infants
with CHD, and parents from high-risk groups or of children that experienced one of the outcome
measures. Qualitative data from the last three sources were gathered via semistructured interviews.
The objective here was to identify actual barriers to health care for infants with CHD, with particular
focus on socioeconomic challenges and to inform subsequent intervention development. Two focus
groups reviewed and discussed the proposed intervention designs.
4. To combine the data and information acquired in the first three objectives to generate the evidence-based
protocol or guideline for surveillance of infants with CHD, including the ‘who?’ ‘when?’ and ‘how?’
this should best be delivered. The ultimate objective was to produce a workable and effective follow-up
surveillance protocol for infants discharged into the community after cardiac surgery, with appropriate
targeting of higher-risk patients and consideration of measures that will be acceptable and useful to
parents and community-based health-care professionals. Intervention development included consideration
of measures of success.
Approvals for the study
Research Ethics Committee
The study was approved by the London Central Research Ethics Committee on 4 October 2012 (reference
12/LO/1398).
National Information Governance Board
The study was approved by the National Information Governance Board now known as the Health
Research Authority (HRA) and permission was granted for the use of identifiable data for the purposes of
record linkage within specified limits (reference 12/LO/1398, November 2012).
Healthcare Quality Improvement Partnership
The use of national audit data from NCHDA and PICANet, including the use of identifiable data for
the purposes of record linkage within specified limits, was approved by Healthcare Quality
Improvement Partnership.
National Congenital Heart Diseases Audit
The use of national audit data for the specified purposes stated in the study protocol was approved by the
NCHDA and is subject to a data sharing agreement (reference 12/CONG/03).
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Chapter 2 Unexpected deaths and unplanned
readmissions in infants discharged home after major
surgery for congenital anomalies: a systematic review
of potential risk factors
Some of the text of this chapter has been published previously as Tregay et al., 2015.20 Reproduced withpermission. © Cambridge University Press 2014.
Introduction
In order to achieve optimal outcomes post discharge in infants going home after intervention, and to offer
targeted support to vulnerable infants and their families at home in the community, it is also important to
understand the risk factors for these late outcomes. We therefore undertook a systematic review of the
published literature with the intent of capturing all studies of infants with congenital anomalies, to identify
the key risk factors, identifiable at the time of discharge home after surgery, that are associated with
unexpected death in the community or unplanned readmission to hospital. In setting up the systematic
review, we aimed to capture studies from other specialist areas of practice, including but not exclusive to
CHD, as we sought transferable knowledge as well as information regarding our specific population
of interest.
Methods
Protocol and registration
The protocol and search strategy is registered in the International Prospective Register of Systematic
Reviews (PROSPERO) as CRD42013003483.21
Search strategy
To ensure a comprehensive review of the evidence, and to capture any pertinent risk factors that may not
yet have been identified in studies with CHD patients, we used a broad search strategy that included other
life-threatening congenital malformations requiring major surgery in the first year of life, for example
gastroschisis or diaphragmatic hernia. We used key terms relating to children, congenital abnormalities,
surgical procedures, hospital discharge and adverse outcomes to electronically search MEDLINE (1980 to
1 February 2013), EMBASE (1980 to 1 February 2013), Cumulative Index to Nursing and Allied Health
Literature (CINAHL; 1981 to 1 February 2013), The Cochrane Library (1999 to 1 February 2013), Web of
Knowledge (1980 to 1 February 2013) and PsycINFO (1980 to 1 February 2013). Conference abstracts
from the Association for European Paediatric Cardiology, the American Heart Association and the
European Surveillance of Congenital Anomalies symposia were searched for the period 2008 to 2012.
A forward citation search was carried out on the reference lists of all selected studies to identify additional
published studies for review.
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Selection of studies
Studies were eligible for inclusion only if they separately reported outcomes for children discharged from
hospital and in-hospital surgical mortality. To ensure relevance to infant survival, only studies involving
children up to the age of 5 years were included in the review and major surgery was defined as requiring
intensive or high-dependency care in the postoperative period. Inclusion criteria for the studies included in
the review are summarised in Box 1.
The titles and abstracts for all studies were independently reviewed by two reviewers (J Tregay and J Wray)
then full-text papers of selected studies assessed by three reviewers (J Tregay, K Brown and R Knowles) to
determine whether or not they met the inclusion criteria. Any discrepancies between reviewers were
resolved through discussion with a fourth reviewer (J Wray) (see Figure 1).
Data extraction
Data extraction was independently completed by two reviewers (J Tregay and R Knowles) using a standard
pro forma that included information on study design, population, diagnosis, comparison groups, outcomes
and risk factors.
Quality assessment
Studies were assessed for methodological quality of study design using levels of evidence rated from one
(most rigorous, e.g. randomised controlled trial) to four (least rigorous, e.g. retrospective uncontrolled case
series).22 Within each evidence level, studies were assessed as A (high quality) to C (lowest quality), using
predetermined criteria such as confounding, completeness of follow-up and objective measurement of
outcomes (see Appendix 2).
BOX 1 Summary of the eligibility criteria for inclusion in the review. Reproduced with permission from Tregay
et al., 2015.20 © Cambridge University Press 2014
Inclusion criteria
Studies that include children:
l aged from birth up to and including 5 years of age
l with a life-threatening congenital abnormality
l who have undergone major surgery (involving intensive care) for potentially life-threatening
congenital disease
l who were discharged home from hospital following their successful surgery.
Exclusion criteria
Studies that:
l refer exclusively to adults, children over the age of 5 years old or where the age group of interest is not
clearly defined
l include previously healthy children who had major surgery as a consequence of traumatic injury
l do not refer to specified adverse outcomes (e.g. death, unplanned hospital readmission)
l do not present postdischarge events and risk factors separately from in-hospital events
l included children discharged home for palliative medical care
l were case series of fewer than 20 cases, personal communications, letters and commentaries
l have no available English-language abstract.
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Data analysis
The outcomes of interest were unexpected death or unplanned readmission to hospital in the first year of
life after discharge following cardiac surgery. Factors associated with increased mortality or readmission risk
are presented in a narrative synthesis.
Results
Study selection
There were 17 studies identified through systematic searches and a further six studies through forward
citations. Of the 23 full-text papers reviewed, eight studies failed to meet inclusion criteria resulting in
15 studies eligible for review (Figure 1). Despite our inclusive search strategy, no studies of post-surgical
outcomes for children with non-cardiac congenital anomalies met the inclusion criteria.
The review included eight retrospective reviews of surgical cases,23–30 four retrospective cohort studies,31–34
two case–control studies35,36 and one randomised controlled trial that was reported in two papers.26,37
Only three studies29,36,37 included a prospective element. Although study designs differed, all studies were
rated as good quality (Table 1); studies that were assigned a lower rating failed to address some
potential confounding factors. Ten reports were of patients with a functional single-ventricle (SV)
diagnosis,23,24,26–28,30,33,35–37 which was most often HLHS. Fourteen papers involved patients who underwent
cardiac surgery during the first year of life and the remaining study31 included cardiac patients operated up
to the age of 18 years with results provided separately for each age group. Only two studies were not
conducted in the USA.23,27 In total, 29,019 patients were followed up for mortality outcomes, of whom
Records identified
through database searches
(n = 888)
Records after 
duplicates removed
(n = 652)
Records screened
(title and abstract)
(n = 652)
Studies included in 
data extraction
(n = 15)
Full-text articles
assessed for eligibility
(n = 23)
Forward citations met
criteria (title and abstract)
(n = 6)
Records excluded
(n = 635)
Records excluded by group consensus
(n = 8)
• No differentiation of in- and 
   out-of-hospital deaths, n = 4
• No data (literature review), n = 1
• No differentiation of patients who had 
   surgery and those who did not, n = 1
• No reference to risk factors, n = 1
• Not life-threatening (cleft lip), n = 1
FIGURE 1 The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow chart showing
study selection process. Reproduced with permission from Tregay et al., 2015.20 © Cambridge University Press 2014.
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1113 (4%) died. Of the 3672 children who underwent SV surgery, 452 (12%) died, compared with
661 (3%) of 25,347 children who underwent other types of cardiac surgery. Of the 1639 children who
were observed in three studies of unplanned readmission, 173 (11%) were readmitted to hospital during
the study follow-up period. Table 2 summarises the included papers.
Adverse outcomes
Reported mortality rates varied markedly and were influenced by the study population at risk as well as the
duration of follow-up. Five studies23,26,30,33,35 involved children with SV diagnoses undergoing staged
palliative surgery and reported ‘interstage’ mortality between first- and second-stage surgery that ranged
from 8% to 16%, with follow-up ending at around 1 year after surgery in most studies. Two further
studies focused on ‘unexpected’ interstage deaths, defined as acute events or sudden cardiovascular
collapse, and reported 4–5% unexpected deaths in neonates discharged home between stages 1 and 2.28,37
Carlo et al.24 and Hansen et al.27 reported interstage mortality of 9% for children discharged home between
second (superior cavopulmonary anastomosis or bidirectional Glenn) and third stage (Fontan) surgery.
Two studies investigated postdischarge mortality after all types of cardiac surgery: Chang et al.31 reported a
low mortality rate of 0.62% at 1 year after any cardiac surgery undertaken in children up to age 18 years,
whereas Pinto et al.29 found a higher mortality rate of 8% in the 2 years following discharge after neonatal
congenital heart surgery. Mortality rates over 10% were reported in studies focusing on specific higher-risk
cardiac defect subgroups32 or patients discharged home on mechanical ventilation.25
TABLE 1 Summary of study quality by levels of evidence.a Reproduced with permission from Tregay et al., 2015.20
© Cambridge University Press 2014
First author, year
LOE
LOE 1: prospective
cohort study, RCT
or meta-analysis
LOE 2: prospective
case–control study
(including records
based)
LOE 3: retrospective
cohort or case–control
study (including
records based)
LOE 4: retrospective
review of cases
without control
patients
Study quality Study quality Study quality Study quality
A B C A B C A B C A B C
Ashburn, 200323 ✓
Carlo, 201124 ✓
Chang, 200631 ✓
Edwards, 201025 ✓
Fixler, 201232 ✓
Ghanayem, 201226 ✓
Hansen, 201127 ✓
Hebson, 201233 ✓
Hehir, 200835 ✓
Kogon, 201234 ✓
Mackie, 200436 ✓
Mahle, 200128 ✓
Ohye, 201237 ✓
Pinto, 201229 ✓
Simsic, 200530 ✓
LOE, level of evidence; RCT, randomised controlled trial.
a Rated A (high quality) to C (low quality).
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Two studies evaluated unplanned hospital readmissions as distinct from mortality29,34 and one further
study36 reported unplanned readmissions as part of a combined outcome measure of mortality and
readmission. Readmission rates within 30 days of hospital discharge ranged from 10%34 to 30%36 and at
2 years post discharge were 45%;29 variations were influenced by duration of follow-up and differences
in data collection methods, which included hospital records review34,36 and telephone survey.29
Risk factors associated with adverse outcomes
Although many different factors were investigated, the findings relating to individual factors were
inconsistent; this may reflect the heterogeneity of participant characteristics and study designs. Figure 2
summarises the factors investigated by different studies and indicates whether or not these were found to
increase mortality risk.
Individual and family factors
Ethnicity,26,29,32,34 socioeconomic status26,32,36 and non-cardiac malformations or genetic syndromes32,34,36 were
the most frequently evaluated individual factors. Hispanic ethnicity14,19,23 and socioeconomic deprivation,
as assessed through measures such as household income,36 family income below the national poverty
threshold26 and deprivation index of the residential area32 were highlighted as risk factors for mortality and
unplanned hospital readmission in the US studies. Preterm birth26,32 and low birthweight23,32 were risk factors
for mortality, but patient sex was not significantly associated with adverse outcomes.24,31,32,35 Children living
90–300 minutes from the cardiac centre were at significantly lower risk of unplanned readmission29
compared with families living under 90 minutes away, but there was no association with mortality.29,32
Family factors, including maternal education, marital status and country of birth, were not associated with
adverse outcomes.32
Cardiac diagnosis and procedural factors
Infants with more complex hypoplastic left heart variants23,24,26,27,35 were at higher risk of mortality or
readmission. Children undergoing more complex operations, based on the Risk Adjustment in Congenital
Heart Surgery (RACHS) – 1 system,9,38 were at greater risk.25,29,34 Several studies reported that Norwood
procedures,31 specific shunt operations,23,26,31,37 total anomalous pulmonary venous connection (TAPVC)
repair31 and truncus arteriosus repair31 were associated with significantly higher mortality, whereas
palliative operations34 increased the risk of unplanned readmission. There was insufficient evidence to
suggest that intraoperative characteristics, such as cardiopulmonary bypass or circulatory arrest time,
had a negative impact on outcome.23,30,35
In children undergoing staged palliative operations, older age at first procedure was associated with higher
mortality risk,23,35 whereas younger age (under 4 months) at the second-stage Glenn procedure increased
the risk of postoperative complications.27 In two papers26,37 reporting findings from the Single Ventricle
Reconstruction (SVR) trial, in which patients with HLHS were randomised to receive different surgical
interventions, higher mortality rates after hospital discharge were observed in the group receiving a
modified Blalock–Taussig shunt (MBTS) than in the group undergoing a right ventricle-to-pulmonary artery
conduit (RVPA); this difference was no longer significant after adjustment for severity of postoperative
atrioventricular valvar regurgitation.
Postoperative symptoms/complications
Five studies explored postoperative feeding difficulties;28,33–36 three of these identified feeding
difficulties,33,34,36 including the need for gastrostomy tube placement,33 as a risk factor for mortality or
unplanned readmission. Peri- and postoperative arrhythmias were also a significant risk factor for mortality
in two studies;28,30 although airway complications, prolonged postoperative length of stay (LOS),
postoperative complications and medications at discharge were not found to influence outcomes
post discharge.
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FIGURE 2 Summary of factors examined in the 15 studies. AV, atrioventricular; ICU, intensive care unit;
SES, socioeconomic status; RACHS category, Risk Adjustment in Congenital Heart Surgery category. a, The cardiac
surgical procedures defined in these studies were palliative procedures, Norwood stage 1, bidirectional Glenn,
shunt construction, thoracic vessel procedures, truncus arteriosus repair, total anomalous pulmonary venous return
repair and open valvotomy. Reproduced with permission from Tregay et al., 2015.20 © Cambridge University
Press 2014.
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Discussion
We identified 15 studies that evaluated the potential risk factors associated with mortality or unplanned
hospital readmission in children successfully discharged from hospital after cardiac surgery for serious
CHDs. Factors identified most frequently by these studies as predicting significantly increased risk of
adverse events were non-white ethnicity,26,29,32,34 lower socioeconomic status,26,32,36 comorbid conditions
including non-cardiac malformations and syndromes,32,34,36 age at surgery,23,31,34,35 operative complexity
or procedure type,23,25,26,29,31,34,37 and postoperative feeding difficulties.33,34,36 Patient sex, parent factors,
intraoperative factors and postoperative complications were also investigated but not found to be
independent predictors of postdischarge outcomes.
Context and limitations
Our review confirms the significant lack of research into adverse outcomes after hospital discharge
following surgery and highlights the fact that the evidence base to inform postdischarge clinical care and
identify infants at high risk for focused support is extremely limited. As many reports derive from North
American studies, and the research population is often limited to infants who have severe and complex
cardiac diagnoses requiring staged surgery, care must be taken in generalising the findings from these
existing studies to the wider UK population of infants with CHDs.
Despite our broad search strategy, which was intended to capture research into other life-threatening
anomalies that require surgery during infancy, such as gastroschisis and diaphragmatic hernia,39 the only
studies of postdischarge outcomes that met the inclusion criteria concerned CHDs. Of all congenital
anomaly subgroups, the highest rate of infant deaths is associated with CHDs, and this may account for
the greater interest in monitoring outcomes after hospital discharge. It is also notable that postdischarge
outcomes of infants with CHDs came to prominence with the introduction of staged palliative surgery for
HLHS, which led to improved early in-hospital outcomes40,41 and highlighted later interstage mortality as an
important concern.15,26
A limitation of our review was the rigour of our eligibility criteria, which excluded any studies that did not
clearly differentiate between deaths that occurred before and after hospital discharge, and thus may have
excluded from the review some studies that evaluated additional risk factors to those reported here.
The relative lack of studies reporting postdischarge surgical outcomes may also simply reflect the limited
monitoring of late adverse events and, specifically, of events occurring in the community or primary
care setting.31
Ethnicity and deprivation
In three US studies26,32,34 included in our review, patients of Hispanic ethnicity were found to be at a
greater risk of adverse outcomes relative to white patients post hospital discharge. This confirms previous
research which has shown that US Hispanic communities are more likely to experience multiple barriers to
health care including language and immigration status, and financial barriers, such as lack of health
insurance or low family incomes.42,43 However, the impact of ethnicity and socioeconomic deprivation
demonstrated in US-based studies may be influenced by an individual family’s ability to pay for care42–49
and the relevance of these findings for the UK health-care system is uncertain. Nevertheless, there is
evidence that lower-income families in the UK also experience a considerable financial burden when caring
for their child with CHD and that this may affect care-seeking behaviours.49 The results of our review
therefore add to the growing body of evidence suggesting that patients from minority ethnic and lower
socioeconomic groups are more likely to experience barriers to timely and appropriate access to care
and underlines the relevance of these factors to the population of infants with CHDs following
hospital discharge.
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Medical factors
Postoperative feeding and growth were also significantly associated with adverse outcome in several
studies33,34,36 identified within the review, consistent with previous research.50 However, the relationship
between feeding difficulties and adverse outcomes post discharge is likely to be complex because of
potential confounding with poorer cardiac status and other comorbidities; therefore, it requires
further investigation.
Readmission to hospital will depend on both the child’s clinical state and the response to this by parents
and medical staff. It is possible that readmission signified a timely response to a child’s deteriorating
clinical state in some cases, whereas in others it was a response to a child who became seriously unwell.
In our review, we considered an unplanned readmission to be an adverse event indicating that a child
deteriorated unexpectedly at home and so did not experience a stable clinical course after discharge.
Nevertheless, it is possible that the risk factors for readmission may differ from those for deaths and this
may have contributed to the breadth of different risk factors identified.
Conclusion
We identified several key medical and social factors associated with a higher risk of mortality or unplanned
hospital readmission for children discharged from hospital after paediatric cardiac surgery. Some of these
risk factors, such as feeding difficulties, would be amenable to modification through specific interventions,
whereas others enable health professionals (HPs) to identify children who are at greatest risk of adverse
outcomes and to offer additional support, such as HMPs, targeted more effectively at vulnerable children
and their families within the community setting. Although there were no studies of social and financial
factors within the UK health-care context, unequal access to care may disproportionately affect minority
ethnic communities and low-income families and should be a focus for future research in the UK. Crucially
this review highlights an evidence gap and important need for longer-term studies to investigate the risk
factors for out-of-hospital outcomes after surgery separately from in-hospital outcomes. Such evidence
would better inform postdischarge care and community-based interventions to improve long-term survival
and quality of life of infants with CHDs.
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Chapter 3 A systematic review of non-invasive
interventions for infants discharged from hospital
after major surgery for congenital anomalies
Introduction
The purpose of this systematic review was to identify and evaluate the effectiveness of non-invasive
interventions, both in and out of hospital, aimed at reducing adverse outcomes when children are
discharged home following major surgery for congenital anomalies. Although the options for intervention
during hospital admissions for surgery and associated early outcomes are reasonably well understood in
this patient population, less is known about non-invasive interventions such as education, training and
home monitoring, which are used in preparation for discharge from hospital and post discharge outside
the hospital setting. We elected to broaden our systematic review beyond the specific patient group of
interest, to incorporate all studies related to major surgery for congenital anomalies, as we considered
the possibility of translatable knowledge between this wider area of practice and the postdischarge
management of babies undergoing surgery for CHD. Information about the range and effectiveness of
treatment packages available is critical to the development of interventions that could reduce out-of-hospital
mortality rates and preventable unplanned readmission in these vulnerable children.
Methods
Protocol and registration
The protocol for this review is registered with the International Prospective Register of Systematic Reviews
(PROSPERO) CRD42013003484.51
Search strategy
Electronic databases
Electronic database searches were carried out on 8 March 2013. MEDLINE (1980 to March 2013), EMBASE
(1980 to March 2013), CINAHL (1981 to March 2013), The Cochrane Library (1999 to 1 February 2013),
Web of Knowledge (1980 to March 2013) and PsycINFO (1980 to March 2013) databases were searched
using the search strategy detailed in Appendix 3.
Reference checking
A forward citation search was carried out on the reference lists of all selected studies to identify additional
published studies for review.
Hand searching of specialist conference abstracts from the Association for European Paediatric Cardiology
and the American Heart Association was also undertaken for the period of 2008–12.
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Selection of studies
Eligibility criteria
Studies published between January 1980 and 8 March 2013 were included. Major surgery was defined as
surgery requiring intensive or high-dependency care in the postoperative period and studies were eligible
for inclusion only if they reported outcomes for children who were discharged from hospital separately
from in-hospital surgical outcomes. To ensure relevance to neonatal and infant survival, only studies
involving children from birth up to the age of 5 years were included in the review. Box 2 includes the list
of criteria.
Titles and abstracts for all studies were scanned by two reviewers (J Tregay and J Wray) against the
eligibility criteria. Full-text articles of studies meeting eligibility criteria were independently assessed by three
authors (J Tregay, K Brown and R Knowles) to determine whether or not they met criteria for inclusion.
Discrepancies between reviewers were resolved through discussion with a fourth reviewer (J Wray).
Data extraction
Data extraction was independently completed by two reviewers (J Tregay and K Brown) and included
information on study design, population, diagnosis, comparison groups, outcomes and the
intervention characteristics.
BOX 2 Summary of the eligibility criteria for inclusion in the review
Inclusion criteria
Studies that include children:
l aged from birth up to 5 years of age
l with a life-threatening congenital abnormality
l who have undergone major surgery (involving intensive care) for potentially life-threatening
congenital disease
l who were discharged home from hospital following their successful surgery.
Exclusion criteria
Studies that:
l refer exclusively to adults, children over the age of 5 years or for which the group of interest is not
clearly defined
l have no abstract or for which the abstract was not available in English
l include previously healthy children who had major surgery as a consequence of traumatic injury
l do not refer to adverse outcomes (e.g. death or unplanned hospital readmission)
l included children discharged home after surgery on a palliative care pathway
l do not refer to an intervention or for which the intervention was invasive
l do not have a control group.
The following were also excluded from the review:
l single case studies and case series of fewer than 20 cases
l personal communications, letters and commentaries.
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Quality assessment
Two reviewers (J Tregay and K Brown) assessed the methodological quality of studies included for review.
Studies were assessed on the basis of study design using levels of evidence (LOEs) rated from 1 to 4; with
more rigorous study designs, for example randomised control trials, given a rating of 1 and the least
rigorous, such as case series, given a rating of 4. Studies within each LOE were assessed as A (high quality)
to C (lowest quality), dependent upon predetermined criteria such as confounding, completeness or
follow-up and objective measurement of outcomes (see Appendix 2).
Data analysis
Data were not combined in a meta-analysis and are presented below in a qualitative synthesis.
This approach to analysis was selected given the small number of studies found and their methodological
quality. Studies were qualitatively reviewed by two researchers (K Brown and J Tregay) attempting to
answer the following questions:
1. What were the constituents of the interventions described in terms of inclusion criteria and
protocols deployed?
2. Was there evidence in respect of treatment effect: what outcome measures have been used and were
there any important biases?
3. Do any important limitations, concerns or constraints exist when considering wider application of the
intervention described?
Results
Presentation of results
Studies included in the review are summarised in Tables 3–6. Table 3 contains information about study
quality; Table 4 provides a comparison between monitored patients and historical control patients in each
of the studies; and Tables 5 and 6 summarise the protocols for the interventions concerned and their
outcomes. Studies conducted by the same research group using the same patients are combined together
for presentation in the tables.
TABLE 3 Summary of study quality by levels of evidencea
First author, year
LOE
LOE 1 LOE 2 LOE 3
Study quality A B C A B C A B C
Dobrolet, 201152 ✓
Ghanayem, 200315 ✓
Ghanayem, 200453 ✓
Ghanayem, 200654 ✓
Hansen, 201255 ✓
Husain, 201256 ✓
Petit, 201157 ✓
Srinivasan, 200958 ✓
a Rated A (high quality) to C (low quality).
DOI: 10.3310/hsdr04190 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 19
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Brown et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
19
TA
B
LE
4
C
o
m
p
ar
is
o
n
b
et
w
ee
n
m
o
n
it
o
re
d
p
at
ie
n
ts
an
d
re
tr
o
sp
ec
ti
ve
co
n
tr
o
l
p
at
ie
n
ts
Fi
rs
t
au
th
o
r,
ye
ar
Pa
ti
en
t
g
ro
u
p
D
at
a
co
lle
ct
io
n
p
er
io
d
Pa
ti
en
t
d
ia
g
n
o
se
s
Su
rg
ic
al
er
a
A
g
e
at
fi
rs
t
su
rg
er
y
in
d
ay
s
(r
an
g
ea
)
M
ed
ia
n
w
ei
g
h
t
at
fi
rs
t
su
rg
er
y
in
ki
lo
g
ra
m
s
(r
an
g
ea
)
N
o
rw
o
o
d
ty
p
e
su
rg
er
y:
%
R
V
PA
ve
rs
u
s
%
M
B
TS
M
ed
ia
n
ag
e
at
d
is
ch
ar
g
e:
en
tr
y
in
to
H
M
P
in
d
ay
s
(r
an
g
ea
)
M
ed
ia
n
ag
e
at
se
co
n
d
-s
ta
g
e
su
rg
er
y
(r
an
g
ea
)
D
ob
ro
le
t,
20
11
52
In
te
rv
en
tio
n
gr
ou
p
Ja
nu
ar
y
20
02
–
Ja
nu
ar
y
20
10
19
H
LH
S
+
40
SV
Ja
nu
ar
y
20
06
–
Ja
nu
ar
y
20
10
5
(±
1)
b
Bi
rt
hw
ei
gh
t
3.
2
(±
0.
1)
N
ot
st
at
ed
39
b
–
C
on
tr
ol
gr
ou
p
36
H
LH
S
+
68
SV
Ja
nu
ar
y
20
02
–
D
ec
em
be
r
20
05
12
(±
2)
b
–
N
ot
st
at
ed
42
b
–
H
an
se
n,
20
12
55
In
te
rv
en
tio
n
gr
ou
p
Ja
nu
ar
y
19
96
–
Se
pt
em
be
r
20
09
45
H
LH
S
O
ct
ob
er
20
05
–
Se
pt
em
be
r
20
09
5
(3
–
29
)b
3.
3
(±
0.
5)
3%
RV
PA
,
97
%
M
BT
S
42
(2
6–
76
)
10
2
da
ys
(6
7–
29
9
da
ys
)b
C
on
tr
ol
gr
ou
p
97
H
LH
S
Ja
nu
ar
y
19
96
–
O
ct
ob
er
20
05
7
(1
–
52
)b
3.
26
(±
0.
58
)
1%
RV
PA
,
99
%
M
BT
S
41
(9
–
18
5)
15
2
da
ys
(7
7–
13
72
da
ys
)b
N
ot
di
sc
ha
rg
ed
20
H
LH
S
Ja
nu
ar
y
19
96
–
Se
pt
em
be
r
20
09
7.
0
(4
–
47
)b
3.
19
±
0.
55
10
0%
M
BT
S
N
/A
77
da
ys
(3
4–
20
7
da
ys
)
H
us
ai
n,
20
12
56
In
te
rv
en
tio
n
gr
ou
p
20
06
–
11
24
H
LH
S
20
08
–
11
–
–
H
yb
rid
–
17
6
da
ys
C
on
tr
ol
gr
ou
p
27
H
LH
S
20
06
–
8
–
–
H
yb
rid
–
16
8
da
ys
G
ha
na
ye
m
,
20
03
15
/
20
04
53
/2
00
65
4
In
te
rv
en
tio
n
gr
ou
p
Ju
ly
19
96
–
O
ct
ob
er
20
04
70
H
LH
S
Se
pt
em
be
r
20
00
–
O
ct
ob
er
20
04
M
at
ch
ed
in
20
03
pa
pe
r
M
at
ch
ed
in
20
03
pa
pe
r
M
BT
S
on
ly
is
m
en
tio
ne
d
37
.4
ap
pr
ox
im
at
el
y
(2
00
3)
4.
2
m
on
th
s
(±
1.
4
m
on
th
s)
b
C
on
tr
ol
gr
ou
p
54
H
LH
S
Ju
ly
19
96
–
Se
pt
em
be
r
20
00
M
at
ch
ed
in
20
03
pa
pe
r
M
at
ch
ed
in
20
03
pa
pe
r
M
BT
S
on
ly
is
m
en
tio
ne
d
43
.1
ap
pr
ox
im
at
el
y
(2
00
3)
5.
6
m
on
th
s
(±
2.
1
m
on
th
s)
b
Pe
tit
,
20
11
57
In
te
rv
en
tio
n
gr
ou
p
Ja
nu
ar
y
20
02
–
Ja
nu
ar
y
20
10
88
of
w
hi
ch
49
H
LH
S
Se
pt
em
be
r
20
07
–
Ja
nu
ar
y
20
10
8.
5
±
6.
6b
3.
09
±
0.
51
24
%
RV
PA
,
64
%
M
BT
S
37
.5
±
19
15
7
da
ys
(±
49
.4
da
ys
)b
C
on
tr
ol
gr
ou
p
11
6,
of
w
hi
ch
82
H
LH
S
Ja
nu
ar
y
20
02
–
A
ug
us
t
20
07
13
.8
±
12
.4
b
3.
17
±
0.
66
1%
RV
PA
,
99
%
M
BT
S
43
.8
±
30
22
1
da
ys
(±
11
2
da
ys
)b
Sr
in
iv
as
an
,
20
09
58
In
te
rv
en
tio
n
gr
ou
p
20
01
–
7
38
H
LH
S
20
05
–
7
6
(2
–
64
)
3.
3
(2
3
–
4.
3)
70
%
RV
PA
,
30
%
M
BT
S
–
15
3
da
ys
(7
1–
32
5
da
ys
)b
C
on
tr
ol
gr
ou
p
28
H
LH
S
20
01
–
4
10
(3
–
21
8)
3.
2
(2
.0
–
5.
7)
58
%
RV
PA
,
42
%
M
BT
S
–
20
6
da
ys
(1
02
–
44
1
da
ys
)b
a
D
at
a
pr
es
en
te
d
as
in
th
e
or
ig
in
al
m
an
us
cr
ip
ts
.
b
Si
gn
ifi
ca
nt
di
ff
er
en
ce
(p
>
0.
05
).
W
he
n
th
e
da
ta
ar
e
no
t
av
ai
la
bl
e
th
is
is
de
no
te
d
by
–
.
A SYSTEMATIC REVIEW OF NON-INVASIVE INTERVENTIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
20
TA
B
LE
5
C
o
n
te
n
t
o
f
H
M
Ps
Fi
rs
t
au
th
o
r,
ye
ar
D
at
a
co
lle
ct
io
n
p
er
io
d
Pa
re
n
t
ed
u
ca
ti
o
n
D
ai
ly
O
2
sa
tu
ra
ti
o
n
D
ai
ly
w
ei
g
h
t
D
ai
ly
fl
u
id
in
ta
ke
Fe
ed
in
g
in
te
rv
en
ti
o
n
?
B
re
ac
h
cr
it
er
ia
/p
ro
to
co
l
H
o
w
m
o
n
it
o
re
d
D
ob
ro
le
t,
20
11
52
Ja
nu
ar
y
20
06
–
Ja
nu
ar
y
20
10
✓
✓
✓
–
Fe
ed
in
g
pr
ot
oc
ol
Y
es
,
bu
t
no
t
sp
ec
ifi
ed
W
ee
kl
y
te
le
ph
on
e
ca
ll
fr
om
a
nu
rs
e
pr
ac
tit
io
ne
r
H
an
se
n,
20
12
55
Ja
nu
ar
y
19
96
–
Se
pt
em
be
r
20
09
✓
✓
✓
✓
N
o
tu
be
fe
ed
in
g
at
di
sc
ha
rg
e
Sa
tu
ra
tio
n
<
75
%
W
ee
kl
y
te
le
ph
on
e
ca
ll
fr
om
a
ca
rd
io
lo
gi
st
W
ei
gh
t
ga
in
<
20
g
in
3
da
ys
W
ei
gh
t
lo
ss
of
>
30
g
in
1
da
y
H
us
ai
n,
20
12
56
20
06
–
11
–
✓
✓
–
–
Y
es
,
bu
t
no
t
sp
ec
ifi
ed
W
ee
kl
y
te
le
ph
on
e
ca
ll
fr
om
a
nu
rs
e
pr
ac
tit
io
ne
r
G
ha
na
ye
m
,
20
03
15
/
20
04
53
/2
00
65
4
Ju
ly
19
96
–
O
ct
ob
er
20
04
✓
✓
✓
–
25
%
ha
d
ga
st
ro
st
om
y
Sa
tu
ra
tio
n
<
75
%
or
ac
ut
el
y
re
du
ce
d
Pa
re
nt
s
ca
ll
sp
ec
ia
lis
t
ce
nt
re
if
cr
ite
ria
ar
e
br
ea
ch
ed
W
ei
gh
t
lo
ss
of
30
g
Fa
ilu
re
to
ga
in
w
ei
gh
t
of
20
g
ov
er
3
da
ys
Pe
tit
,
20
11
57
Ja
nu
ar
y
20
02
–
Ja
nu
ar
y
20
10
✓
✓
✓
–
Fe
ed
in
g
in
te
rv
en
tio
n
in
cl
ud
in
g
ga
st
ro
st
om
y
an
d
nu
tr
iti
on
is
t
Sa
tu
ra
tio
n
<
75
%
W
ee
kl
y
te
le
ph
on
e
ca
ll
fr
om
nu
rs
e
pr
ac
tit
io
ne
r;
m
ul
tid
is
ci
pl
in
ar
y
te
am
m
ee
tin
g
×
1
pe
r
w
ee
k
Fa
ilu
re
to
ga
in
w
ei
gh
t
fo
r
3
da
ys
Sr
in
iv
as
an
,
20
09
58
20
01
–
7
✓
✓
✓
–
80
%
ha
d
ga
st
ro
st
om
y
Sa
tu
ra
tio
n
<
75
%
or
ac
ut
el
y
re
du
ce
d
Pa
re
nt
s
ca
ll
sp
ec
ia
lis
t
ce
nt
re
if
cr
ite
ria
ar
e
br
ea
ch
ed
W
ei
gh
t
lo
ss
of
30
g
Fa
ilu
re
to
ga
in
w
ei
gh
t
of
20
g
ov
er
3
da
ys
W
he
n
th
e
da
ta
ar
e
no
t
av
ai
la
bl
e
th
is
is
de
no
te
d
by
–
.
DOI: 10.3310/hsdr04190 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 19
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Brown et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
21
TA
B
LE
6
H
o
m
e
m
o
n
it
o
ri
n
g
p
ro
g
ra
m
m
es
an
d
o
u
tc
o
m
es
Fi
rs
t
au
th
o
r,
ye
ar
D
at
a
co
lle
ct
io
n
p
er
io
d
Pa
ti
en
ts
B
re
ac
h
%
O
u
tc
o
m
es
,
n
o
te
d
w
h
er
e
si
g
n
if
ic
an
t
d
if
fe
re
n
ce
b
et
w
ee
n
g
ro
u
p
s
p
<
0.
05
Ea
rl
ie
r
st
ag
e
2
su
rg
er
y
D
et
ec
ti
o
n
o
f
re
si
d
u
al
le
si
o
n
s
Im
p
ro
ve
m
en
ts
in
w
ei
g
h
t
g
ai
n
Im
p
ro
ve
d
in
te
rs
ta
g
e
m
o
rt
al
it
y
(%
H
M
P
vs
.%
co
n
tr
o
l)
Im
p
ro
ve
d
lo
n
g
er
-t
er
m
su
rv
iv
al
w
it
h
H
M
P
D
ob
ro
le
t,
20
11
52
Ja
nu
ar
y
20
06
–
Ja
nu
ar
y
20
10
54
H
LH
S
+
ot
he
r
SV
;
10
4
hi
st
or
ic
co
nt
ro
l
pa
tie
nt
s
–
–
✓
–
Y
es
(2
.5
%
vs
.
7%
)
–
H
an
se
n,
20
12
55
Ja
nu
ar
y
19
96
–
Se
pt
em
be
r
20
09
45
H
LH
S;
97
hi
st
or
ic
co
nt
ro
lp
at
ie
nt
s
31
✓
–
✓
Y
es
(2
.5
%
vs
.1
2.
4%
)
–
H
us
ai
n,
20
12
56
20
06
–
11
24
H
LH
S;
27
hi
st
or
ic
co
nt
ro
lp
at
ie
nt
s
62
.5
–
–
✓
N
o
(2
1%
vs
.
26
%
)
–
G
ha
na
ye
m
,
20
03
15
/
20
04
53
/2
00
65
4
Ju
ly
19
96
–
O
ct
ob
er
20
04
70
H
LH
S;
54
hi
st
or
ic
co
nt
ro
lp
at
ie
nt
s
57
✓
–
–
Y
es
(1
%
vs
.1
5.
5%
)
A
ct
ua
ria
ls
ur
vi
va
l
Pe
tit
,
20
11
57
Ja
nu
ar
y
20
02
–
Ja
nu
ar
y
20
10
88
H
LH
S
+
ot
he
r
SV
;
11
6
hi
st
or
ic
co
nt
ro
l
pa
tie
nt
s
–
✓
–
✓
N
o
(8
%
vs
.1
2%
)
1-
ye
ar
su
rv
iv
al
Sr
in
iv
as
an
,
20
09
58
20
01
–
7
38
H
LH
S;
28
hi
st
or
ic
co
nt
ro
lp
at
ie
nt
s
–
–
–
–
N
o
(1
0%
vs
.1
2%
)
Su
rv
iv
al
to
st
ag
e
2
W
he
n
th
e
da
ta
ar
e
no
t
av
ai
la
bl
e
th
is
is
de
no
te
d
by
–
.
A SYSTEMATIC REVIEW OF NON-INVASIVE INTERVENTIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
Studies selected
Title and abstract screening identified 20 studies for potential inclusion in the review. A further four studies
were identified through forward citations. Following full-text screening of these 24 studies, 16 studies did
not meet eligibility criteria and were excluded, leaving a total of eight studies for inclusion in the review
(Figure 3).
Methodological quality
Eligible studies were all prospective cohort studies using retrospective historic controls and were of fair to
good quality (rated A or B; see Table 3). Typically, controls were drawn from the time period immediately
preceding introduction of the intervention.
Study populations
Despite a broad search strategy designed to encompass a range of congenital conditions requiring surgery,
all studies (eight studies from six research groups) that were eligible for inclusion related to patients with
CHD, specifically SV diagnoses, such as HLHS. HLHS is complex congenital heart defect necessitating a
series of palliative surgical procedures to sustain life, including two in the first year. Infants undergoing
these palliative procedures remain fragile, with mortality between their first and second operations a
recognised complication for a range of reasons, many of which relate to the underlying heart disease30,35
becoming more stable after the second-stage operation.
Records identified
through database searches
(n = 3060)
Records after 
duplicates and references
before 1980 removed
(n = 2308)
Records screened
(title and abstract)
(n = 2308)
(n = 20)
Studies included 
for review
(n = 8)
Full-text articles
assessed for eligibility
(n = 24)
Forward citations met
criteria (title and abstract)
(n = 4)
Records excluded
(n = 2288)
Records excluded by group consensus
(n = 16)
• No data, for example reviews, n = 4
• No control group, n = 4
• No intervention, n = 1
• Outcome not mortality or unplanned 
   readmission, n = 3
• Abstract only/insufficient data, n = 4
FIGURE 3 Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) flow chart showing study
selection process.
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The terminology used to describe diagnoses and operative procedures differed slightly between studies:
this information is summarised in Table 4, which indicates that four of the research groups studied infants
with diagnoses of predominantly HLHS and other related lesions that went down the pathway of a
Norwood type stage 1 operation with either MBTS or RVPA15,53–55,58 or a hybrid procedure56 (the hybrid
approach is a more recently developed treatment pathway applicable to HLHS and related conditions,
which incorporates a series of palliative procedures involving both surgery and interventional cardiology or
catheterisation), and two of the research groups studied both infants with HLHS type diagnoses who
underwent a Norwood type stage 1 operation and infants with other SV diagnoses who underwent an
appropriate operation based on diagnosis including isolated MBTS, Damus–Kaye–Stansel repair and
pulmonary artery banding.52,57 Five of six research groups were from the USA and one was from Germany.
Comparison between monitored patients and control patients
All patients in HMP groups were compared with historical control patients, typically taken from the period
immediately prior to the commencement of the HMP under evaluation (see Table 4). This means that the
studies under review are covering the surgical period between 1996 and 2009, with the shortest period of
time between the first historical control patient and the last patient to be included in the HMP being 5 years
in the study of infants undergoing the hybrid procedure56 and the longest being 13 years in the study from
Germany.55 There appeared to be a trend in practice towards slightly younger age at initial palliative
operation by era across the studies, leaving the patients in the historic control groups slightly older at
surgery and at discharge than the patients in the more recently recruited HMP group.
Intervention types
All studies meeting criteria for inclusion involved the evaluation of HMPs, which represent detailed
protocols for management from hospital discharge (details in Home monitoring programmes) aiming to
enhance patient supervision and respond early to any deterioration. No studies involving any other
intervention types focusing on the post-hospital discharge period were identified as meeting inclusion
criteria; however, in one study58 home monitoring was only one component of a broader protocol-based
intervention that began in hospital prior to surgery. In this study, Srinivasan et al.58 detail a standardised
management protocol for the treatment and follow-up of infants undergoing the Norwood procedure,
a complex surgical intervention for patients with SV congenital heart diagnoses incorporating all aspects of
in-hospital and early post-hospital management including a HMP.
Home monitoring programmes
Although information about the content of the monitoring was inconsistently reported across studies,
it was clear that all HMP included daily oxygen saturation and weight monitoring with the use of ‘breach
criteria’ as detailed first by Ghanayem in 2003:15 see Table 5 for details.
l All studies excepting one, which was a briefer conference abstract,56 explicitly mentioned parent
education as a component of the HMP. This education typically involved giving information about how
to operate any monitoring equipment, feeding, medications and signs and symptoms including ‘breach
criteria’. The way in which this information was given to families was not always specified but may
have involved different approaches. One study52 described a comprehensive written guideline outlining
when to contact their cardiologist or high-risk team in addition to a ‘medical passport’ which included
information about their child’s anatomy, surgical procedures and expected oxygen saturations. In the
same study parental empowerment to initiate contact with HPs is highlighted as a key factor. In another
study,55 parent education involved one night of ‘rooming in’ with their baby for at least 24 hours in
order to learn how to operate the vital sign monitor they were to use to monitor their child at home.
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Despite similarities in the content of monitoring and ‘breach criteria’, the studies differed in respect of:
l Feeding, which in particular was approached very differently across the studies. Gastrostomy was
explicitly mentioned as being a primary strategy for feeding at home for infants with feeding difficulties
by three research groups across four studies,53,54,57,58 with uptake of gastrostomy as high as 80% in
one study.58 One study52 incorporated a postdischarge feeding protocol concerning the type of formula
and target intake, and another involved a feeding team to oversee this aspect.57 In contrast to these
US-based studies, the German study55 specified that infants should meet home surveillance criteria,
which included the ability to feed without tube supplementation for at least 1 week prior to discharge:
12% of patients remained in hospital interstage because they did not achieve this milestone.
l The approach to contact post discharge: infants were typically monitored by the specialist paediatric
cardiac centre by way of both routine follow-up appointments and weekly telephone calls from either a
nurse practitioner52,56,57 or a cardiologist.55 In two studies, details of the specialist centre follow-up were
not reported, although parents were instructed to telephone the centre if criteria were breached.53,58
In one study, a multidisciplinary team met weekly to review all patients on the HMP.57 This team
consisted of six paediatric cardiologists, six nurse practitioners, a social worker, a nutritionist and a
developmental paediatrician. The same study noted increased resource use in terms of clinic visits and
hospital admissions in the HMP group.
Outcomes
All studies reported a degree of positive effect linked to HMP:
l Three research groups reported reduced interstage mortality rates in monitored patients versus control
patients.53,55,56 Two studies reported improved initial survival after stage 1 surgery, a non-significant
difference (trend to improvement with HMP) in interstage outcome and improved survival at 1 year.57,58
The latest study by Ghanayem et al.54 reported improved actuarial survival with HMP in addition to
reduced interstage mortality. Interestingly, the only study including patients that underwent a hybrid
procedure reports the highest interstage mortality and the highest rate of breaches in both HMP and
control groups (non-significant trend towards improvement with HMP).56
l The three research groups which included data on age at stage 2 operations reported that stage 2
surgery was performed at a younger age in monitored patients than in control patients;15,53–55,57 two of
the relevant research groups noted that the earlier, and in their view more optimal, patient-specific
timing of stage 2 operations was linked to a reduction in interstage mortality.53,55
l Three studies reported that monitored patients showed improvements in weight gain relative to
control patients.55–57
l Three studies reported the statistics for breaches of the HMP: these occurred in 31%,55 57%15,53,54 and
62.5%56 of patients (most commonly desaturation) with interventions being enabled for the patients
concerned potentially in a more timely manner. One study noted that HMP enabled the timely
detection of residual lesions, which could then be treated.52 The study reporting interstage emergency
admissions in patients from the control groups (notably the study on hybrid patients) stated that the
number of readmissions was similar in the HMP and control groups;56 however, comparisons between
the HMP and the control groups are difficult in this regard because control participants did not have
breach criteria.
Discussion
The systematic review aimed to identify and evaluate postdischarge interventions for infants following
major congenital surgery. Despite using a search strategy designed to encompass all congenital
abnormalities requiring surgery, only eight studies from six research groups relating to HMP for infants
with CHD diagnoses (HLHS and SV) met criteria for inclusion in the review. There was a paucity of such
studies based in Europe and, notably, none was from the UK. The included studies shared similarities
in terms of the HMP deployed in that all of them involved standardisation of discharge and follow-up
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processes including the designation of professionals responsible for this, parental education, and enhanced
patient monitoring including regular measurement of weights and saturations. It was noted in a recent
review of HMP that, since the causes of interstage death in these infants are multifactorial, a single
intervention on one aspect of care is unlikely to help hence favouring a package of care.59
Outcomes with home monitoring programme
All studies reported benefit in terms of outcome; however, comparisons between patient groups were
based on historic control patients in an era during which outcomes for children with CHD have
improved.3,60 Although it seems likely that interventions such as HMP have contributed to improved
long-term outcomes over the era in which these have been introduced, the lack of randomised studies
means that this cannot be confirmed.
The mortality rate at 1 year is an outcome measure that offsets the effect of earlier stage 2 surgeries in the
context of HMP, and hence a shortened period of interstage follow-up, which is a bias to consider when
the reduced interstage mortality rate is presented as a primary outcome measure. Three of the research
groups presented evidence for improved longer-term survival (to stage 2 in the form of competing hazards
over time,58 to 1 year57 and actuarial survival54) in the context of HMP; however, two of the research
groups attributed these improvements to the whole patient pathway, in particular immediate post-stage 1
outcomes. These two studies57,58 found non-significant reductions in interstage mortality with HMP; given
that these are single-centre studies involving a maximum of 204 patients, and that mortality in the control
group was 12% in each case, studies may be underpowered unless there is very large drop in interstage
mortality in the HMP group.
Specific patient types
Hypoplastic left heart syndrome
Three of the study populations in the review (in five of the papers15,53–55,58) were infants with HLHS-type
conditions being managed using the Norwood pathway, among whom the interstage mortality rate,
in the absence of a HMP, has been reported as between 10% and 14%.35 Additional informative data
on interstage mortality in HLHS come from the SVR trial, which is a large North American multicentre
randomised trial of 426 patients comparing surgical techniques (MBTS vs. RVPA) for the stage 1 operation,
in which the interstage mortality was 12% in 2012.26 Although HMP is reportedly widely accepted as the
standard practice for patients post Norwood operation in the USA, the protocols for HMP may vary.61 The
SVR trial data indicate that in the North American population concerned, interstage death rates also vary
depending on the surgical approach for stage 1 operation (see Table 2; MBTS is higher risk than RVPA),
specific cardiac risk factors, prematurity, ethnicity and deprivation (see Chapter 2). Among the eight studies
reviewed, the surgical approach to stage 1 was reportedly broadly similar in HMP and control groups;
however, from the presented data it is not possible to be sure that other important patient factors did not
differ between groups. That said, the data do support the benefit of HMP for HLHS-type conditions.
Other types of functionally univentricular heart (not hypoplastic left
heart syndrome)
Two of the included study populations52,57 were a mixture of infants with HLHS and other SV diagnoses
who underwent, for example, MBTS procedure or pulmonary artery banding only, and hence the
interstage mortality may have been influenced by a slightly lower average patient complexity. One of these
studies reported the lowest interstage mortality for the control group at 7%, although with a HMP this
was significantly reduced, to 2%.52 SV infants undoubtedly suffer interstage mortality without HMP, as
evidenced by the control groups in the included two studies52,57 and other reports of interstage mortality in
SV infants without HMP which may be as high as 10%.62 Although suggestive of benefit, there are fewer
data available on HMP for SV infants who are not on a Norwood pathway (two studies in the review that
also contained HLHS patients compared with five studies devoted to HLHS patients). SV patients have a
diverse range of diagnoses and undergo several different surgical pathways depending on what is
appropriate for the individual patient; this is a further challenge in terms of evaluating the issue.
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Hybrid patients
To date the information on infants with a hybrid circulation in terms of benefit from HMP is very limited,
comprising only one conference abstract56 (included in this review), which, as discussed in Outcomes,
showed the worst patient outcomes in both HMP and control groups (see Table 6). Intuitively, infants with
hybrid circulations are as vulnerable as, if not more vulnerable than, infants with a Norwood circulation,
and hence it would be difficult to exclude them from HMP if advocating this for Norwood infants.
Practical and resource implications
The included studies indicated that HMPs involve the commitment of considerable dedicated resources; for
example, one study reported that a multidisciplinary team comprising six paediatric cardiologists as well as
several other professionals met weekly to discuss patients.57 In addition, studies noted that the burden
in terms of clinical visits and other patient contacts was increased with HMP. However, conversely,
information about the health-care costs of infants who deteriorate in the absence of surveillance, and for
example who require intensive interstage care, is lacking. Interestingly, the use of gastrostomy to provide
feeding assistance in SV infants and infants with HLHS appears to be higher in the USA than in Europe
(26% of infants in the SVR trial were fed by gastrostomy tube between stages);26 in Europe infants may be
kept in hospital as inpatients because of feeding problems55 or, alternatively, given nasogastric feeding at
home but are very rarely fitted with a gastrostomy tube (personal communication from Dr R Franklin, Royal
Brompton Hospital, and L Smith, Great Ormond Street Hospital, both in London, UK, 2013). These
alternative approaches may have differing resource implications, and a more detailed evaluation of this
aspect is required in order to understand it better.
Studies of interest that did not meet inclusion criteria
Studies that were detected by the search strategy and reviewed as part of the study, but did not meet
inclusion criteria included the following.
Discharge of the high-risk neonate (protocol from USA)
Discharge and follow-up protocols for high-risk infants have been issued by the American Academy of
Pediatrics.16,63,64 These guidelines address the needs of (1) the preterm infant; (2) the infant with special
health-care needs or dependence on technology; (3) the infant at risk because of family issues; and
(4) the infant in whom early death is expected; however, no specific studies were found detailing the
implementation or effectiveness of these guidelines.
Telecardiology
One study65 described the use of novel methods, including ‘telecardiology’, for surveillance of high-risk
infants in a low-resource rural setting. ‘Telecardiology’ was found to be a successful method of obtaining
a diagnosis in infants with CHD. In another study, ‘telecardiology’ was used to aid follow-up in
developed-world setting, including in a rural population.66 However, these studies did not report data on
the effectiveness of use of these methods in a post-procedural context and hence did not meet inclusion
criteria for the review.
Conclusion
This review set out to describe and evaluate postdischarge interventions for infants who have undergone
major congenital surgery. Surprisingly, only studies involving HMP for infants with CHD (HLHS or SV) met
the criteria for inclusion in the review. The prominence of CHD in this review may be a result of the
relatively high risk of postdischarge morbidity and mortality in these patients, particularly those undergoing
staged palliative procedures. The evidence base for postdischarge interventions in this population would
be strengthened by further prospective studies, such as randomised controlled trials, in patients with
congenital heart disease and those with other complex congenital conditions; studies from research groups
outside the USA; reporting of longer-term outcomes, to at least a year; and more detailed reporting of the
content of intervention programmes and of demographic information such as ethnicity and socioeconomic
status, which are known to be associated with adverse outcomes in paediatric patients with cardiac disease.
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Chapter 4 Development of a risk model for death
or emergency readmission within 1 year following
hospital discharge from infant cardiac intervention for
congenital heart disease and identification of patient
risk groups for the purposes of service improvement
Some of the text of this chapter has been published previously as Crowe et al., 2016.67 © 2016 TheAuthors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an
open access article under the terms of the Creative Commons Attribution‐Non Commercial License, which
permits use, distribution and reproduction in any medium, provided the original work is properly cited and
is not used for commercial purposes.
Introduction
The main focus for the audit of paediatric cardiac surgery outcomes in registries or multi-institutional databases
to date has been operative mortality, expressed as either 30-day11 or discharge outcome.68 These early mortality
outcomes have improved over time to the current, historically low, levels.4 However, although important, these
outcome measures are relatively limited in scope, and longer-term measures of outcome and metrics such as
morbidity or complications are also essential to consider in quality assurance and improvement. A challenge for
the audit of longer-term events for patients with CHD at a population level, in national or international
registries outside the UK, such as the European Association of Cardiac Surgery database and the Society of
Thoracic and Cardiovascular Surgery database in North America, is the reliable capture of appropriate data.
The UK has a unique resource in mandatory national audit data sets for both paediatric cardiac procedures,
represented by NCHDA,69 and paediatric intensive care unit (PICU) admissions, represented by PICANet,70 as
well as life status tracking that enables late deaths to be reliably and independently ascertained. In respect of
life status ascertainment, the NCHDA submits regular requests to the Central Register of NHS patients, as
approved by the National Health Research Authority, in order to ascertain the survival or life status of patients.
This information is reliably forthcoming for all patients possessing an NHS number who are based in England
and Wales. Unfortunately, life status tracking is not currently available in Scotland or in Northern Ireland, where
the two relevant specialist centres are responsible for ascertaining the life status of their own patients.
These UK national audit data sources enabled a national study addressing the following aims.
l To explore patient-level risk factors for postdischarge death outside a planned PICU admission
(outcome 1) and for postdischarge death or emergency readmission to PICU (outcome 2) in infants
with CHD undergoing interventions in the UK.
l To develop a clinically meaningful classification of patients in terms of the level and nature of their risk
of outcome 2, with a view to informing improvements to the services provided for infants discharged
alive following an initial major intervention for CHD.
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Methods
Constructing the data set for analyses
Data sources and patient population
Data submissions to NCHDA have been mandatory since 2000 for all hospitals performing cardiac surgery
in the UK, with data validated and subject to a quality assurance processes (all hospitals are inspected
annually with local records examined to ensure every case has been submitted and a random sample of
case notes examined to assess data quality).71 All UK PICUs submit data to PICANet, which is also validated
and subject to a quality assurance processes (PICUs receive annual visits from a PICANet team, during
which submitted data are verified against hospital notes and admissions numbers are checked).72
For this study, all children who received their first recorded interventional catheterisation or cardiac surgery
procedure for a congenital heart defect at < 1 year of age and in the period 1 January 2005 to
31 December 2010 were identified by NCHDA. (Data were requested for the period 1 January 2005 to
31 March 2011 but were supplied for the time period specified above because of reporting restrictions
within NCHDA.) In accordance with governance approvals, records within PICANet for these patients were
then identified by a trusted third party by matching of unique patient NHS number. Data extracts fulfilling
these criteria from each audit were provided to the study team as two separate data sets with the same
patient-level identifier (pseudonymised NHS number). A single patient potentially had multiple procedure-
based records in the NCHDA extract and multiple admission-based records in the PICANet extract. A flow
diagram indicating the number of records present for each stage of this process is provided in Appendix 4.
The study team then constructed a single patient-based analysis data set by linking events pertaining to the
same patient within each of the extracts and between the two using the patient-level identifier. This enabled
information from both sources to be used in the analysis, with cardiac-related details and life status available
in NCHDA and rich comorbidity and emergency PICU admission information available in PICANet.
Defining the index admission period and index procedure
The index admission period for each child was defined as the continuous period as an in-patient within
a specialist paediatric cardiac hospital or PICU that started with or included their first surgical or
interventional catheter procedure (see Appendix 5 for the list of procedures and their subgroupings; we
included interventional cardiology procedures applicable to neonates or small infants that are undertaken
with the aim of either primary correction or primary palliation such that a child can be discharged home).
This period defined the index LOS within the specialist hospital (and associated PICU care).
Within the NCHDA data set, each procedure is described by a combination of up to eight individual
procedural International Pediatric and Congenital Cardiac Codes (IPCCCs).73 An algorithm developed by
the NCHDA Steering Committee (which includes experienced paediatric cardiac surgeons and cardiologists)
links the individual IPCCCs for a given record to one of 57 specific procedures, that is recognisable surgical
operations or catheter procedures (see Appendix 5). The algorithm imposes a hierarchy, with the record
assigned the most complex specific procedure consistent with the collection of codes recorded.
Approximately 85% of procedures fall into one of these 57 specific procedures.
As some children undergo more than one procedure within a single index admission period, an individual’s
index procedure was defined by applying the NCHDA-specific procedure hierarchy across all of the
interventions carried out during the index admission. Therefore, the index procedure for each patient was
defined as the most complex (specific) procedure (either surgery or interventional cardiology procedure)
undergone during the index admission period. In a small subset of patients, an interventional catheter
procedure was logged in NCHDA before the index admission. Based on clinical knowledge of the patient
histories the research team considered that these early interventional catheters, which in most case were
balloon atrial septostomy for a neonatal transposition of the great arteries (TGA), should not represent the
index procedure. Instead the index procedure was considered to be an arterial switch operation carried out
during a subsequent admission.
DEVELOPMENT OF A RISK MODEL FOR DEATH OR EMERGENCY READMISSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
Exclusions
Children undergoing an excluded catheter procedure only (see Appendix 5 for the list of catheters included
and excluded; rationale stated above), and therefore without an index admission, were excluded from the
analysis. Premature babies who underwent only ligation of patent ductus arteriosus were also excluded
because, unlike other infants with disease, the majority of these premature infants would have been subject
to discharge and follow-up processes run mainly from neonatal intensive care units. Similarly, transplant
patients have their own specific pathway of care and so were removed from the analysis. Finally, patients
with unknown life status were removed (this included all patients within two UK cardiac units outside
England whose life status was not linked to the NHS Central Register; see comment in Introduction).
Patient variables
Potential risk factors available in the patient-based analysis data set that would be known at the point
of discharge were prespecified and are listed in Table 7, grouped according to whether they were
non-medical, preoperative or postoperative factors. As detailed in the following sections, some variables
were simplified prior to the statistical analyses in order to reduce the number of values (degrees of
freedom) in the model and hence the risk of overfitting (see Harrell et al.76). An appropriate power
calculation was performed. The origin of each risk factor (either the PICANet or the NCHDA data set) is
noted in Table 2, along with whether it relates to the index procedure or index admission period or is a
characteristic of the child. Where both audits contained information on a particular risk factor, the risk
factor was taken from the source that was most descriptive and complete or, in the case of ethnicity, a
combination of the two (see Table 7). Some post-procedural factors originating from different audits
overlap but were considered to provide sufficiently different information to include within multivariate
analyses. In what follows, we briefly describe each of the patient variables considered in the analysis.
Non-medical variables
Deprivation was defined using quintiles of the English Index of Multiple Deprivation (IMD) 2010,74 which is
calculated at the level of small (≈ 1500 people) geographic areas covering England and combines
deprivation indicators across income, employment, health and disability, education skills and training,
barriers to housing and other services, crime and living environment.77
Ethnicity information is recorded in both audits, with NCHDA using a bespoke classification scheme and
PICANet using the Census 2001 classification used by the Office for National Statistics.78 PICANet was
therefore used as the primary source for our ethnicity variable for the purposes of potential comparability
with the Office for National Statistics population statistics, with further collapsing of codes into seven groups
for considerations of model stability: white, mixed, Asian, black, Chinese, other and not stated. The most
frequently recorded ethnic group was assigned to the child if they had multiple admission records.
Preprocedural variables
Cardiac diagnoses and procedural information
Each NCHDA record contains up to six IPCCC diagnostic codes, the combination of which can be mapped
to 1 of 24 primary cardiac diagnoses using a hierarchical scheme developed by Brown et al.75 For the
purposes of this study, this mapping scheme was implemented with two minor adjustments (see Appendix 6
for details). In addition to their overall primary cardiac diagnosis, a child was identified as having an acquired
cardiac diagnosis if any of his or her records included an IPCCC diagnostic code mapping to this category,
for example ventricular dysfunction and ventricular hypoplasia. Some non-cardiac IPCCC diagnostic codes
were identified as post-procedural morbidities (see Non-cardiac diagnosis and comorbidity information and
Appendix 7 for details).
For reasons of model reliability and validity of predictive discrimination (i.e. to reduce the risk of
overfitting), we grouped the diagnostic categories into four cardiac diagnosis groups considered clinically
meaningful to the study focus (see Appendix 6 for mappings, including the relevant references
underpinning our selection of the groupings). The choice of groupings was informed by the literature
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TABLE 7 Descriptions of the prespecified potential risk factors considered in the analysis.a Reproduced from
Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original work
is properly cited and is not used for commercial purposes
Prespecified
potential risk
factor Description Variable level Values
Source
data set
Non-medical
Deprivation Quintiles of the English IMD 201074 as
recorded for the index procedure
Child 1–5 (1 most deprived,
5 least deprived)
NCHDA
Ethnicity Census 2001 classification used by the
Office for National Statistics. If the child
had multiple records, the most frequently
recorded ethnic group was used
Child White, mixed, Asian,
black, Chinese, other,
not stated
PICANet
Preoperative
Cardiac diagnosis
group
Aggregated groupings of the cardiac
diagnosis categories assigned through
application of a modified version of the
hierarchical mapping scheme developed
by Brown et al.75 across all cardiac
records for a child (see Appendix 6)
Child VSD, HLHS, UVH/PA,
other
NCHDA
Acquired cardiac
diagnosis
Assigned if any cardiac record in the
index admission period had an IPCCC
diagnostic code corresponding to the
acquired cardiac diagnosis category
(see Appendix 6)
Index admission Yes, no NCHDA
Specific procedure
group
Aggregated groupings of the index
specific procedures assigned through
application of the NCHDA-specific
procedure hierarchy across all
interventions within the index admission
period (see Appendix 5)
Index procedure Corrective, palliative,
ungrouped
NCHDA
Congenital anomaly Assigned if any PICU record during the
index admission period contained a Read
Code corresponding to the congenital
anomaly category (see Appendix 6)
Index admission Yes, no PICANet
Neurodevelopment
condition
Assigned if any PICU record during the
index admission period contained a
Read Code corresponding to the
neurodevelopmental category
(see Appendix 6)
Index admission Yes, no PICANet
Prematurity Assigned if any PICU record for the child
contained a Read Code corresponding
to prematurity or preterm birth
(see Appendix 6)
Child Yes, no, missing PICANet
Sex Most frequently occurring sex across all
cardiac records for a patient (or sex at
index procedure if tied)
Child Male, female NCHDA
Age at index
procedure
Age recorded in cardiac record for the
index procedure
Index procedure Continuous variable NCHDA
Weight-for-age
z-score
Standardised weight-for-age at index
procedure, calculated from index
procedure weight and age using World
Health Organization reference standards
Index procedure Continuous variable NCHDA
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TABLE 7 Descriptions of the prespecified potential risk factors considered in the analysis.a Reproduced from
Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original work
is properly cited and is not used for commercial purposes (continued )
Prespecified
potential risk
factor Description Variable level Values
Source
data set
Antenatal diagnosis Assigned if coded in any cardiac record
for the child
Child Yes, no, missing NCHDA
Clinical deterioration Assigned if any PICU admissions prior to
discharge from the index admission were
urgent and unplanned
Index admission Yes, no PICANet
Postoperative
LOS The length in days of the continuous
period as an in-patient within a specialist
paediatric cardiac hospital or PICU that
surrounds a child’s first interventional
cardiac procedure in infancy
Index admission Continuous variable NCHDA
and
PICANet
Additional surgical
procedures
Assigned if any surgical procedures were
performed during the index admission in
addition to the index procedure
Index admission Yes, no NCHDA
Additional catheter
procedures
Assigned if any catheter procedures were
performed during the index admission in
addition to the index procedure
Index admission Yes, no NCHDA
Need for renal
support
Assigned if any PICU record within the
index admission period indicated renal
support was required (including dialysis
and haemofiltration)
Index admission Yes, no, missing PICANet
Need for ECMO Assigned if any PICU record within the
index admission period indicated ECMO
support was required
Index admission Yes, no, missing PICANet
Acquired
comorbidity
Assigned if any PICU record during the
index admission period contained a Read
Code identified as an acquired condition
(categories 1–8 in Appendix 7)
Index admission Yes, no, missing PICANet
Events in PICU Assigned if any PICU record during the
index admission period contained a Read
Code corresponding to collapse or
cardiac arrest, acquired injury or
complications, or a non-cardiac operation
in PICU (categories 9–11 in Appendix 7)
Index admission Yes, no, missing PICANet
Post-operative
morbidity
Assigned if any cardiac record during the
index admission period contained
an IPCCC code identified as a
post-procedural morbidity
Index admission Yes, no NCHDA
ECMO, extracorporeal membrane oxygenation.
a The table indicates whether a given variable relates to the index procedure, index admission period or is a characteristic
of the child; the possible values of the variable; and its source data set (PICANet or NCHDA). All variables would be
known at the point of discharge and are grouped according to whether it is a non-medical, preoperative or
postoperative factor.
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reviews in that the majority of the included studies referred to HLHS as being at higher risk and of special
interest for late mortality. Other studies, although a smaller number, noted higher risk with other types
of SV conditions and palliated circulations (see procedural groupings that follow):
l HLHS
l functionally univentricular heart (UVH) or pulmonary atresia (PA) (including PA with an intact
ventricular septum)
l ventricular septal defect (VSD)
l ‘other’ (the remaining 22 diagnosis categories).
Alongside this, the index (specific) procedures were aggregated into three procedural groups (see
Appendix 5 for mappings including the relevant references underpinning our selection of the groupings);
again this grouping was based on the findings of the literature review in Chapter 2, which noted a higher
risk in babies with palliated circulations:
l palliative (e.g. Norwood, bidirectional cavopulmonary shunt, arterial shunt)
l corrective [e.g. truncus arteriosus repair, atrioventricular septal defect (AVSD) complete repair,
tetralogy repair]
l ‘ungrouped’ if not a specific procedure.
Non-cardiac diagnosis and comorbidity information
Non-cardiac diagnosis and comorbidity information was primarily sourced from PICANet, in which any
given PICU admission can record up to 24 clinical Read Codes (a clinical coding system used as standard in
general practice in the UK and maintained by the Health and Social Care Information Centre). In total
3325 discrete Read Codes were present in the data set and so to explore the potential for this information
to add discriminatory power to the risk model, we developed a new clinically intuitive scheme linking each
code to at most 1 of 17 system-based categories (see Appendix 7).
If any PICU admission within the index admission period contained a Read Code in the congenital
anomaly category, then the child was assigned this attribute. This included syndromes such as Down and
DiGeorge and non-syndromic congenital anomalies such as urogenital/renal malformations, tracheal/
tracheo-oesophageal malformations, vision/hearing deficits and exomphalos/gastrointestinal malformations.
Similarly, if any Read Code within the index admission period was linked to the neurodevelopmental
category, then the child was assigned this attribute. These comprised a range of acquired and congenital
conditions including epilepsy/seizures, developmental delay, sleep apnoea, hydrocephalus, retinopathy of
prematurity, stroke, hemiparesis/hemiplegia, anoxic encephalopathy, cerebral venous sinus thrombosis and
cerebral palsy. Finally, a child was assigned the attribute of prematurity (< 37 completed weeks’ gestation)
if a Read Code linked to this category appeared within any of his or her recorded PICU admissions.
Additional preprocedural patient variables
Additional preprocedural factors considered on the basis of potential clinical relevance and availability within
the NCHDA data set were patient sex, age at procedure, weight-for-age at procedure (calculated using
World Health Organization reference standards) and whether or not there was an antenatal diagnosis.
From the PICANet data set it was determined if the patient had clinically deteriorated prior to the index
intervention (assigned as such if the index admission or any prior PICU admissions were urgent
and unplanned).
Post-procedural variables
The following post-procedural patient variables known at the point of discharge were considered: LOS for
the index admission period; whether or not any surgical or catheter procedures were performed during the
index admission in addition to the index procedure; whether or not renal support was required during
the index admission (including dialysis and haemofiltration); whether or not extracorporeal membrane
oxygenation (ECMO) support was required during the index admission; whether or not the index admission
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was associated with any intensive care unit events (assigned as such if any admission to PICU during the
index admission period contained a Read Code category for collapse or cardiac arrest, acquired injury or
complications or a non-cardiac operation in PICU); whether or not the index admission was associated with
any acquired comorbidities [assigned if any admission to PICU during the index admission period contained
a Read Code acquired category (1–8 in Appendix 7)]; and whether or not the index admission was
associated with post-procedural morbidity (assigned if any NCHDA record during the index admission
period contained an IPCCC code corresponding to a post-procedural morbidity).
Missing data
When ethnic group was not available from PICANet, the NCHDA ethnic code was used to assign white,
Asian or black ethnicity (which showed strong concordance across the two audits) but not to assign
Chinese, other or mixed ethnicity (which showed poorer concordance). Sensitivity analyses were performed
excluding records without PICANet-derived ethnicity. Index procedure weights recorded as zero
(i.e. missing) were replaced by weight recorded within the same index admission (if available). Weight-for-age
z-scores outside the range ± 5 z-scores were assumed erroneous and treated as missing.
Outcomes
Two nested outcomes of interest were defined.
l Outcome 1: death within 1 year following discharge from the index admission and not during a
planned admission.
l Outcome 2: either death (outside a planned admission) or an emergency unplanned readmission to
PICU within 1 year following discharge from the index admission. Outcome 2 was viewed as including
‘near misses’ for death, given that all patients experiencing emergency intensive care unit admission are
gravely ill. A decision was made to combine deaths and near misses for this section of the analyses in
order to increase the number of events, and to form a useful basis for classification and regression tree
(CART) analysis was used to identify patient groups with different ‘profiles of risk’ that could usefully
inform the development and prioritisation of interventions aimed at improving outcomes within this
patient population.
In order to ascertain these outcomes the following information was used: age at death (if applicable) and life
status, which were available in NCHDA; emergency unplanned admissions to PICU were extracted from
PICANet (defined as admission type ‘unplanned’ or ‘unplanned after surgery’ AND identified as a retrieval from
another unit as an emergency transfer AND not defined as an elective admission). Note that death within
1 year of discharge from index admission that occurred during a planned readmission to intensive care was not
considered an adverse outcome in this analysis designed to inform improvements in postdischarge services.
Statistical methods
Descriptive and univariate analyses
Descriptive analyses were performed to characterise the data set and univariate logistic regression analysis
was used to assess the relationship of each candidate predictor with each outcome using fractional
polynomials to investigate departure from linearity. This informed which variables were considered in two
further, complementary, strands of analysis: the development of risk models for outcomes 1 and 2; and
the identification of patient groups differentiated by risk of outcome 2.
Developing risk models for outcomes 1 and 2
The significant variables from the univariate analysis were investigated in a multivariable model for each
outcome in turn. Initially, models for outcomes 1 and 2 were developed in which the continuous predictors
were used in their original form. For the final model development, however, the continuous predictors
were categorised through a process of discussion between clinicians and analysts influenced by
considerations of model interpretability as well as statistical performance.
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Multiple imputation assuming data were missing at random was used to investigate missing data when
fitting the models. We generated 20 data sets and ran a backward stepwise logistic regression (factors
where p< 0.05 remained in the model), implementing a bootstrap (200 samples) for each imputed data
set. This was done for preoperative and postoperative factors only. Factors were selected based on the
inclusion frequency of each predictor, over the imputed data sets, that is the proportion of times that
the factor appeared in the model.79 A threshold of 50% was set and estimates were combined using the
Rubin rules.80 The final models were estimated by taking up the factors whose inclusion frequency
exceeded the threshold, and estimating the regression weights of this predictor set on the imputed data.
Sensitivity analysis for the multiple models derived on the complete case data was also performed to
explore the effect of including and excluding prematurity from the set of potential predictors (using Akaike
criteria to assess model fit). Sensitivity of the results to adjustment for clustering at both the hospital level
and regional level (English Primary Care Trusts81) was assessed for each model. The Hosmer–Lemeshow
statistic was used to test calibration (goodness of fit)82 and discrimination was described using the
c-statistic (area under the receiver-operator curve), corrected for overfitting using bootstrapping
(an internal validation method that is an alternative to data-splitting and cross-validation83).
All analyses were performed in Stata statistical software (Version 12.1 StataCorp LP, College Station, TX,
USA) and a p-value of < 0.05 was considered statistically significant.
Identifying patient groups differentiated by risk of outcome 2
Classification and regression tree analysis was used to identify patient groups with different ‘profiles of
risk’ that could usefully inform the development and prioritisation of interventions aimed at improving
outcomes within this patient population. The analysis was designed to fulfil this purpose rather than, for
example, the development of a prediction tool (which was not our intention). For other examples of CART
applications in health care, see Ridley et al.,84 Garbe et al.85 and Fonarow et al.86 Given our aim here was
to inform service improvement, we focused on outcome 2 so as to include the ‘near misses’ as well as
deaths (with the combined higher incidence rate also providing greater model stability). The technique
recursively partitioned the data into subsets that were as homogeneous as possible with respect to
outcome 2, that is into subsets of increasing ‘purity’.87 This was implemented using a Gini impurity
measure with minimum change in improvement of 0.0001. All variables significantly associated with
outcome 2 in univariate analysis (and weight-for-age z-score) were included in the CART analysis.
The continuous variables were entered in their categorised form used in the risk model development
(see Table 9). To prevent overfitting, the CART groups were developed in a random 60% of the data.
In order to limit the number of groups created (for reasons of statistical robustness and potential usability),
we restricted the tree depth to 4 and required a minimum of 100 cases for branching to continue, with at
least 50 cases in either branch. The resulting classification tree was applied to the patients in the remaining
40% of the data set and the occurrence of outcome 2 among patients at each node was compared with
the corresponding group in the development set to assess model stability. All analysis was performed in
SPSS 22 (IBM SPSS statistical software 2013, Armonk, NY, USA).
Results
Data set and headline outcomes
Approximately 20% of records in NCHDA did not have a valid NHS number (the unique patient identifier
used in this study to match across the two audits); many of these records pertain to overseas patients as
only patients resident in England or Wales are allocated an NHS number. A total of 12,390 infants with a
valid patient identifier and meeting the inclusion criteria for the study were identified in NCHDA, of whom
9385 (76%) were linked to at least one record in PICANet. Failure to link a record from NCHDA with one
in PICANet could be accounted for by a procedure (in general a catheter) which occurred without an
intensive care admission or the lack of an NHS number for a given patient in PICANet. A total of 115
children who underwent only an excluded catheter procedure were excluded from the analysis, as were
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765 premature babies who underwent ligation of patent ductus arteriosus (PDA) only and 24 transplant
patients. A further 505 patients with unknown life status were also removed.
Of the remaining 7976 patients, 333 [4.2%, 95% confidence interval (CI) 3.7 to 4.6] died during their index
admission period and were excluded from our analyses, leaving a final data set comprising 7643 infants
discharged alive from their index admission. Of these, 246 (3.2%, 95% CI 2.8 to 3.6) died within 1 year
following discharge from the index admission and not during a planned admission (outcome 1). A total of
514 children (6.7%, 95% CI 6.2 to 7.3) either died or were admitted unplanned, as an emergency, to a PICU
within 1 year following discharge from the index admission (outcome 2). Finally, 115 children (1.5%, 95% CI
1.2% to 1.8%) died during a planned admission to PICU within 1 year following discharge from the index
admission (which was not considered an outcome in this analysis), giving an overall mortality within the year
following discharge from index admission of 4.7% (95% CI 4.2% to 5.2%).
Ethnic group was not available from PICANet for 1703 children in the final data set. Of these, the NCHDA
ethnic code was used to assign white (n= 1001), Asian (n= 243), black (n= 113) or missing (n= 346)
ethnicity. Excluding records without PICANet-derived ethnicity from the analyses did not significantly affect
the results. In a total of 528 children weight-for-age was missing or anomalous (assumed erroneous and
treated as missing). The variable for which the level of missing data was highest, markedly so, was
prematurity [n= 2101 (27.5%)]; sensitivity analysis comparing models with and without prematurity
showed a marginally better fit if it was included (based on Akaike criteria) and very little difference in the
odds ratio coefficients for all other factors.
Descriptive and univariate analyses
The following variables showed no univariate association with either outcome and so were not considered
in further analyses: sex, and whether or not any catheter procedures were performed during the index
admission in addition to the index procedure. Both outcome 1 and outcome 2 were significantly associated
with all of the other candidate variables in univariate analysis (p-value < 0.05). Table 8 shows the observed
numbers of patients and rate of outcomes 1 and 2 in the data set for those parameters significant in
univariate analysis (and weight-for-age), along with the results of the univariate analysis.
The relationship between LOS and both outcomes was non-linear and the fractional polynomial
transformation was used in the subsequent risk model development analyses; for age we used a log
transformation. The relationship between weight-for-age and each outcome did not depart significantly
from linearity.
Developing risk models for outcomes 1 and 2
In the multivariate analysis in which continuous variables were treated as such, the significant risk factors
for both outcomes were age at procedure (continuous), weight-for-age z-score (continuous), index
procedure group, cardiac diagnosis group, non-cardiac congenital anomaly, prematurity, ethnicity and LOS
in a specialist centre (continuous). Preprocedure clinical deterioration was additionally significant to
outcome 1, whereas neurodevelopmental condition and acquired cardiac diagnoses were additionally
significant to outcome 2.
In the final model development, in which ease of interpretation was considered as well as statistical
performance, the continuous predictors (age at procedure, weight-for-age z-score and LOS) were
categorised as shown in Table 9 (along with observed numbers of patients and rate of outcomes 1 and 2
in the data set). The final risk model for outcome 1 comprises age at procedure (categorical), weight-for-age
z-score (categorical), index procedure group, cardiac diagnosis group, non-cardiac congenital anomaly,
prematurity, ethnicity, LOS in specialist centre (categorical) and clinical deterioration. The final risk model for
outcome 2 comprises age at procedure (categorical), weight-for-age z-score (categorical), index procedure
group, cardiac diagnosis group, non-cardiac congenital anomaly, prematurity, ethnicity, LOS in specialist
centre (categorical), neurodevelopmental condition and acquired cardiac diagnoses. Details of the regression
models (odds ratio, standard errors and 95% CIs) are shown in Tables 10 and 11.
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TABLE 8 Observed numbers of patients and rate of outcomes 1 and 2 in the data set.a Reproduced from
Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes
Patient variable n (%) overall
Outcome 1 Outcome 2
n (%)
Univariate odds
ratio (p-value) n (%)
Univariate odds
ratio (p-value)
Non-medical
Deprivation
1 – most 2205 (28.9) 79 (3.6) 1 157 (7.1) 1
2 1563 (20.4) 51 (3.3) 0.91 (0.60) 104 (6.7) 0.93 (0.58)
3 1242 (16.3) 41 (3.3) 0.92 (0.66) 77 (6.2) 0.86 (0.30)
4 1078 (14.1) 38 (3.5) 0.98 (0.93) 79 (7.3) 1.03 (0.83)
5 – least 1085 (14.2) 23 (2.1) 0.58 (0.02) 64 (5.9) 0.82 (0.19)
Missing 470 (6.1) 14 (3.0) – 33 (7.0) –
Ethnicity
White 5728 (75.0) 166 (2.9) 1 348 (6.1) 1
Mixed 196 (2.6) 4 (2.0) 0.70 (0.48) 9 (4.6) 0.74 (0.39)
Asian 867 (11.3) 38 (4.4) 1.54 (0.02) 73 (8.4) 1.42 (< 0.01)
Black 345 (4.5) 12 (3.5) 1.21 (0.54) 34 (9.9) 1.69 (< 0.01)
Chinese 28 (0.4) 1 (3.6) 1.24 (0.83) 1 (3.6) 0.57 (0.59)
Other 133 (1.7) 12 (9.0) 3.32 (< 0.001) 19 (14.3) 2.58 (< 0.001)
Not stated 346 (4.5) 13 (3.8) 1.31 (0.36) 30 (8.7) 1.47 (0.05)
Preoperative
Cardiac diagnosis group
VSD 1348 (17.6) 25 (1.9) 1 60 (4.5) 1
HLHS 390 (5.1) 48 (12.3) 7.43 (< 0.001) 70 (18.0) 4.70 (< 0.001)
UVH/PA 531 (7.0) 41 (7.7) 4.43 (< 0.001) 73 (13.8) 3.42 (< 0.001)
Other 5374 (70.3) 132 (2.5) 1.33 (0.19) 311 (5.8) 1.32 (0.06)
Acquired diagnosis
Yes 479 (6.3) 25 (5.2) 1.73 (0.01) 57 (11.9) 1.98 (< 0.001)
No 7164 (93.7) 221 (3.1) 1 457 (6.4) 1
Specific procedure group
Corrective 4973 (65.1) 86 (1.7) 1 219 (4.4) 1
Palliative 1629 (21.3) 119 (7.3) 4.48 (< 0.001) 205 (12.6) 3.13 (< 0.001)
Ungrouped 1041 (13.6) 41 (3.9) 2.33 (< 0.001) 90 (8.7) 2.05 (< 0.001)
Congenital anomaly
Yes 1608 (21.0) 90 (5.6) 2.23 (< 0.001) 209 (13.0) 2.81 (< 0.001)
No 6035 (79.0) 156 (2.6) 1 305 (5.1) 1
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TABLE 8 Observed numbers of patients and rate of outcomes 1 and 2 in the data set.a Reproduced from
Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes (continued )
Patient variable n (%) overall
Outcome 1 Outcome 2
n (%)
Univariate odds
ratio (p-value) n (%)
Univariate odds
ratio (p-value)
Neurodevelopment condition
Yes 307 (4.0) 27 (8.8) 3.13 (< 0.001) 75 (24.4) 5.08 (< 0.001)
No 7336 (96.0) 219 (3.0) 1 439 (6.0) 1
Prematurity
Yes 828 (10.8) 44 (5.3) 1.59 (< 0.01) 93 (11.2) 1.63 (< 0.001)
No 4714 (61.7) 161 (3.4) 1 340 (7.2) 1
Missing 2101 (27.5) 41 (2.0) – 81 (3.9) –
Age at index procedure
(continuous)
Median 64 days;
IQR 11 to 153;
missing= 0
Not shown 0.99 (< 0.001) Not shown 0.99 (< 0.001)
Weight-for-age z-score
(continuous)
Median –1.7;
IQR –2.8 to –0.6;
missing= 528
Not shown 1.02 (0.69)b Not shown 0.95 (0.13)b
Antenatal diagnosis
Yes 2146 (8.1) 105 (4.9) 2.04 (< 0.001) 219 (10.2) 2.03 (< 0.001)
No 5046 (66.0) 124 (2.5) 1 268 (5.3) 1
Missing 451 (5.9) 17 (3.8) – 27 (6.0) –
Clinical deterioration
Yes 1469 (19.2) 85 (5.8) 2.29 (< 0.001) 154 (10.5) 1.89 (< 0.001)
No 6174 (80.8) 161 (2.6) 1 360 (5.8) 1
Postoperative
LOS (continuous) Median 10 days;
IQR 7 to 17;
missing= 0
Not shown (< 0.001) Not shown (< 0.001)
Additional surgical procedures
Yes 414 (5.4) 23 (5.6) 1.85 (< 0.01) 54 (13.0) 2.21 (< 0.001)
No 7229 (94.6) 223 (3.1) 1 460 (6.4) 1
Need for renal support
Yes 522 (6.8) 31 (5.9) 1.99 (< 0.01) 57 (10.9) 1.82 (< 0.001)
No 6721 (88.0) 207 (3.1) 1 425 (6.3) 1
Missing 400 (5.2) 8 (2.0) – 32 (8.0) –
continued
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TABLE 8 Observed numbers of patients and rate of outcomes 1 and 2 in the data set.a Reproduced from
Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes (continued )
Patient variable n (%) overall
Outcome 1 Outcome 2
n (%)
Univariate odds
ratio (p-value) n (%)
Univariate odds
ratio (p-value)
Need for ECMO
Yes 64 (0.8) 5 (7.8) 2.53 (0.05) 9 (14.1) 2.32 (0.02)
No 7290 (95.4) 236 (3.2) 1 480 (6.6) 1
Missing 289 (3.8) 5 (1.7) – 25 (8.7) –
Acquired comorbidity
Yes 1481 (19.4) 84 (5.7) 2.19 (< 0.001) 165 (11.1) 2.15 (< 0.001)
No 5918 (77.4) 158 (2.7) 1 326 (5.5) 1
Missing 244 (3.2) 4 (1.6) – 23 (9.4) –
Events in PICU
Yes 634 (8.3) 47 (7.4) 2.70 (< 0.001) 89 (14.0) 2.58 (< 0.001)
No 6765 (88.5) 195 (2.9) 1 402 (5.9) 1
Missing 244 (3.2) 4 (1.6) – 23 (9.4) –
Post-operative morbidity
Yes 113 (1.5) 9 (8.0) 2.66 (< 0.01) 17 (15.0) 2.51 (< 0.01)
No 7530 (98.5) 237 (3.2) 1 497 (6.6) 1
MVA, multivariate analysis; IQR, interquartile range.
a The table includes parameters significant in univariate analysis (and weight-for-age), along with the results of the
univariate analysis.
b Weight-for-age z-score (continuous) showed no univariate association with either outcome but was nonetheless taken
forward to the multivariate analyses.
Note
There are missing data in this table where data were not available for all patients.
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TABLE 9 Details regarding the categorisation of age at procedure, weight-for-age z-score and LOS.a Reproduced
from Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart Association, Inc.,
by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐Non
Commercial License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited and is not used for commercial purposes
Patient variable n (%) overall n (%) outcome 1 n (%) outcome 2
Age at index procedure
> 3 months 3202 (41.9) 55 (1.7) 129 (4.0)
1–2 months 1427 (18.7) 45 (3.2) 110 (7.7)
10–30 days 1114 (14.6) 43 (3.9) 90 (8.1)
0–10 days 1900 (24.8) 103 (5.4) 185 (9.7)
Weight-for-age z-score
> –2 SDs 4064 (53.2) 128 (3.1) 243 (6.0)
–2 to –4 SDs 2467 (32.3) 71 (2.9) 168 (6.8)
< –4 SDs 584 (7.6) 19 (3.3) 50 (8.6)
Missing 528 (6.9) 28 (5.3) 53 (10.0)
LOS
0–7 days 2564 (33.6) 35 (1.4) 84 (3.3)
7–30 days 4327 (56.6) 146 (3.4) 302 (7.0)
> 1 month 752 (9.8) 65 (8.6) 128 (17.0)
SD, standard deviation.
a These were originally continuous variables that were categorised because of the considerations of potential model
usability and clinical face validity. The observed numbers of patients and rates of outcomes 1 and 2 in the data set in
each category are shown for the categorised variable.
TABLE 10 Details of the final multivariate regression model for outcome.a Reproduced from Crowe et al., 2016.67
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open
access article under the terms of the Creative Commons Attribution‐Non Commercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes
Patient variable Odds ratio Standard error 95% CI
Ethnicity
White Reference category
Mixed 0.68 0.35 0.25 to 1.88
Asian 1.38 0.26 0.95 to 2.01
Black 1.00 0.31 0.54 to 1.85
Chinese 1.46 1.53 0.19 to 11.43
Other 2.82 0.94 1.46 to 5.44
Not stated 1.53 0.47 0.85 to 2.78
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TABLE 10 Details of the final multivariate regression model for outcome.a Reproduced from Crowe et al., 2016.67
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open
access article under the terms of the Creative Commons Attribution‐Non Commercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes (continued )
Patient variable Odds ratio Standard error 95% CI
Cardiac diagnosis group
VSD Reference category
HLHS 3.07 0.97 1.65 to 5.71
Functionally UVH/PA 2.31 0.69 1.29 to 4.15
Other 1.12 0.26 0.70 to 1.77
Specific procedure group
Corrective Reference category
Palliative 2.14 0.38 1.50 to 3.04
Ungrouped 1.77 0.36 1.20 to 2.63
Congenital anomaly
No Reference category
Yes 2.43 0.37 1.81 to 3.27
Prematurity
No Reference category
Yes 1.64 0.30 1.16 to 2.34
Clinical deterioration
No Reference category
Yes 1.66 0.24 1.25 to 2.22
Age at index procedure
> 3 months Reference category
1–2 months 1.32 0.28 0.87 to 2.01
10–30 days 1.89 0.45 1.19 to 3.02
0–10 days 2.54 0.60 1.61 to 4.03
Weight-for-age z-score
> –2 SDs Reference category
–2 to –4 SDs 1.59 0.28 1.12 to 2.26
< –4 SDs 2.28 0.61 1.34 to 3.87
LOS
0–7 days Reference category
7–30 days 1.56 0.31 1.06 to 2.31
> 1 month 2.70 0.63 1.71 to 4.26
SD, standard deviation.
a For each patient variable the multivariable odds ratio, standard error and 95% CI is presented and the reference
category is indicated.
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TABLE 11 Details of the final regression model for outcome 2.a Reproduced from Crowe et al., 2016.67 © 2016
The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access
article under the terms of the Creative Commons Attribution‐Non Commercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes
Patient variable Odds ratio Standard error 95% CI
Ethnicity
White Reference category
Mixed 0.63 0.23 0.31 to 1.29
Asian 1.21 0.17 0.92 to 1.61
Black 1.43 0.29 0.96 to 2.12
Chinese 0.65 0.68 0.09 to 5.02
Other 2.39 0.65 1.40 to 4.08
Not stated 1.76 0.37 1.16 to 2.65
Cardiac diagnosis group
VSD Reference category
HLHS 2.46 0.58 1.55 to 3.90
UVH/PA 2.15 0.46 1.41 to 3.28
Other 1.20 0.19 0.88 to 1.64
Specific procedure group
Corrective Reference category
Palliative 1.65 0.21 1.28 to 2.13
Ungrouped 1.61 0.22 1.23 to 2.11
Congenital anomaly
No Reference category
Yes 2.71 0.29 2.19 to 3.35
Neurodevelopment condition
No Reference category
Yes 2.81 0.44 2.06 to 3.82
Prematurity
No Reference category
Yes 1.59 0.21 1.22 to 2.06
Acquired diagnosis
No Reference category
Yes 1.85 0.30 1.35 to 2.53
Age at index procedure
> 3 months old Reference category
1–2 months old 1.59 0.23 1.20 to 2.10
10–30 days old 2.21 0.37 1.59 to 3.06
0–10 days old 2.93 0.48 2.12 to 4.04
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For each patient variable the multivariate odds ratios, standard errors and 95% CIs are presented and the
reference category indicated.
We note that, although variable selection was based on > 50% inclusion frequency over the imputed data
sets, in practice there was clear discrimination between those factors that were included in the model
(≥ 90%) and those that were not included (< 40%). For both outcomes, sensitivity analysis of the models
derived on complete case data showed a marginally better fit to the data when prematurity was included,
based on Akaike criteria. However, for models with and without prematurity the odds ratios for all other
factors remained very similar, indicating robustness of model variable selection. Furthermore, for all
models, adjusting for clustering at either the hospital level or regional (primary care trust) level had no
significant impact on results so we have presented the unadjusted results.
Risk model performance
The final (categorical) model for outcome 1 gave a combined c-index of 0.78 (95% CI 0.75 to 0.82),
indicating good discrimination. This was only marginally less discriminative than the continuous model
(c-index 0.80). The final (categorical) model for outcome 2 also showed good discrimination with a
combined c-index of 0.78 (95% CI 0.75 to 0.80), compared with a c-index of 0.78 for the continuous
model. Calibration of the final categorical and continuous models for both outcomes was also good, with
Hosmer–Lemeshow p-values ranging from 0.10 to 0.75 across the models fitted on the 20 imputed data
sets, indicating no statistically significant differences between observed and expected number of deaths
when calculated in deciles of predicted risk for each of the imputed data sets.
Identifying patient groups differentiated by risk of outcome 2
Figure 4 depicts the final tree generated by the CART analysis along with, for each node, the test set
figures for the number of patients and rate of outcome 2. The rate of outcome 2 evaluated across the
entire data set is shown below the box for each final patient group. The rate of outcome 2 across the
entire analysis data set (total number of patients 7643) was 6.7%. The rate of outcome 2 within a 60%
development subset was 7.0%, compared with 6.3% in the 40% test set.
TABLE 11 Details of the final regression model for outcome 2.a Reproduced from Crowe et al., 2016.67 © 2016
The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access
article under the terms of the Creative Commons Attribution‐Non Commercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes (continued )
Patient variable Odds ratio Standard error 95% CI
Weight-for-age z-score
> –2 SDs Reference category
–2 to –4 SDs 1.72 0.22 1.34 to 2.21
< –4 SDs 2.60 0.48 1.81 to 3.75
LOS
0–7 days Reference category
7–30 days 1.54 0.21 1.19 to 2.00
> 1 month 2.73 0.44 1.99 to 3.75
a For each patient variable the multivariable odds ratio, standard error and 95% CI is presented and the reference
category is indicated.
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Of the 18 variables entered in the analysis, CART identified presence/absence of a neurodevelopmental
condition as the best single discriminator between patients experiencing outcome 2 or not. For those
without a neurodevelopmental condition, the next best discriminator is whether the cardiac diagnosis is
high risk (HLHS, UVH or PA) or low risk (VSD or ‘other’). Of the latter, the next best discriminator is
presence/absence of a congenital anomaly followed by the LOS in the specialist hospital (threshold
1 month). This branching creates six discrete patient groups, details of which are set out in Table 12.
n = 191/3044
6.3%
Neurodevelopmental condition?
n = 169/2929
5.8%
Primary cardiac diagnosis
No Yes
Group 1
n = 22/115
19.1%
(24.4%)
n = 119/2585
4.6%
Congenital anomaly?
VSD/Other HLHS/(UVH or PA)
Group 3
n = 50/344
14.5%
(15.2%)
Group 5
n = 43/494
8.7%
(8.6%)
< 1 month > 1 month
Group 2
n = 21/76
27.6%
(24.0%)
Group 6
n = 45/1880
2.4%
(2.8%)
< 1 month > 1 month
Group 4
n = 10/135
7.4%
(9.3%)
n = 64/570
11.2%
Length of stay (index admission)
Yes No
n = 55/2015
2.7%
Length of stay (index admission)
FIGURE 4 Patient groups derived from classification and regression tree analysis. The final tree generated by the
CART analysis along with, for each node, the test set figures for the number of patients and rate of outcome 2.
The rate of outcome 2 evaluated across the entire data set is shown below the box for each final patient group.
Reproduced from Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American Heart
Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons
Attribution‐Non Commercial License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited and is not used for commercial purposes
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Discussion
As far as we are aware, based on the systematic review reported in Chapter 2, this is the first study of its
kind to explore adverse postdischarge outcomes for infants with CHD based on national audit data with
equivalent universal coverage. Of 7643 infants discharged alive following an initial major intervention for
CHD, representing the entire case load for England and Wales over a 6-year period, 246 (3.2%) died within
1 year and not during a planned readmission (outcome 1) and 514 (6.7%) either died or had an emergency
unplanned readmission to PICU within 1 year (outcome 2). The following risk factors were associated with
increased multivariate risk of both adverse outcomes: younger age at procedure, lower weight-for-age
z-score, index procedure group (palliative procedures higher risk), cardiac diagnosis group (HLHS, UVH,
PA higher risk), non-cardiac congenital anomaly, prematurity, ethnicity (‘other’ ethnicity higher risk), LOS in
specialist centre (> 1 month higher risk). In addition, for outcome 1 preprocedure clinical deterioration was
associated with increased multivariate risk whereas for outcome 2 neurodevelopmental conditions and
acquired cardiac diagnoses were additionally associated with increased multivariate risk.
When considering the results of the two multivariable models in the context of previous evidence identified
within the systematic review outlined in Chapter 2, one barrier is that very few of the previous studies
presented risk factors for a large diverse group of CHD patients. There was concordance for the following
risk factors being linked to adverse outcome: index procedure group (palliative),31,34 which relates to
cardiac diagnosis group (HLHS was the predominant condition represented in the systematic review),
non-cardiac congenital anomaly,34,36 prematurity32 and ethnicity26 (albeit in relation to different ethnic
populations based in the USA).
The risk models in our study further identified the following factors: lower weight at operation,
which is a factor in risk models for adverse early outcome11 and may be correlated with feeding difficulties
that featured in the systematic review as a higher risk;33 acquired cardiac diagnoses and preoperative
clinical deterioration, which would suggest that individual patients with more severe forms of a given
CHD type are at higher late risk (as was the case for HLHS within systematic review studies26,88); and
neurodevelopmental conditions, which did not feature in the systematic review, although these may have
overlapped with congenital anomalies in previous studies (see previous paragraph).
One patient characteristic that featured as an adverse risk factor in the systematic review (in relation to
populations from the USA)26,32 but was not linked to risk in our study was lower socioeconomic status
[we included a measure of deprivation (IMD) as a potential risk factor in our analyses]. Further descriptive
information on deprivation and a wider discussion of ethnicity is presented in Chapter 5, but we note that
our data originate from a different health-care system to the USA (i.e. the NHS) and speculate that this
may have a role in these observed differences.
Prolonged LOS in hospital was an important adverse risk factor in our study, but within the systematic
review evidence in respect of this was conflicting: two studies indicated LOS to be a risk factor34,36 and
one smaller single-centre study presenting the opposite viewpoint.30 Prolonged LOS may reflect numerous
different aspects of a patient’s condition and journey, but generally indicates greater complexity including
potentially being a surrogate measure of postprocedural complications,89 which may lead to greater
fragility post discharge. Younger age at surgery was associated with higher risk in our study, and in
two studies in the systematic review that included a range of different CHD types,31,34 yet the systematic
review indicated older age to be associated with higher risk of HLHS and aortic stenosis.23,35 It is likely that
the finding of higher risk at younger age represents a broad effect, such as neonates being generally more
vulnerable than older infants post discharge.
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Our results reflect outcomes within the context of recent historical provision of services for major forms of
CHD requiring treatment in infancy, and are potentially insightful for ongoing quality improvement
initiatives. To this end, we identified distinct patient groups using CART analysis with a view to informing
the design (and potential targeting) of appropriate interventions and service improvements. The six groups
that were identified span a wide range of risk of late death or emergency readmission to PICU (3–24%
outcome 2). The groups are defined in terms of the following patient characteristics: neurodevelopmental
conditions; cardiac diagnosis of HLHS, UVH or PA+ intact ventricular septum (IVS); congenital anomalies;
and LOS > 1 month. The two highest-risk groups are made up of patients with a neurodevelopmental
condition (group 1: 24% outcome 2) and patients with a low-risk cardiac diagnosis who have a congenital
anomaly and long LOS (but no neurodevelopmental condition) (group 2: 24% outcome 2). Group 3
comprises those patients most widely recognised as vulnerable to late death (see Chapters 2 and 3),
namely patients with cardiac diagnoses of HLHS, UVH or PA+ IVS (and no neurodevelopmental condition)
(15% outcome 2), although we note that some patients in group 1 may also have these cardiac diagnoses.
Therefore, the groups identified by these population-based data as high risk include patients with
diagnoses other than those conventionally recognised as benefiting from enhanced surveillance, that is
HLHS52–54 and in small number of studies, other UVH conditions.57 Our findings suggest that as well as
HLHS, infants with UVH and PA+ IVS are also at significant risk of poor interstage outcome and that these
patient groups are candidates for home monitoring. Our study also indicates that it is important to
mitigate risks arising from patient factors beyond simply cardiac diagnosis, in particular we note the very
significant risks of poor postdischarge outcome in the presence of neurodevelopmental conditions and
congenital anomalies with prolonged LOS. The implications of this for service provision are discussed
further in Chapter 10.
Strengths and weaknesses
The national audit data underpinning this study offer a unique opportunity for a population-based analysis,
and the study was designed, conducted and reported based on the Strobe Statement for observational
studies.90 First, the data are of high quality (as demonstrated by the results of a regular systematic
independent validation process). Second, life-status tracking based on NHS number enables late deaths
outside treatment centres to be reliably ascertained. Third, the mandatory and universal nature of the data
submission means that all relevant cases are captured. Our findings may therefore be considered more
generalisable than those based on single-centre studies or those from a more limited geographical area.
That said, our study outcomes inevitably reflect recent historic services provision by the NHS in addition to
intrinsic medical risk; hence, findings may differ to some extent between geographical regions. The study
also reflects the demographics of the UK in terms of ethnicity, which may in turn have implications for the
distribution of CHD types and other congenital anomalies.91
A further positive feature of the study is that the combined data set used is more valuable for the purposes
of this study than either of the individual audit data sets in isolation, since each contains different types of
information concerning potential risk and, when variables in the two data extracts overlapped, the item
with the highest data completeness and discrimination was selected. The strength of the NCHDA data set
includes the detailed cardiac-specific information as determined by IPCCC codes related to CHD and the
cardiac interventions undertaken. The strengths of the PICANet data set include the rich medical coding
and information pertaining to the type of admission (such as where an emergency occurred), as well as
intensive-care supports and interventions.
We note, however, that our results reflect only those elements that are captured within the national
audit data and so certain known risk factors, for example postprocedural weight gain33 and selected
abnormalities based on echocardiography,36 could not be incorporated. Furthermore, there may be other
as yet unknown risk factors that are not captured in the registry data.
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It was necessary to group cardiac diagnoses and procedures in order to render them tractable for statistical
analysis (to reduce the degrees of freedom in the data set). Although this was performed with a strong
clinical sense of what was pertinent, based on literature and clinical experience, we note that such
groupings are to an extent subjective and, as in other registry-based studies, there remained a subset of
ungrouped procedures. The choice of diagnosis group ‘HLHS’ reflects the body of literature related to
‘interstage’ deaths in this population. A separate group of ‘UVH or PA+ IVS’ was chosen because of the
high-risk nature of these conditions, although with a view to distinguishing these from HLHS patients.
Of the remaining cardiac diagnosis groups, we elected to review the VSD group separately in order for us
to evaluate the face validity of comparisons between HLHS or UVH/PA+ IVS and the much larger, less
homogeneous group of mainly biventricular diagnoses. We note that results for the VSD group and the
diverse ‘other’ group were comparable.
We note that the ethnicity group classified as ‘other’ was associated with higher risk: this is discussed in
more detail in Chapter 5. The audit data will not have captured the scenario in which babies were
discharged to home on a palliative care pathway, and hence our outcomes may have incorporated a
subset of babies that were expected to die. However, local audit of cases at two English tertiary centres
suggests this occurs in only a minority of cases.6 Finally, given its focus on the population of infants who
have undergone an intervention, the analysis does not include infants awaiting intervention who are also
known to be potentially vulnerable.
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Chapter 5 Ethnic influences on the prevalence and
outcomes of infants undergoing paediatric cardiac
surgery for congenital heart defects
Introduction
In the IHS, we have used national audit data to explore the medical and sociodemographic variables that
may be related to adverse outcomes for infants with CHD discharged home following cardiac surgery.
The risk model presented in Chapter 4 highlighted the increased mortality risk for children in the ‘other’
ethnic group and, in order to better understand this phenomenon, we undertook additional analyses to
investigate the influence of ethnic group on incidence, associated non-cardiac comorbidities and timing of
death in the linked audit data set. Our objective was to identify ethnic variations in the distribution of CHD
and associated health outcomes, and to determine whether ethnicity-related factors might present
additional challenges to health-care provision for affected infants. Although racial and ethnic variations in
CHD prevalence and outcomes have been reported globally,92 there are significant differences in the ethnic
composition of different national populations, which often reflect historical patterns of migration;
therefore, it was important to investigate the impact of ethnicity within a UK population.
The prevalence of all CHDs, as well as specific CHD subtypes, varies by ethnic, or racial, group.93–96 It is
reported that hospital stays after cardiac surgery are longer, and in-hospital mortality rates are higher,
among black and Hispanic children than among white children,97,98 and ethnic variations in mortality rates
appear to persist into later childhood.99–101 Although genetic, biological or socioeconomic factors may
partly explain racial and ethnic variations, some US authors have suggested that unequal access to
diagnosis and care also contributes to differences in mortality.102,103 However, these findings may not apply
within the context of the UK health-care model. It is also important to note that some large minority ethnic
populations in the USA do not exist in the UK, for example the Hispanic, Native American or Pacific
Islander populations, and the Asian population of the UK has very different migratory origins to Asian
populations in North America. Moreover, Flores46 has emphasised the importance of understanding these
as diverse individual populations rather than grouping them under the term non-white.
Few population-based studies have been undertaken in the UK to explore ethnic variations in CHD incidence
and outcomes. In a single-centre UK study, Sadiq et al.104 demonstrated a higher prevalence of complex CHDs
in children of Asian origin, which may imply a requirement for complex interventions and specific considerations
when designing health-care provision appropriate to the cultural and language needs of this patient group.
An audit of data from two London hospitals for the years 2000 to 2009 has also provided evidence that babies
with CHDs who are of non-white British ethnicity experience a higher mortality risk after hospital discharge.19
The linked national audit data from NCHDA and PICANet provided us with a unique patient-based data set to
investigate ethnic variations in the incidence and distribution of CHD, as well as the mortality risk associated with
cardiac surgery for affected infants. UK national paediatric audit data have not previously been analysed on an
individual patient basis with a view to informing quality improvement and care pathways after hospital discharge.
Methods
Our investigation is based on a linked data set included individual records for 7529 infants with CHDs who
underwent a bypass operation or interventional catheterisation for structural CHDs from 1 January 2005 to
31 December 2010, as described for the risk model and CART analyses in Chapter 4.
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As the PICANet and NCHDA ethnicity classifications were not directly comparable, we investigated
concordance using Cohen’s kappa statistic. Furthermore, taking the PICANet ethnic category as the
reference standard, we calculated the proportion of patients whose NCHDA ethnic group was concordant
with the PICANet-recorded ethnicity (sensitivity) and the probability that a patient with a given NCHDA
ethnic group had the corresponding PICANet ethnic group (positive predictive value). For analyses of the
concordance of ethnic classifications, we excluded 1954 children who had missing ethnicity either from
NCHDA or from PICANet. However, for our analyses of the distribution of patient-based characteristics and
outcomes associated with ethnicity, we excluded children for whom ethnicity was not available in PICANet
and could not be inferred from the NCHDA ethnicity record.
Descriptive statistics are presented as numbers and percentages, or median and interquartile ranges (IQR),
and 95% CIs were estimated for the difference between two proportions. Weight-at-index procedure was
converted to age- and sex-standardised z-scores (British 1990 growth reference105) to facilitate comparison
across age groups.105 z-score values that were outside 5 standard deviations (SD) were considered to be
clinically anomalous and treated as missing.
Estimates of the incidence and relative rates of children operated for CHD within the first year of life
were calculated by sex and ethnic group for all CHD and each specific CHD subgroup, using mid-year
population estimates for the years 2006 to 2009 as the denominator. Binomial exact 95% CIs were
estimated for rates. To ensure that analyses of incidence included only audit years in which there was
complete ascertainment of infant procedures as well as the period from birth to age 1 year, we based
incidence analyses only on children whose index procedure was between 1 January 2006 and
31 December 2009 (excluding 2179 children whose index procedure was before or after this date).
The incidence data set included 266 children who lacked any record of ethnicity. We investigated the
relative risk of infant mortality by ethnic group using the white ethnic group as the reference.
We explored the distribution by ethnic group of specific cardiac diagnosis and individual patient characteristics
defined for our analyses in Chapter 4, including sex, cardiac diagnosis, gestation at birth, ethnicity, area
deprivation, associated comorbidities at the time of index procedure, weight at admission, antenatal diagnosis
and clinical codes describing the child’s status during the index hospital admission. Given the lack of knowledge
on this topic and our interest in building up a better descriptive picture of the links between ethnicity and
various key factors within the population, in this section of the analyses we included the more detailed cardiac
diagnosis (all primary cardiac diagnosis groups listed in Appendix 6) as a variable in our analysis of ethnic
variations. Given the larger number of diagnosis groups analysed in this section, and the close links between
cardiac intervention performed and detailed cardiac diagnosis, as well as the knowledge that some children
undergo more than one procedure even over the first year, we excluded procedure type and procedure-related
variables from these analyses. The risk model and CART analyses used a simplified diagnostic categorisation
including only four broad diagnostic categories, and furthermore we explored risk after the first index operation
only, again using very broad operative groups such as ‘palliative, corrrective’; therefore, additional procedure
variables (in respect of that index operation) were included in the risk models detailed in Chapter 4.
We investigated the risk ratio (RR) for mortality (both within-hospital and for outcome 1) by ethnic group
using white ethnicity as the reference. The factors associated with each mortality outcome were
investigated by fitting a univariate generalised linear model (binomial log-linear)106 to determine the RR
coefficients for ethnicity, with white as a reference category.
Results
Our results are presented in three parts: concordance of ethnic classifications between the two audit
databases; incidence of CHD by ethnic group; and infant characteristics and outcomes by ethnic group.
Data reported in tables omits cells in which the number of individuals is < 5 to reduce disclosure risk.
All analyses were undertaken using Stata SE version 12.1.
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Concordance of the ethnic classifications used in the National Congenital
Heart Diseases Audit and Paediatric Intensive Care Audit Network data sets
During the development of the risk model data set, we explored the concordance of ethnic classification
within the NCHDA and PICANet audit databases using a similar methodology to Saunders et al.107
This determined the ethnic classification subsequently used in the risk model and CART analysis.
The NCHDA database uses a bespoke ethnic classification comprising five ethnic groups: Caucasian, Asian,
black, Oriental and ‘other’ (‘other’ in NCHDA also includes children of mixed ethnicity; therefore, we refer
to it below as ‘other – mixed’). Ethnicity is recorded in the PICANet database using the detailed
(16 category) UK census classification (Table 13), which is often aggregated into six large groups. As ethnicity
was recorded for each admission, the recorded ethnic group varied between admissions for some children;
in these cases, the most frequently reported ethnic group (mode) for each child was selected as the child’s
ethnic group.
TABLE 13 Detailed ethnic group recorded by PICANet for each individual child operated on from 2005 to 2010
Ethnic group n
White (total) 4624
White British 4410
White Irish 19
Any other white 195
Mixed (total) 197
Mixed white/black Caribbean 51
Mixed white/black African 22
Mixed white/Asian 66
Any other mixed 58
Asian (total) 624
Asian/British-Indian 173
Asian/British-Pakistani 271
Asian/British-Bangladeshi 68
Any other Asian 112
Black (total) 218
Black/British Caribbean 31
Black/British African 143
Any other black 44
Chinese (total) 26
Chinese 26
Other (total) 127
Any other ethnicity 127
Missing (total) 1713
Not stated 1713
Total 7529
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As the PICANet and NCHDA ethnicity classifications were not directly comparable, we estimated Cohen’s
kappa statistic as a measure of agreement. Furthermore, taking the PICANet ethnic category as the
reference standard because of its more widespread use and comparability with national population
statistics, we calculated the proportion of patients whose NCHDA ethnic group was concordant with the
PICANet-recorded ethnicity (sensitivity) and the probability that a patient with a given NCHDA ethnic group
had the corresponding PICANet ethnic group (positive predictive value).
Ethnicity was not recorded for 1713 (22.8%) children in the PICANet data set (see Table 13); however,
ethnic group was available from NCHDA for 1438 of these, of whom the majority were Caucasian
(n= 1002; Table 14). Using a data set including only children who had a record in both NCHDA and
PICANet (n= 5575), we explored the concordance between the two classifications to determine whether
or not the NCHDA ethnic group could inform the missing PICANet record. The PICANet categories white,
black, Asian, Chinese, other and mixed were matched against the NCHDA categories of Caucasian, black,
Asian, Oriental and ‘other – mixed’, respectively. Cohen’s kappa statistic for agreement of PICANet and
NCHDA recorded ethnicity was 0.83 overall.
The sensitivity and positive predictive value of each NCHDA ethnic category with respect to the
corresponding PICANet category, was evaluated using the pairings white/Caucasian, black/black,
Asian/Asian, Chinese/Oriental, other/‘other – mixed’ (Figure 5).
Around half of the children in the NCHDA Oriental category were classified as Asian (Pakistani,
Bangladeshi, Indian or other Asian) in PICANet (see Table 14). The PICANet ‘mixed’ category does not exist
in NCHDA; 58 (31.0%) of these children were classified as white in NCHDA and the remainder were
distributed equally between the black, Asian and other categories.
The Caucasian, black and Asian categories in NCHDA demonstrated good concordance with the PICANet
ethnic groups of white, black and Asian, respectively (see Figure 5), and risk of misclassification was low
(positive predictive value ≥ 79.7%). The Chinese/Oriental and other/‘other – mixed’ categories were poorly
concordant and the NCHDA category predicted the corresponding PICANet group in < 68% of cases.
To facilitate comparison with population denominator data and reduce missing data, children with
ethnicity missing in PICANet but recorded in NCHDA as Caucasian, black or Asian were assigned to the
ethnic groups of white, black or Asian, respectively, whereas children in the Oriental and ‘other – mixed’
NCHDA categories who had no PICANet ethnicity record remained unchanged in PICANet. Using this
TABLE 14 Direct comparison of ethnic group recorded by PICANet and by NCHDA for each individual (2005–10)
Ethnic group (PICANet)
Ethnic group (NCHDA)
Caucasian Black Asian Oriental Other – mixed Ethnicity missing Total
White 4368 6 21 a 37 189
Black 10 189 5 a a 10
Asian 18 a 562 12 9 20
Chinese a a a 19 a a
Other and mixedb 98 39 58 a 104 21
Ethnicity missing 1002 113 250 20 53 275
Total 7529
a Cells with n< 5 are included in the total but omitted individually to reduce statistical disclosure risk.
b Children of mixed ethnicity are recorded under ‘other – mixed’ in NCHDA, whereas in PICANet, ‘mixed’ is a separate
group. For this comparison the mixed and other groups in PICANet have been merged.
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method to map children to a PICANet ethnic group, we created a data set in which only 4.6% (348 out of
7529) of children had missing data for ethnic group; further analyses described here, including the risk
model, CART analysis and analyses of ethnic variation, use this data set. Of 348 children with missing data,
20 were classified as Oriental and 53 as ‘other – mixed’ in NCHDA, while the remainder had no ethnicity
record in either data set.
Incidence of congenital heart disease types by ethnicity
The incidence of CHD surgery in the first year of life in England and Wales from 2006 to 2009 was 2.0
(95% CI 1.9 to 2.0) per 1000 children (n= 5350; Table 15). Although this incidence rate approximates
birth prevalence, actual birth prevalence would be slightly higher, as some children will survive the first
year of life without an intervention, will remain undiagnosed, or will die without an intervention.
Compared with the white ethnic group, the relative rate of CHD was higher in children of Asian, black and
‘other’ ethnicity and lower in children of Chinese or mixed ethnicity (Table 16). In sensitivity analyses
including only children with ethnicity recorded in PICANet (n= 4127), these relationships did not change;
however, the CIs around the relative rate for the black and Chinese groups included 1.
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The incidence of specific CHD subtypes varies by ethnic group (Figure 6). Compared with the white
reference group, the following subtypes were more common: in the Asian ethnic group the relative rate of
UVH, TGA+ IVS, PA, tetralogy of Fallot, TAPVC, VSD, atrial septal defect (ASD) and PDA; in the black
ethnic group HLHS, UVH, AVSD and VSD; and, in the ‘other’ ethnic group, HLHS, truncus arteriosus,
TGA, PA+ VSD, AVSD, tetralogy of Fallot and VSD (Table 17). Although specific defects appeared to be
under-represented in non-white ethnic groups compared with the white ethnic group, as a result of small
numbers there was insufficient precision to identify any significant differences.
Association between ethnicity and individual characteristics of children
operated on (2005 to 2010)
Descriptive statistics are presented in Table 18. Although characteristics of children with no record of
ethnicity in either data set (n= 348; ‘ethnicity not stated’) were explored, it is difficult to draw inferences
about this group because of its potential heterogeneity and a lack of information about why ethnicity was
not recorded. However, it is relevant to note that a higher percentage of children without a record of
ethnicity appear to have died during the index hospital admission; therefore, information may be lacking
because of an early death or this may represent a particularly vulnerable group.
There were more boys than girls in the data set overall [n= 4189; 55.6% (95% CI 54.5% to 56.8%)] and
within each ethnic group except the black and mixed ethnic groups, which each had a preponderance
of girls [black ethnic group: boys 48.3% (95% CI 42.8% to 53.9%); mixed ethnic group: boys 48.7%
(95% CI 41.6% to 55.9%)].
TABLE 15 Annual incidence of operated serious CHD in England and Wales in 2006–9 (n= 5350)
Year
Mid-year population
aged under 1 year
Number of children
operated on
Rate per 1000 infants
(95% CIa)
2006 653,400 1250 1.9 (1.8 to 2.0)
2007 674,700 1292 1.9 (1.8 to 2.0)
2008 702,800 1344 1.9 (1.8 to 2.0)
2009 698,800 1464 2.1 (2.0 to 2.2)
2006–9 2,729,700 5350 2.0 (1.9 to 2.0)
a Binomial exact method.
TABLE 16 Incidence and relative rates by ethnic group (for children operated on between 2006 and 2009)
Ethnic group
(n= 5084)a CHD cases (%)
Total mid-year populationb
(aged 0–1 year)
Annual incidence per
1000 infants (95% CI)
Relative rate
(95% CI)
White 3968 (78.0) 2,230,400 1.8 (1.7 to 1.8) Reference
Asian 604 (11.9) 220,100 2.7 (2.5 to 3 0) 1.54 (1.41 to 1.68)
Black 240 (4.7) 93,700 2.6 (2.2 to 2.9) 1.44 (1.26 to 1.64)
Chinese 22 (0.4) 19,700 1.1 (0.70 to 1.7) 0.63 (0.39 to 0.95)
Mixed 146 (2.9) 151,500 1.0 (0.8 to 1.1) 0.54 (0.46 to 0.64)
Other 104 (2.0) 14,300 7.3 (5.9 to 8.8) 4.09 (3.33 to 4.97)
a Excludes 266 children for whom ethnicity was not stated in either data set.
b Mid-year population denominator for infants from birth to 1 year in England and Wales.
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FIGURE 6 Distribution of CHD subgroups by ethnicity for children operated between 2006 and 2009. (a) white;
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Children with CHD admitted to the PICU were more likely to be resident in the most deprived areas if they
were from non-white ethnic groups than from the white ethnic group (Figure 7). Analysis of distribution
across the quintiles by detailed 16-category ethnic groups demonstrated that there was variation within
these broad ethnic groups, such that, within the Asian group the proportion of children of Asian-Pakistani
and Asian-Bangladeshi ethnicity living in the most deprived areas was higher than the proportion of
Asian-Indian ethnicity, more white-British children than white-Irish were found in the most deprived
quintile, and children of black-African ethnicity were more likely than those of black-Caribbean ethnicity
to be found living in deprived areas.
Compared with the white ethnic group, the proportion of children recorded as having neurodevelopmental
abnormalities during the index admission was significantly higher within the Asian, black and mixed ethnic
groups (white 3.5%, Asian 6.4%, black 5.4%, mixed 6.1%; see Table 18).
Variation by ethnic group in the proportion of children with associated non-cardiac congenital anomalies
and acquired comorbid conditions was not significant (see Table 18). The proportion with congenital
anomalies ranged from 20.6% to 38.3% between ethnic groups, and we do not currently have a
breakdown by type of congenital anomaly between ethnic groups (the range of possible anomalies was
very wide).
The proportion of infants born preterm (before 37 completed weeks’ gestation) was 10.2% (n= 766),
which is higher than in the general population, but no significant variation by ethnic group was observed
(see Table 18). Overall, 2253 children (29.9%) were diagnosed antenatally with CHD and 1504 children
(20.0%) showed evidence of clinical deterioration prior to their index admission; no significant differences
were found by ethnic group.
Age at index procedure was categorised into four groups: under 10 days, 10–30 days, 31 days to 3 months,
and over 3 months. Most children were operated aged either > 3 months or < 10 days and this distribution
was similar for all ethnic groups (see Table 18).
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FIGURE 7 Distribution of cases by ethnic group and deprivation quintile.
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Infants were also categorised by their weight z-score at the time of their index procedure: more than –2 SDs
of the mean weight for their age (normal), between –2 SDs and –4 SDs of the mean (low) and more than
–4 SDs below the mean (very low). Within all ethnic groups, most children (49.7% to 59.7%) were within
the normal weight-for-age category (see Table 18).
Ethnic variations in mortality and unplanned readmission outcomes
There were 318 deaths during the index hospital admission; 232 deaths occurred within the first year after
discharge home from hospital following the index procedure and were associated with an unexpected
collapse in the community or an unplanned readmission to hospital (outcome 1 in the risk model;
see Table 18). A further 252 children who went home after the index admission had an unplanned
emergency readmission but did not die within 1 year of discharge; therefore, a total of 484 children
experienced outcome 2 (see Table 18).
In univariate analyses (Table 19), children of Asian ethnicity had a higher mortality risk [RR 1.6 (95% CI 1.2
to 2.2)] than the white reference group during the period of the index hospital admission. Following
discharge, the ethnic group that experienced a higher rate of unexpected deaths (outcome 1) than the
white ethnic group were children of ‘other’ ethnicity [RR 3.4, (95% CI 1.9 to 5.9)]. In the first year
following discharge from hospital, children of Asian, black and other ethnicity had a significantly higher
univariate risk of outcome 2 [Asian RR 1.3 (95% CI 1.0 to 1.7), black RR 1.6 (95% CI 1.1 to 2.3), other
RR 2.1 (95% CI 1.3 to 3.4)] than the white reference group.
TABLE 19 Risk ratios for outcomes during index admission and the first year after discharge associated with ethnic
group (reference: white)
RRs for different outcomes RR 95% CI p-value
RRs for mortality during the index hospital admission
Asian 1.6 1.2 to 2.2 < 0.001
Black 1.5 0.9 to 2.4 0.10
Chinese 1.0 0.2 to 7.2 0.96
Mixed 1.7 0.9 to 2.9 0.08
Other 1.3 0.6 to 2.8 0.54
RRs for outcome 1 (unexpected death following index hospital discharge)
Asian 1.3 1.0 to 2.0 0.08
Black 1.1 0.6 to 2.0 0.82
Chinese 1.4 0.2 to 9.4 0.75
Mixed 0.7 0.3 to 1.9 0.52
Other 3.4 1.9 to 5.9 < 0.001
RRs for outcome 2 (unexpected death or readmission following index hospital discharge)
Asian 1.3 1.0 to 1.7 < 0.03
Black 1.6 1.1 to 2.3 < 0.01
Chinese 0.7 0.1 to 4.5 0.67
Mixed 0.8 0.4 to 1.5 0.45
Other 2.1 1.3 to 3.4 < 0.001
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Discussion
Linkage of the national paediatric cardiac interventional and intensive care audit data provided us with a
unique patient-based data set with which to investigate ethnic variations in the incidence of CHD, associated
comorbidities and outcomes for infants. This extended analysis was pertinent to the findings of the risk
model, which suggested a higher likelihood of postdischarge death for infants of ‘other’ ethnicity. Moreover,
our initial analysis of the concordance of ethnicity records within the two data sets contributed to the risk
model and CART analysis by informing methods to address missing ethnic group data.
In the analyses presented in this chapter, we identified a higher incidence of CHD overall within the Asian,
black and other ethnic groups than in the white ethnic group, as well as a higher relative rate of specific
complex and severe defects that carry a high early mortality risk, for example HLHS in the black and
other ethnic groups, and UVH in the Asian and black ethnic groups. Furthermore, the Asian, black
and other ethnic groups were more likely to live in more deprived areas and Asian and black ethnic groups
had higher rates of neurodevelopmental problems (which based on Chapter 4 place them at higher risk).
These distributions of additional features within the infant CHD population by ethnic group need to be
borne in mind when designing postdischarge care pathways for higher-risk infants; for example, the
potential for language barriers or cultural differences to play a role in the level of success or acceptability
of a HMP needs to be considered.
The comparison of deaths among children of non-white ethnicity and those of white ethnicity
demonstrated that children of Asian ethnicity experienced a higher mortality risk during the hospital stay.
We present here univariable analyses only, as in-hospital mortality was outwith the scope of this project
and is being further explored as an extension to the original proposed analyses. Children of ‘other’
ethnicity experienced higher mortality in the community or during an unexpected hospital readmission in
the first year after discharge home, and this finding remained after multivariable analyses as laid out in
Chapter 4. The univariate risk for outcome 2 in Asian and black patients presented above dropped out
during the multivariable analyses presented in Chapter 4, leaving only the ‘other’ ethnic group at
higher risk.
Data in context
In the UK, infant mortality (death in the first year after birth) is highest in the black Caribbean, Bangladeshi
and Pakistani ethnic groups (at over 6 deaths per 1000 live births); this is twice as high as in the white
ethnic groups. In 2012 UK data from the Office for National Statistics, the most common cause of death
reported for most ethnic groups (black 54%, mixed/Chinese/any other ethnic group 44% and white 43%)
was ‘immaturity-related conditions’, whereas for Asian infants the most common cause of death was
congenital anomalies (41%).108
Analysis of UK infant mortality statistics2 has also shown ethnic variation in mortality risk for babies born
with congenital anomalies. Compared with affected babies born to mothers of white British ethnicity,
there is evidence for a fourfold increased risk of death in the first year for infants born to mothers of
Pakistani ethnic origin and a 45% higher infant death risk for babies born to mothers of ‘all other’
ethnicity (a group that includes other, Chinese and mixed ethnicity in our analysis). Some authors have
suggested that excess infant mortality in the Pakistani population may be because of consanguinity91 and,
based on a meta-analysis across different populations, Bittles109 suggests that children of closely related
parents have a 3.3% median excess risk of congenital anomalies compared with children of unrelated
parents. Nevertheless, Bittles also emphasises noticeable variations in the baseline prevalence of congenital
anomalies between different populations.
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It is possible that our risk model did not demonstrate a higher infant mortality or emergency admission
rates associated with Asian ethnicity, as has been demonstrated in some previous studies,19,110 because the
higher death rate among Asian babies during the index hospital admission meant that many infants did
not survive to hospital discharge. These early in-hospital deaths are likely to have disproportionately
affected babies with more severe cardiac defects or associated comorbid conditions, such as more severe
types of non-cardiac congenital anomalies or prematurity. This aspect has not to date been explored in
detail and goes beyond the scope of our research project.
Different mortality rates after birth will also be influenced by the likelihood of prenatal detection for
different defects, and views about the acceptability of pregnancy termination will determine whether or
not the diagnosis of a severely affected infant leads to a live birth. In 1999, Bull reported that a serious
CHD was diagnosed in 23% of all pregnancies, but only 12% of live births were affected by a CHD;
pregnancies affected by CHDs were terminated in around 50% of cases, and this varied by gestation at
diagnosis but not by region of birth.111 Although analyses of termination rates for pregnancies affected by
CHDs by ethnic group have not been reported in the UK, a recent analysis of pregnancy terminations for
neural tube defect reported to two English regional data sets suggested that UK mothers of Pakistani,
black African and black Caribbean ethnicity were less likely to terminate an affected pregnancy than
mothers of white, Indian or Bangladeshi ethnicity.112
It is more difficult to determine the underlying reasons for the higher postdischarge mortality of babies
within the ‘other’ ethnic group, because this group is heterogeneous and has not often been described in
detail. An analysis of UK Census data,113 which reviewed the country of birth of individuals identified
within this group, found that over half were born in the Far East (including the Philippines, Japan, Thailand
and Vietnam), 10% were born in the Middle East (mainly Iran and Iraq) and 7% were born in North Africa
(including Egypt, Morocco, Algeria and Libya). The ethnic group classed as ‘other’ warrants further
evaluation and exploration in order to better understand what factors are at play, given that we do not
know how to explain the finding with any certainty. An unproven hypothesis is that a proportion of
families of patients in the ‘other’ ethnic group within this study may have recently travelled or migrated to
the UK, in some cases for treatment, although all those included in this data set had an NHS number and
hence were residents in the UK at the time of surgery. The particularly high incidence of CHD (highest
incidence of all ethnicities) in the ‘other’ ethnic group supports this hypothesis. Recent migrants to the UK
may have less awareness of and access to services important post discharge, and this may have an adverse
effect upon outcome. Further qualitative assessment of families in the ‘other’ ethnic group is required to
address these questions.
Conclusion
Although this detailed analysis of routine audit data has highlighted a lack of consistency and completeness
in ethnic coding, it has nevertheless provided very valuable insights into the influence of ethnicity on the
distribution of CHD in the UK infant population and on outcomes for affected infants. Further investigation
of the impact of ethnicity on pregnancy termination rates and infant mortality for babies diagnosed with
CHDs is merited. Further investigation of the links between ethnicity, other aspects of case mix and
outcome incorporating different stages of the patient journey over the first year of life (incorporating
multivariable modelling) is warranted.
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Chapter 6 Qualitative study of family viewpoints
expressed via an online discussion forum hosted by
the Children’s Heart Federation
Introduction
Recent years have seen a significant increase in the use of online social networks, with evidence suggesting
that 72% of adults worldwide now use social media.114,115 Social networks provide a quick and easy means
of sharing ideas, information and opinions, have a broad population reach and are widely used in every
sphere of life.114,116 Developments in technology have also resulted in an increasing use of electronic
methods to collect data for research and there is evidence to support their feasibility, the prompt response
of participants, the richness of data collected by these means and the reduction of human errors.117–119 One
method of electronic data collection is the online forum, which allows asynchronous interactions, whereby
participants are able to join discussions at their own convenience, in contrast to methods that require
synchronous interactions, such as chat groups. They have been reported to be relatively easy to use, safe,
accessible and observable, and it has also been suggested that they offer a more comfortable mechanism
for the discussion of sensitive or personal health issues and are a feasible alternative to more traditional
research tools, such as face-to-face focus groups.120–122 Furthermore, they offer flexibility to researchers and
participants alike, thus reducing participant burden and pressures of time.
Parents of children with significant health conditions can find it challenging to participate in face-to-face
research for a variety of practical reasons; however, those who are harder to reach via traditional data
collection methods often have important and salient contributions to make. As we were interested in
exploring parents’ experiences of taking a baby home after congenital heart surgery, we identified that an
online forum would enable a greater number of parents to participate, particularly those who would find it
more difficult to attend a focus group or take part in an interview. We decided that the most appropriate
way to facilitate the online forum was via the Children’s Heart Federation (CHF) and that this should
happen via its Facebook page (www.facebook.com). Facebook is the dominant social network worldwide
and many health-related groups have arisen on Facebook that are predominantly used for raising
awareness, social support and fundraising. The CHF has an active presence and following on Facebook
and Twitter (www.twitter.com) and at the time of setting up the forum the CHF Facebook page had
around 3120 members (75% female, most aged 25–40 years). Furthermore, the CHF has experience of
running OFs and, being a national charity, its forums are accessed by parents of children treated at all of
the specialist paediatric cardiac centres in the UK.
The aims were:
l to set up an OF to ask parents about their experiences of caring for a baby at home after congenital
heart surgery
l to collect information that could inform the development of questions for the indepth family interviews (FIs).
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Methods
A closed online discussion group was set up via the main Facebook page of the CHF. The discussion group
was advertised through the charity’s web page and interested participants were then directed to the
charity’s Facebook page. Participants were required to provide some basic demographic information (their
age, sex, ethnicity and geographical region). Once this information was received by the CHF, the
participants were given access to a private or ‘closed’ Facebook group and were able to begin responding
to questions posted there. The CHF was responsible for all day-to-day running and moderation of the
forum in line with a standard operating procedure developed in collaboration with the research team. The
standard operating procedure included processes for managing inappropriate and/or offensive messaging
and distressed users, as well as procedures for the day-to-day running of the forum. The research team
provided questions to be posted on the forum (Box 3). The CHF was asked to probe further if it noticed
any of the following issues in participant responses:
l social and practical issues, for example socioeconomic status, financial, educational issues, transport
l issues to do with language or cultural differences
l difficulties accessing support in the community
l understanding information from health-care providers.
Forum responses were anonymised by the CHF before being sent to the research team in a weekly update.
Data analysis
Responses were collated into a single transcript and thematic analysis was used to analyse forum
responses. Thematic analysis involves:
l familiarisation with the data
l generating initial codes
l searching for themes among these codes (but not by counting them)
l reviewing themes
l defining and naming themes.
Analysis was conducted by members of the research team working as a group.
BOX 3 Examples of questions posted on the online forum for parents/carers of children with CHD
In-hospital information and support:
What information were you given about looking after your baby at home after his/her surgery?
Community support and hospital follow-up:
What was your experience of the support available in the community when you took your baby home
from hospital?
When there was a problem:
Could you tell us a bit about your experience of getting support when you were worried about your baby?
Final question:
If there was one thing that would have made a difference (or did make a difference) to you and your
family when you took your baby home from hospital, what would that be?
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Results
Participants and participation
The forum ran from February to May 2013. During this period, a total of 91 participants (mean age 35 years;
range 23–58 years; 89 female; 89 parents, two grandparents) submitted demographic information and were
given access to the closed forum group. Participants came from all over the UK and were predominantly of
white British ethnicity (85 out of 91). Of these, 73 parents participated in the forum discussion and most
responded to between one and five questions. Neither of the two grandparents contributed to the forum
discussion. The questions with the most responses were those about information provided about caring for
their baby at home (symptoms and how prepared they felt); community support [particularly experiences
with general practitioners (GPs) and health visitors (HVs)]; and support from cardiac liaison nurses (CLNs).
Parents also responded to others’ posts, offering support and sharing experiences, and towards the end of
the forum parents became more open in identifying with other parents’ experiences: ‘After reading this it
was like reading my own story’; ‘It is so good to read about someone who has done so well’. Selected
quotations are included in Boxes 4–9.
Findings
The core theme emerging from the data was the family experience of isolation, epitomised by the
following quote: ‘It’s a pretty lonely place’. This was described in terms of the way in which that isolation
was experienced (physical, social and knowledge) and the resulting psychological impact, together with the
factors that made that worse or better. There was also a theme of time, as parents moved from feeling
overwhelmed and lacking in knowledge and skills to becoming ‘expert parents’ with a corresponding
increase in their knowledge and skills. Figure 8 is a schematic representation of this.
Physical isolation
A number of parents described being physically isolated as a result of having a baby with CHD, which was
sometimes because of their own anxieties and concerns, particularly about the risk of infection. In other
situations, parents identified that professionals, particularly HVs, were anxious about mothers taking their
babies to a busy clinic, preferring instead to make home visits, but this in turn could compound the
challenges that the families were facing.
BOX 4 Selected quotations from parents about physical isolation
I felt it too risky to go to clinic, with infections.
I didn’t see a soul . . . from leaving hospital to returning for review.
It was all such a huge shock, on discharge we were told she was like any other baby, but obviously there
were differences. I was very scared about taking her out and catching a cold or something, or visitors
bringing in germs.
. . . home visits were lovely but made me feel more isolated.
[My health visitor] was nervous about me going to baby clinics, etc. for weekly weights but I needed to
get out.
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BOX 5 Selected quotations from parents about social isolation
Loads of mum formed their friendships at that time. I was left behind and still am because of his
additional needs.
Didn’t have any support wasn’t even allowed to take her to baby group so was very isolated.
Absolutely no support groups . . . or help . . . feel quite isolated sometimes.
Other mums looking at me as he was tube fed, etc. felt very isolated.
No one where I lived had a CHD child.
For a long time I struggled to feel like his mummy and not a nurse because that was all I seemed to be
doing . . . medications, meds and more meds.
Very disappointed with my health visitors. I had three visits in total. Seemed more interested in me filling in
post natal depression form than in my son.
Health visitor only decided to visit 4 months after he was discharged home. Prescriptions again were a
problem. No contact from GP. Local consultant at hospital didn’t even know he’d had open heart surgery
or a stroke post-op! V v frustrating!
I’ve had good support from local GP’s practice and the local hospital when needed. No one has ever made
me feel like I’m wasting time and have always reassured me that if I am worried they are more than happy
to see her.
She [the CLN] was brilliant, with information, care and support. In hospital and afterwards. If there was
any questions she would be there and if needs be go and find information and get back to us quickly.
My health visitor is and continues to be a positive influence in relation to our situation. Only ever a phone
call away and visits on a regular basis.
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BOX 6 Selected quotations from parents about knowledge
There has been no one in the community or local hospital that had the answers.
GP has been very supportive but tends to send my daughter to hospital rather than make decisions himself.
HV lack of experience with CHD made her slightly apprehensive with us which came across as dismissive.
I felt a bit overwhelmed and like I didn’t know what I was doing at all.
I found that we know lots more than they [community HPs] did about her condition, which was both
understandable . . . and terrifying in equal measures.
. . . just sick of explaining to everyone. I wish someone could tell me about him not the other way around.
My [health visitor] was good too & did the best she could for us despite not having all the answers about
concerns regarding baby’s heart defect. She contacted other professionals to seek advice or support for us.
She helped as much as she could . . . she admitted she didn’t know much about chds . . . but was there
when she saw I was starting to have anxiety . . .
We were [nasogastric] feeding, everything we needed to be told we were told and if we needed
support/help they were there for us.
Complete lack of information. One general leaflet about chd’s and that was it.
We was given a folder with phone numbers of ward and heart charities in it also how to care for your
child’s scar and what to look out for with the scar. I would of found it helpful if id been told what sats to
look out for as i didn’t have a clue.
BOX 7 Selected quotations from parents about the psychological and emotional impact of caring for a child after
cardiac surgery
Felt out of my depth and very scared.
It was a lonely scary time and was just left to it.
It has been the most traumatic year of my life and yet I feel I can’t really talk to anyone else about it.
The child is discharged and the parents are left walking around in an often traumatised state with no
suitable support.
Your whole life changes and no one tells you that . . . I think I had a bit of post-traumatic stress but I was so
grateful my baby was home I didn’t want to say how terrified I was constantly and how much I relived
every moment.
The last few months have been like walking in a fog, feeling completely lost at times.
I was having panic attacks and quite ‘fog-like’ for months, felt quite isolated but there seemed to be
nobody really asking about the parents.
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BOX 8 Selected quotations from parents about challenges they faced once home after surgery
We got bombarded with info in hospital but once home there’s no information as to what to look out for.
A rollercoaster of information and procedures.
Always chasing receptionists for prescriptions. Even when I have explained long lead time for meds they
don’t make any accommodations. Computer says no!
At one point we were left without heart meds for one week. Doctor refused to prescribe because the
strength of medicine needed wasn’t exactly as it was written on his notes (even tho the dosage was the
same). They told me they would phone the cardiologist to check. They didn’t. Needless to say my baby
was getting sicker & sicker. I ended up crying down the phone pleading for a prescription.
GP was supportive but nowhere local could do instant INR checks on a baby so had to travel to
[paediatric specialist centre] every couple of days which was 100 mile round trip
I had . . . this baby that struggled to feed, cried if I touched her and lost weight constantly. All I got was
‘just persevere and top her up with her [nasogastric]’
The first few days were a nightmare . . . I ended up syringing milk into her mouth as she wouldn’t take a
bottle at all.
. . . very time-consuming and lots of pressure to keep it up.
I remember feeling so lost and helpless as I tried to breast feed without hurting her.
We had a horrendous 6 months and it was me that sought out support [for feeding issues] it wasn’t just
there for us.
We weren’t offered anything. I researched myself and paid to go on a babies/children first aid course.
Think it would’ve been massively useful (if only to instill some confidence in us as parents that we could
cope if a situation had arisen) to have had some basic training or advice.
. . . we feared an emergency could happen at any time.
We were not prepared for complications other than cardiac ones so again felt lost, scared to death that
something horrendous was going to happen every time she became slightly unwell.
I was very scared about taking her out and catching a cold or something or visitors bring in germs.
Went to mother and baby group once to get him weighed and never went again as was so upsetting by
HV and other mums looking at you child’s scar and not talking.
I found my doctor very ‘stand-offish’ as if scared of him [baby].
I feel they [GP] think you are an over-reactive mum.
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BOX 9 Selected quotations from parents about factors that helped after hospital discharge
We were asked in the hospital to give her meds under the nurse’s supervision so she could check we were
administering them correctly. We were given all doses and medicines written down and plenty of syringes
to take home. We were given a lot of info on care of her wound, what to do if she went blue, etc. and
numbers for the CLN, the ward and were told any queries just to call the ward direct which we did on a
couple of occasions and got great and prompt advice.
The cardiac unit made sure we knew what was normal for him and what we should act on if we saw it.
. . . told to look for blue lips. fingers. if she got breathless tired sweaty while feeding also if oxygen levels go low.
We have open access at local hospitals and have [been] made to feel very welcome and nothing ever too
big or small to come and see them.
Our local hospital told us their doors were always open to us . . . we were always taken seriously.
We could phone the ward or community nurses at any time & discuss any concerns.
She [the CLN] was always on hand via phone or in person to answer questions and help explain stuff to us
in layman’s terms. I honestly believe she made a world of difference to our ability to cope.
Local hospital would have [baby] in for 1–2 nights so THEY knew what to expect and how to treat.
No problem was too small for the GP, she would phone the hospital if she needed to while I was waiting
and send me straight away if she was worried about her.
My health visitor is and continues to be a positive influence in relation to our situation. Only ever a phone
call away and visits on a regular basis.
Our community nurse was brilliant, she even gave me her home number just in case I needed her. The health
visitor was great, ENT [Ear, Nose and Throat] feeding specialist was really helpful and still helps if I need her.
. . . nothing is ever too small a question.
She [the CLN] was a familiar face in a whirlwind of unknowns . . . a friend in the know.
Our cardiac liaison nurses are worth their weight in gold. They are always there if I have any concerns . . .
I could not do without them now.
I will ask the other heart mums and dads first as they usually know what’s what.
My lifeline throughout the whole experience was the ‘Heartline’ charity forum [online] I got a tremendous
amount of support and got in contact with 2 mums (both with heart children) who have supported me
through the whole process.
. . . most of my support and advice has come from heart mums/dads on Facebook and the support groups there.
. . . it is the emotional support of friends and family that pulls you through.
We used to go to our local to see friends just to try and get some normal life and conversation.
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Social isolation
Social isolation was described in terms of interactions with other parents and about the support parents of
a child with CHD received from professionals. Being unable to participate in ‘normal’ mother and baby
activities resulted in mothers feeling isolated from other new mothers, with the impact sometimes having
consequences beyond the first weeks and months. Some parents described a lack of support and how the
particular needs of their baby singled them out from other parents but also had an impact on their
parenting role.
A number of parents were very specific in their descriptions of what they considered to be failings in the
support they were given, identifying specific professionals and what they thought was lacking, together
with the lack of communication between professionals about their child. In contrast, other parents
reported feeling well supported by their local community team and by the CLNs.
Knowledge
Some parents described their own and others’ knowledge, or lack of knowledge, as both challenging and
isolating. There was a lot of agreement that professionals in both secondary and primary care did not have
sufficient information about CHD and/or their child’s specific heart condition. Parents also described their
own stress associated with knowledge, in terms of either feeling that they did not know enough about
their child’s condition or, conversely, the responsibility of needing to communicate knowledge to local HPs,
which in itself could be burdensome. Others talked about the efforts that HPs in the community went to in
order to become more knowledgeable about CHD or to get advice from other professionals. Finally,
parents talked about the information they were given by the specialist centre, highlighting the degree to
which tertiary centres varied in the information they gave families about local services and support
networks, both in terms of what they provided and how they provided it.
Psychological and emotional impact
Caring for a child after cardiac surgery can have a significant psychological and emotional impact, and
parents described their anxiety, which for some developed into symptoms of post-traumatic stress or
served to heighten their feelings of isolation. One parent talked about feeling unprepared for how life had
changed and the tension between feeling grateful that her child had come through the surgery and was
back home and not feeling able to tell the team how anxious she felt. A number of parents also described
feeling in a ‘fog’ when they got home after their baby’s surgery.
Challenges
Parents provided insight into a number of challenges that they faced once home after their child’s surgery,
which contributed to and compounded the overall feeling of isolation. Some of these challenges were
related to practical issues, such as information, although other parents described a number of practical
difficulties associated with aspects of the treatment regimen, such as getting prescriptions or having to
have blood levels checked. Such perceived difficulties can undermine local health services and reduce
parents’ trust and confidence in them.
Feeding was identified as a significant challenge by a number of the parents, which was related to the
difficulties the baby had in feeding, the time it took and some of the practicalities for those children who
were tube fed. Some mothers also talked about breastfeeding; for example, one mother described her
worry about whether or not feeding would hurt her baby, whereas others discussed the lack of support
they experienced around feeding issues.
Taking home a vulnerable baby after surgery was a further source of stress for a number of parents,
related to the risk of complications, infections or the fear of something going wrong, and several
parents identified that a lack of training had contributed to their anxiety.
Finally, parents described the challenge of dealing with the reactions of others, both professionals and
other parents, to them and their baby.
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Mitigating factors
Although some parents described the challenges of caring for a baby with a heart condition after cardiac
surgery, many also talked about what helped and the factors that lessened feelings of isolation. A number
of the mitigating factors were related to the same topics that were challenges for other parents. For
example, in a number of cases parents were provided with, or had access to, training and information
before they left the specialist centre. Several parents were also given specific information about signs and
symptoms to look for in their baby. A number of parents had open-access arrangements with their local
hospital, which were clearly highly valued and helped to reassure parents. Others described the accessibility
of advice and the importance of that to the parents.
Although some parents had experienced negative reactions from HPs, others had a very positive
experience of care and support after hospital discharge from professionals in both primary and secondary
care. Parents also valued ongoing support from the CLNs in the specialist centres. Support from people
other than HPs was also identified as an important factor for reducing isolation and facilitating coping.
Parents described three main sources of non-medical support: the support of other heart families, online
and charity support, and the support of family and friends. One mother talked about wishing that she had
had ‘. . . contact with someone who had “been there done that” ’. Another mother saw parents in similar
situations to hers as her first port of call for support. Online and charity contact were recognised as
important and helpful sources of support, primarily as a means of having contact with other parents. The
support from family and friends was mentioned less frequently than other sources of support, but those
parents who did describe it saw it as an important facilitator of coping with the experience and it was also
attributed to helping parents find some normality outside of their child’s heart condition and care.
Discussion
As far as we are aware, using a charity online forum as a systematic means of eliciting views from parents
about their experiences of having a child with a health condition has not been undertaken previously
within a research project. Collection of data using this method enabled us to reach a large number of
potential participants, including those harder to reach families who may find it more difficult or not wish
to participate in projects that use more common methods of data collection such as focus groups,
interviews or questionnaires. Furthermore, the ability to see other participants’ posts may have had a
positive impact on reluctant responders and encouraged and empowered them to engage.
The core theme emerging from the forum was one of isolation, which parents described in terms of social
and physical isolation, and isolation related to knowledge. Physical and social isolation are common
themes expressed by parents of children with health needs including parents of children with other chronic
illnesses,123 autism124 and mothers of extremely preterm babies.125 Parents also talked about the stress
associated with knowledge about their child’s condition, in terms of feeling that they did not have enough
knowledge, particularly in the early stages after hospital discharge, but also the burden of responsibility as
the ‘keeper’ of the knowledge about their child’s condition and the need to inform less knowledgeable
professionals in primary care in particular. Over time parents became ‘expert parents’ in relation to the
specifics of their child’s condition and treatment, a phenomenon seen in parents of children with other
chronic conditions,126,127 but there was also some ambivalence about this role associated with the need to
assume responsibility for informing HPs outside the tertiary centre.
The psychological and emotional impact of CHD on parents is well documented128–131 and parents’
descriptions of their anxiety and symptoms of post-traumatic stress on the online forum corroborate
findings in the literature.132,133 What we were able to additionally elicit, however, were parents’ views
about the specific challenges they faced following discharge after their child’s surgery and their
perceptions about what helped mitigate their feelings of isolation and psychological distress. Key themes
that emerged were related to information, training, practical issues and support, and examples were
provided in all of these areas of when things went well and when things went badly. Interventions to
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ameliorate some of the negative factors and enhance some of the positive ones could focus on aspects
such as improving communication between HPs in tertiary, secondary and primary care; providing
appropriate training and information to parents and also to HPs, who are not specialists in CHD and its
treatment, about what to look for and what to do if a problem arises; ensuring practical aspects are in
place prior to discharge, such as open access at the local hospital, having necessary equipment locally
such as INR machines, ensuring that prescriptions are organised appropriately; and managing parent
expectations of community health services so that they are prepared for their local HPs having less
specialist knowledge without assuming that this means that their child will not receive good support.
Limitations
There were a number of limitations with this element of the study, related to the method of collecting the
data. The sample was predominantly white British, most of whom were mothers, corroborating research
which has identified that the majority of internet users are women and participants in online interactions
tend to be predominantly white, younger and highly educated.134 In order to participate they required
access to the CHF website and familiarity with Facebook, which meant that parents who did not speak
English and were not able or willing to use social media could not participate. Furthermore, participants
required a certain level of computer skills because of the requirement to register and login to the site.
It is probable that parents from a more ethnically diverse population face additional challenges and have
different experiences, which this method of data collection prevented us from capturing. Furthermore,
families who are in contact with charities offering support may be more likely to engage with this type of
research, thus limiting the representativeness of the sample. Finally, although questions posted on the
forum related to discharge after infant cardiac surgery, some of the parents provided information and
views about other stages of their journey (e.g. after surgery in later childhood). Although we did not
include these posts in our analysis when this was made explicit, it is possible that some posts were
included when the time that parents were referring to was not identified as being other than following
cardiac surgery in infancy.
Online forums also have some inherent limitations compared with more traditional face-to-face methods
of data collection. For example, non-verbal and contextual cues cannot be picked up on and specific
participant comments cannot be probed, resulting in the potential loss of some richness of the data.
Moreover, responses were generally much shorter than would be elicited in an interview. The automatically
generated transcript, while being a benefit of this research method, was also not perfect, as has been
identified previously in online forum research.135 We did not collect information about the time spent on
the site or number of visits participants made while the forum was running and we also did not know if
any participants had technical problems accessing the site at any time or whether or not potential
participants failed to join the forum at all. However, it is also important to consider the aims of this part of
the study and the fact that we were not conducting a qualitative study requiring data saturation but
wanted to elicit information about parental experiences to inform the development of a topic guide for the
in-depth interview in the next phase of the study.
Conclusion
Use of an online forum provided a means of eliciting a large number of parents’ experiences of caring for
their child after discharge from hospital following cardiac surgery. Parents engaged with the forum and
were able to articulate what went well and what went less well, in addition to sharing their stories and
supporting each other through doing so. Information gained from the forum was used to shape the
questions for the parent interviews in a subsequent phase of the study and has been used to inform the
development of an intervention, in conjunction with other findings from the study, for parents of high-risk
babies following discharge after cardiac surgery.
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Chapter 7 Signs of deterioration in infants
discharged home following congenital heart surgery
in the first year of life: a qualitative study
Some of the text of this chapter has been published previously as Tregay et al., 2016.136 © Article author(or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH) under licence. This is an
Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY
4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Background
To understand more about parent perspectives of caring for a child with complex needs after congenital
heart surgery, we undertook a qualitative study involving semistructured interviews with parents. Our study
aimed to describe the ways in which parents recognise and make decisions about their child’s symptoms,
their experience of seeking help when there was a concern, and any barriers they encountered in
engaging with services to support their child.
Methods
Parents were invited to take part in the study if their child underwent major congenital heart surgery in
their first year of life at one of three UK children’s hospitals who subsequently died or was readmitted
unexpectedly to intensive care following their initial discharge. Parents were invited to interview if their
child had their index surgery in the last 5 years and were initially approached by local specialist nurses who
obtained consent to pass on their details to the research team.
All interviews were conducted face to face by a single researcher (JT) and all but one took place in parents’
own homes. Parents were asked about caring for their child at home following surgery, the support they
received and the events leading up to any emergency readmissions. Interviews were tape-recorded and
transcribed verbatim before being analysed using framework analysis.
Framework analysis
Framework analysis137 is a structured approach to managing qualitative data that allows researchers to
organise and extract themes from the data more easily. It is a systematic approach that aims to reduce bias
and make analysis of large data sets more manageable and involves entering qualitative data (e.g. quotes
and summaries) into charts to aid interpretation, ensuring key themes are systematically searched for
across each transcript.
Analysis using the framework approach consists of five stages.
l Familiarisation: listening to audiotapes, reading transcripts, becoming aware of key ideas/recurrent
themes and noting them.
l Identifying a thematic framework: recognising emerging themes in the data set; may be guided by a
priori issues but must also be open-minded to new themes; making judgments about meaning,
relevance and importance of issues; may be tentative at this stage.
l Indexing: identifying data (e.g. quotes) that correspond to a particular theme.
l Charting: data identified during indexing are now arranged in charts of themes.
l Mapping and interpretation: analysis of key characteristics laid out in the charts; should be able to
provide a schematic diagram.
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Members of the core research team worked collaboratively and iteratively on the development of the
frameworks, mapping and interpretation of the data for each of the participant groups.
Results
Descriptive information
Specialist nurses contacted 25 families, 21 of whom agreed to be interviewed. One family was excluded,
as they did not meet inclusion criteria, leaving a total of 20 families who were interviewed for the study.
Of these families, 12 were bereaved. Fourteen interviews were conducted with one parent alone
(n= 14 mothers), and six with both parents together. A range of ethnic, educational and socioeconomic
backgrounds was represented in the sample (Table 20). One parent did not speak English as a first
language and two were bilingual.
All children had their first surgery between September 2009 and October 2013. Following their initial
surgery, 12 children were discharged home directly from the specialist surgical centre; the remainder were
discharged to their local hospital in a ‘step-down’ arrangement. A case-by-case summary of complications
and symptoms for each patient is provided in Table 21.
Data are presented in three main sections. The first describes symptoms of deterioration noted by families
and is divided into five subsections: no symptoms, feeding, respiratory distress, appearance and behaviour.
The second section focuses on decision-making about symptoms and the final section describes families’
experiences of seeking help. Additional quotes are presented in Boxes 10–16.
TABLE 20 Family demographics. Reproduced from Tregay et al., 2016.136 © Article author (or their employer) 2016.
Produced by BMJ Publishing Group Ltd (& RCPCH) under licence. This is an Open Access article distributed in
accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to
distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/
Demographic information Number
Ethnicity (of child)
White
British 14
European 1
Asian
Bangladeshi 1
Pakistani 1
Other 1
Mixed
White/black African 1
White/black other 1
Educational history (primary caregiver)
Learning disability 1
Primary/secondary 11
Graduate 5
Postgraduate 3
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TABLE 21 Case-by-case summary of diagnoses, complications result in readmission and symptoms. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH) under
licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
ID Diagnosis Complication Symptoms
FR01 SV disease (not HLHS) Right diaphragm palsy
with plication
Respiratory distress
FR02 HLHS Wound infection
(emergency sternal
wound debridement)
Reduced feeding
Severe vomiting
Abdomen ‘not quite right’ (respiratory distress)
FB03a TGA (plus or minus
other features)
Out-of-hospital cardiac
arrest (cause unknown)
Collapsed at home after a feed
No other symptoms
FB04a HLHS Sudden collapse at home.
Died in A&E
Excessive crying and screaming
Collapsed at home
FB05a HLHS Aspirated at home Reduced feeding
Severe vomiting
Dry nappy
FB06a VSD plus significant
medical comorbidity
Sudden collapse at home Slight cough
FR07 SV disease (not HLHS) Blocked left shunt
(urgent redo)
Respiratory distress
Recessing chest
Purple fingertips and lips
Did not notice first time but symptoms pointed out
at routine scan at local hospital
FR08 Tetralogy of Fallot Blocked shunt
(urgent central shunt)
No obvious symptoms
Low saturation detected during home visit
FR09 TGA (plus or minus
other features)
Resection of aortic
aneurysm
No obvious symptoms
Mother felt something was wrong but did not know
what it was, ‘mother’s instinct’
FB10a SV disease (not HLHS)
and significant medical
co morbidity
Aspirated at home Breathing
Pale colouring
Severe vomiting
Crying
Found in the night in respiratory distress
FB11a HLHS Sudden collapse at home.
Died in A&E
Excessive crying
Unable to settle
FB12a SV disease (not HLHS) Blocked shunt Breathlessness noted by paediatrician 2 days before,
appeared ‘normal’ to parents
Sleepier after feeds
Screaming and unable to comfort
Collapsed at home
continued
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TABLE 21 Case-by-case summary of diagnoses, complications result in readmission and symptoms. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH) under
licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ (continued )
ID Diagnosis Complication Symptoms
FB13a HLHS Blocked shunt No obvious symptoms
Routine vaccinations day before and following this:
More lethargic than usual
Diarrhoea in night
Deteriorated over the course of the day
Respiratory distress leading to collapse at home
FB14a Anomalous coronary
artery from pulmonary
artery
Sudden collapse at home.
Died in A&E
Severe sweating and vomiting after feeds
‘Spelling’ intermittently (pale/blue/grey lips)
Quiet and weak in the morning
Grunting/straining sounds
Started screaming during feed and collapsed
FR15 SV disease (not HLHS) Severe mitral
regurgitation and left
ventricular failure
Reduced appetite
Lethargic
Vomiting
Cough
‘Grunting’ breath sounds
FR16a SV disease (not HLHS) Pacemaker pocket
infection and dehydration
Severe crying and restless at night
Rapid breathing
Blue face/hands/lips
Recessing under ribs
FB17a SV disease (not HLHS) Sudden collapse at home.
Died in A&E
Appeared ‘agitated’ and generally less settled
Taking less feed in one go
Slight cough
Routine vaccinations week prior to death
Collapsed during feed
FB18a SV disease (not HLHS) Sudden collapse at home.
Died in A&E
More ‘emotional’ and ‘moody’
More difficult to comfort
Easily tired
Breathless on activity
Napping more during daytime
More unsettled at night
Blue hands and feet at times
Vomiting in hot weather
Sweating
Woke in night crying, vomiting and short of breath,
then screamed and collapsed
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TABLE 21 Case-by-case summary of diagnoses, complications result in readmission and symptoms. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH) under
licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ (continued )
ID Diagnosis Complication Symptoms
FR19 TGA (plus or minus
other features)
Readmitted for
coarctation repair
High BP picked up at local review resulting in
readmission to tertiary centre
No clinical signs observed
FR20 TAPVD Increasing LUPV stenosis,
ongoing tachypnoea and
hepatomegaly with
increased right heart
pressures secondary to
increased pulmonary
venous pressures
General ‘grumpiness’
Mother feeling that something was not right
High rate of breathing
Vomiting
A&E, accident and emergency; BP, blood pressure; ID, identification number; LUPV, left upper pulmonary vein;
TAPVD, total anomalous pulmonary venous drainage.
a Indicates that the child is deceased.
Broad diagnostic grouping have been used to preserve the anonymity of patients with rare conditions.
BOX 10 Selected quotations from parents whose child showed no obvious symptoms of deterioration. Reproduced
from Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd
(& RCPCH) under licence. This is an Open Access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this
work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/
The whole thing of, ‘You will know when your child is so unwell.’ Well, clearly he deals with it pretty well.
FR09
Everything was normal, literally, until the morning that we lost her.
FB12
She was absolutely fine, she was feeding, she was doing everything that we needed her to do,
and she was kind of growing nicely. So I think it came as a bit of a shock.
FR19
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BOX 11 Selected quotations from parents describing feeding and gastrointestinal symptoms in their child.
Reproduced from Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing
Group Ltd (& RCPCH) under licence. This is an Open Access article distributed in accordance with the terms of the
Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon
this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/
The last week of her life, she started being sick and she’s never been sick. And I said to the community
nurse ‘she’s been a bit sick and she’s not bringing up her wind . . . There’s something wrong.
FB05
He was sick the whole time. He couldn’t drink a bottle without being sick.
FR09
I think it was around that time he started to take off his feeds as well.
FB17
One thing we did notice was that if it was quite a hot day, he would be a bit sick.
FB18
BOX 12 Selected quotations from parents’ descriptions of respiratory distress in their child. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH)
under licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
It was his tummy and he was just, it wasn’t he was breathing funny, but it was just something-, he wasn’t
quite comfortable. Something wasn’t quite right.
FB02
That little bit of the whistle in her chest again and basically just the breathing, you know, with the ribs.
I don’t know how to describe it. The tummy sort of goes right in and then you can see, like, the outline
of the ribs when someone’s breathing a bit funny.
FR07
In the morning, when he’d wake up, he’d cough. I now learned that that’s because he had lots of fluid
resting on his lungs . . . At the end of August he started wheezing, but really randomly, to the point that I
knew something was wrong.
FR09
We woke up in the night time, and we noticed that [his] breathing-, he looked different and his breathing
was very hard.
FB10
‘Is she more breathless?’ I don’t actually know whether she was or not . . . I think it’s quite hard if it’s a
gradual thing. To this day I still don’t really know whether she was more breathless or not, but she was
her normal usual self.
FB12
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Sometimes she would do a noise, as if she was straining.
FB14
. . . his nose will flare.
FR16
I noticed around seven months he would be a bit more breathless, he would have to nap more often
because he would get tired more often . . . His stomach was sinking in.
FB18
He was breathing quite fast and I was like, ‘Slow down, slow down’, I didn’t know breaths could get
that fast.
FR20
BOX 13 Selected quotations from parents describing changes in their child’s appearance. Reproduced from Tregay
et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH) under
licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
We, kind of noticed her fingernails at the end were going a little bit purple. Just around here, of her lips,
they were a little bit purple.
FB02
He was smiling and happy but when he was lying down he just looked a bit-, in hindsight,
he was incredibly puffy.
FR09
. . . sometimes he was a bit pale.
FB10
I noticed that she was sweating in her hair . . . When I stripped her off, then I noticed her chest was blue,
and that-, I would have said she was sweating, but actually in retrospect she was clammy.
FB12
Her colour is a dark grey, blue and yellow. You see? There is no colour in her lips . . . My husband couldn’t
tell . . . nobody could tell, except me.
FB14
I found that he would, even if it was very cool . . . in his sleep, he would sweat an awful lot. Around his
back, his shoulders, his neck. I started to notice the blueing of the hands and his mouth . . . I think from six
months on I mentioned at every appointment that I would notice more often that his hands would get
blue, his feet would get blue, his lips.
FB18
BOX 12 Selected quotations from parents’ descriptions of respiratory distress in their child. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH)
under licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
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BOX 14 Selected quotations from parents describing a range of behavioural changes in their child. Reproduced
from Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd
(& RCPCH) under licence. This is an Open Access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this
work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/
It was quite sudden for us. He cried quite a lot and we could not know that he is not well. There was not
any sign that he was not well.
FB10
. . . apart from the day he passed away, that was the only time [we noticed anything]. Then I wasn’t overly
concerned, to me he was just crying, he didn’t look any different. [We] just couldn’t stop him crying …
Probably for a normal child, baby, that’s normal. I don’t know, being a new mother, whether that’s
normal or not normal. He was crying, and after everything I’d tried, he still wouldn’t stop crying.
FB11
I did wonder if she was head bobbing a little bit, but thought ‘She’s really tired,’ . . . so I took her back up
with me and literally within five minutes of putting her down she just started screaming.
FB12
. . . she wasn’t herself, she was a lot quieter than she usually was, a lot drowsier.
FB13
He’ll start crying a lot more, he’ll wake himself up . . . He was really unsettled, he wouldn’t sleep . . . [later:]
He kept hurling himself over, screaming like he was in pain.
FR16
He would have to nap more often . . . Also he started to get more unsettled at night. He was just more
unsettled generally.
FB18
I felt something was wrong, but I couldn’t put my finger on it.
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BOX 15 Selected quotations illustrating parent’s decision-making about their child’s symptoms. Reproduced from
Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& RCPCH)
under licence. This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
We just said [baby] just needs to be known, that’s all it is, just get known because if you present him in an
iller condition, he’s deteriorating, they need a baseline to compare it against.
FR01
It felt like total care to none at all.
FB11
I think that was the problem in the end because I was so focused on the paperwork than actually my
baby. I couldn’t see what else was going on with her because I was so worried about every drop of milk.
FB05
That’s the first time I’d seen anything like that, so I wasn’t really aware of what was going on until they
said, ‘well okay, this is the kind of stuff you need to look for’ . . . I think once you’ve seen it once you can
tell after that.
FR07
When I really feel strongly about something I just have to act on it and I need to take him to see someone
and then I can go, ‘Look, I just think that there’s something wrong here. Help me out, because I can’t tell
you what it is’.
FR09
They told you what to look out for, his blue lips and his eyes, but I think from a parent point of view,
you do not really see it as much as a medic would.
FB11
I think it’s quite hard if it’s a gradual thing. To this day I still don’t really know whether she was more
breathless or not, but she was her normal usual self.
FB12
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BOX 16 Selected quotations illustrating parent’s descriptions of seeking help when they were concerned about
their child. Reproduced from Tregay et al., 2016.136 © Article author (or their employer) 2016. Produced by
BMJ Publishing Group Ltd (& RCPCH) under licence. This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix,
adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/
[Our cardiologist] gave him some antibiotics and it cleared up, but he said ‘At what point were you going
to go to your GP?’ We said, ‘We see you.’ . . . there’s a threshold – we went the wrong side of it and
[the cardiologist] reigned us back in.
FR01
I feel like my community, my borough itself was the biggest let down for me, the hospital being the
first one.
FB04
They need to listen, ’cause that nurse that came here, she didn’t listen to me that day . . . and she was
saying ‘Wait until the meeting next week’ [review appointment at the specialist centre] . . . They’re
drumming it into me ‘make sure this, make sure that’ . . . and then they let her down.
FB05
I have always questioned, ‘Should I contact her?’ . . . ’Maybe I’m just being a little paranoid,’ but who
cares? She’s never ever gone, ‘I really wouldn’t worry about it’.
FR09
. . . what gets me is that, I have all the information, as in I know all the symptoms, I know the nitty gritty,
and I feel, sometimes, that I’m not listened to very well.
FR15
They had originally told me that being his mum . . . I would know the signs . . . then when I started to
notice things . . . and I told them, I just felt like I wasn’t being listened to.
FB18
It didn’t seem like there was any plan in place at all. They didn’t know how to deal with it or what to do
. . . They were actually trying to look through [his] red health record book for answers . . .
FR19
If he is sick, I have to decide by 5 o’clock how sick I think he is. Even in [accident and emergency] then,
there is nobody around except some overworked registrar who might not know him so well and not be so
experienced, so it has got to be done in the day or not at all . . . You have to be pushy, you have to be
proactive, otherwise I don’t know what would happen.
FR20
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Symptoms
No symptoms
A small number of families reported very mild or no obvious symptoms at all followed by the very sudden
collapse and deterioration of their child. Two apparently non-symptomatic children were readmitted as
a result of routine saturation and blood pressure monitoring, which identified a blocked shunt in one
case and the imminent need for further palliative surgery in another.
Feeding and gastrointestinal symptoms
Many families noted changes in their child’s feeding behaviour, which included a reduction in feeding,
becoming more tired during feeds and the presence or an increase in vomiting. For many families these
were symptoms that came on gradually and occurred within the context of challenging feeding behaviour
characteristic of cardiac babies. In one case a prolonged bout of diarrhoea following routine vaccinations
the previous day resulted in the very rapid decline of a previously well child.
Respiratory distress
A variety of terms were used by parents to describe respiratory symptoms in their baby. These included
descriptions of breath sounds such as ‘wheezing’, ‘grunting’, ‘straining’ and ‘whistle’; changes in the rate,
pattern or work of breathing including ‘breathlessness’; or their child’s appearance such as flaring nostrils
and recessing under the ribs, which was sometimes described by parents as an abdominal, rather than
a respiratory, symptom.
Appearance
It was common for parents to describe changes in their child’s appearance. This included changes in colour
around the lips and extremities, which in the earlier stages may have been transitory, appearing in ‘spells’
or during exertion. Interestingly, there was variation in the ways that parents described the colour of their
child: ‘blue’, ‘purple’, ‘pale’, ‘grey’ and ‘yellow’. Some parents reported that the colour changes were so
subtle that they either missed them completely or the changes were not apparent to anyone but them. The
colour change was sometimes noted in conjunction with cold hands and feet. Some parents also reported
that their child had started to become more ‘sweaty’ or ‘clammy’, particularly at night or during a feed.
Behaviour
One of the more difficult areas to quantify was parent reports of behaviour changes in their child, many of
which were subtle and not dissimilar to behaviours exhibited by healthy babies. This made these symptoms
particularly difficult for parents to evaluate. Sometimes these subtle behavioural changes were the sole
indicator that the child was unwell. In the early stages of their child’s deterioration, several parents noticed
their child becoming increasingly weak and lethargic and tiring more quickly during exertion or feeds.
Some parents noted changes to their child’s sleep pattern, sleeping more during the day and waking more
frequently in the night.
Another early sign was their child being generally more ‘moody’, ‘grouchy’, ‘emotional’, ‘agitated’ or
‘unsettled’, and generally ‘not themselves’. Parents described babies that cried more frequently and were
more difficult to comfort than usual. The changes they described were not out of keeping with what
would be expected for a healthy baby but rather they were unusual for their own child. Several parents
found this very difficult to interpret, and described a feeling of knowing something was wrong but being
unable to identify what it was. In the late stages, only hours before their child’s collapse, a number of
parents reported these behavioural symptoms increasing dramatically into persistent crying followed by
high-pitched ‘screaming’ that preceded their child’s rapid deterioration.
Decision-making about symptoms
Although many, but not all, parents recalled being given information about signs and symptoms during their
child’s hospital admission this was not always sufficient to enable them to recognise these symptoms out in
the community. Even when symptoms were recognised, parents sometimes struggled to describe these and
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to make decisions about a course of action. This was particularly true if symptoms appeared very subtle or
had a gradual onset. One parent also commented that as this was her first child she found it difficult to
evaluate symptoms, as she did not know what was ‘normal’ for a healthy baby. Several parents spoke of the
burden of completing monitoring forms at home, particularly in relation to feeding, with one parent
explicitly stating that she felt she may have missed early warning signs in her child as a result. There was also
some difficulty identifying change when the child’s baseline was atypical. A small number of parents said
that they did not recognise the symptoms on the first occasion but that once these had been pointed out to
them on their own child they found it much easier to identify them on subsequent occasions.
Often decision-making about symptoms took place in the context of local services that were relatively
unfamiliar with CHD in comparison with the specialist centres where their child had their surgery and,
in some cases this had a detrimental effect on parent’s trust in their local hospital. Despite this, some
families still recognised the need for their child to be known to local services.
Experience of seeking help
For symptoms that parents judged to be non-urgent, their first point of contact would typically be the HP with
whom they felt they had the best relationship, often the CLN at their specialist centre or the community nurse.
However, in some cases parents waited until their next follow-up appointment to discuss their concerns with
their local paediatrician or their cardiologist, resulting in a delay in their child receiving treatment. Several
parents mentioned fear of appearing ‘silly’ or ‘paranoid’, particularly to more senior HPs, although this could
be countered by positive experiences of seeking help and reassurances at an early stage, typically from the
liaison nurse, that they should telephone with any concern no matter how small.
Parents reported an overwhelmingly positive experience of the support they received from their CLN with
this link being described by one family as a ‘lifeline’. This was particularly true if this was someone they
had met during their hospital admission. In some cases the liaison nurse was able to intervene with a
family’s local hospital to facilitate more rapid access and treatment in an emergency, discuss treatment
plans with local HPs and arrange transport back to the specialist centre when required.
Not all families had a good experience of seeking help when they were concerned about their child, and
several families said they felt that their concerns were not taken seriously by their local services. In some
cases, parents were falsely reassured about symptoms or told to wait until their next follow-up
appointment to discuss it with their cardiologist. Several parents described occasions when they had to
be particularly assertive with HPs in order to get the right care for their baby.
In a number of cases parents felt that their local accident and emergency (A&E) staff were unprepared to
manage a child with CHD in an emergency, and in some cases there were also problems with A&E staff
gaining access to the information they needed to treat the child. Out-of-hours service at A&E was also
raised by some parents, with many detailing long wait times and one parent describing having to make
decisions about the severity of her child’s symptoms within working hours in order to get the best care.
Discussion
Our study has described the ways in which parents recognise and make decisions about their child’s
symptoms at home after congenital heart interventions in the first year of life and details parental accounts
of seeking help. Our findings suggest that, although the potential for postdischarge deterioration in these
children is well known (see Chapter 2), information given to parents may not always sufficient for them to
make decisions about their child’s symptoms in the community.
One difficulty is in the language used to describe symptoms to parents. For example, some classic
descriptions of heart failure suggest that parents look out for ‘blue’ skin colour in their child. A number of
parents in our study found this vocabulary ambiguous and difficult to interpret with several different
descriptions of colour being used by parents to describe cyanosis in their child. Decision-making may
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be particularly challenging if symptoms appear gradually or if parents have no previous experience of
seeing their child unwell. Our study also highlighted behavioural symptoms as being a potentially
under-recognised sign of deterioration in these children. Within our sample many parents described subtle
changes in their child’s behaviour such as changes in sleep pattern, lethargy, crying and general irritability.
These were some of the more difficult symptoms to interpret as they often presented subtly at first and
could be difficult to distinguish from behaviour typical of a healthy infant. It is important that parents are
encouraged to seek advice at the earliest opportunity and that those HPs at the front line have access to
the information they need in order to respond in an appropriate and timely way. We suggest that such
subtle signs as a behaviour change should be considered within the wider context of an infant’s medial
history, normal or usual clinical state and physical examination at a given time point, since these may
represent an early warning of true deterioration.
Although it is important for parents to be trained to recognise symptoms of deterioration in their child it is
also important that they are able to summon prompt and appropriate medical care when they have a
concern. Several barriers to accessing prompt medical assistance were identified and these included
parents’ fear of appearing ‘silly’ or ‘paranoid’, parents feeling that their concerns were not taken seriously,
and long wait times and lack of protocols at A&E. Several parents described feeling let down by their local
services after flagging symptoms of concern and either being falsely reassured or advised to wait until
their next follow-up appointment to discuss their concerns with their cardiologist. Factors that facilitated
access to appropriate support included parents having a trusted point of contact with whom they could
safely discuss their concerns and having the confidence to assert themselves with HPs when they were not
satisfied that their concerns had been addressed. A role for home monitoring (Ghanayem et al.15) was
also noted as potentially useful in identifying high-risk children who appear clinically well. In some cases,
apparently asymptomatic children were identified with the aid of home monitoring or measurements taken
at routine follow-up appointments suggesting that these more objective forms of surveillance may be
effective for identifying children who require intervention but appear clinically well.
Limitations
Our study has a number of limitations. First, parents approached to take part in the study were those
known to the specialist nurses who assisted with recruitment. As this meant that parents were approached
by someone familiar to them, resulting in a high opt-in rate, it is possible that those families who opted
into the study are those who had a better relationship with the specialist nurses at their hospital. An
important consideration of qualitative research methods is to describe, rather than quantify, the views held
by a population of interest; therefore, it is important to ensure that the study sample represents the
diversity present in the population being described. Our study included parents of children with a range of
diagnoses, outcomes and discharge pathways. We also attempted to achieve diversity in our sampling of
ethnicity and parent educational level, although, as is often typical in UK research, our sample included
parents of predominantly white British children. We also struggled to recruit parents’ whose first language
was not English, despite offering access to interpretation, and it is likely that these parents face additional
challenges not captured by this study.
Conclusion
Many of the complications that can arise following congenital heart surgery may lead to relatively rapid
deterioration in a small infant, thus leaving a small window of opportunity within which to intervene.
This makes it particularly important for parents to be supported to recognise symptoms in their child and
for them to be able to summon help quickly when there is a concern. The family burden of caring for
a child with complex health needs is well known,138–144 and as families responding to their infant’s symptoms
are likely to be acting under stress, it is important that the information they are provided with is straightforward
and that help is readily accessible. Therefore, our study has implications for HPs involved in the discharge
and follow-up of babies after congenital heart surgery, in relation to both interpretation of reported
symptoms and the processes they follow in response.
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Chapter 8 Going home after intervention for
congenital heart disease in infancy: qualitative
analyses of family and health professional viewpoints
Some of the text of this chapter has been published previously as Tregay et al., 2016.145 This is an OpenAccess article distributed in accordance with the Creative Commons Attribution Non Commercial
(CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work
non-commercially, and license their derivative works on different terms, provided the original work is
properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Introduction
UK paediatric cardiac services work within ‘congenital heart networks’, partly to improve postdischarge
care and outreach services.17 Some evidence indicates that increased surveillance at home (known as
HMPs) may improve outcomes in complex cardiac babies52,53,55,57,58 (see Chapter 3); however, the extent of
implementation of HMPs in the UK is unclear and other elements of the patient pathway after discharge
may also warrant improvement. We aimed to qualitatively assess the discharge process and subsequent
care of infants undergoing major interventions for CHD based on the interview data collected within our
wider study from a range of HPs and families.
Methods
Parents whose child had undergone cardiac interventions in infancy in one of three hospitals and who
subsequently had an emergency readmission to a PICU or died outside the tertiary centre were interviewed
(see Chapter 7 for details of families that were interviewed).
Cardiologists from all paediatric cardiac centres received a mail-shot through the British Congenital Cardiac
Association (BCCA), followed by a direct approach. Tertiary nurses were recruited through cardiologists or
one another, and community nurses and HVs through their links with a cardiac centre: this ensured
that they had experience of providing support for at least one infant following paediatric cardiac surgery.
Paediatricians, including paediatricians with expertise in cardiology (PECs), and GPs were approached via a
study collaborator. We attempted to gain representation from both rural and urban communities. Interviews
with HPs were conducted face to face or by telephone and lasted between 30 and 90 minutes. Topic guides
for these interviews included identification of ‘high-risk’ patients; discharge planning; handover between
tertiary and non-tertiary services; specialist centre follow-up; maintenance in the community, including
details of any HMP; and systems for readmission if a child becomes unwell in the community.
Interviews were tape-recorded, transcribed verbatim and organised using framework analysis,131 a
structured approach to managing and reducing bias in qualitative data. Our frameworks used a priori
research questions and review of the transcripts to ensure all key themes were captured; each transcript
was read by at least three members of the research team. Data from each transcript were then entered
into the framework and the completed frameworks used to summarise key themes.
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Results
Descriptive information
Information in respect of participating families is reported in Chapter 7.
The health professionals
A total of 36 HPs were interviewed: 25 were from the tertiary centres and 11 were involved in the care of
children after discharge from the tertiary centres (Table 22). One cardiologist was interviewed from each
tertiary centre (12 surgical and two non-surgical centres).
Qualitative data from interviews
Data are presented below in sections corresponding to the patient journey, with illustrative quotations.
Each section first comments on the areas of concern that were raised by respondents, and then highlights
aspects of service provision they perceived to be effective. Illustrative quotes for each section are shown
in Boxes 17–19.
Preparing for discharge
At all specialist centres, parents receive information and training using a range of verbal and written
materials, delivered by several types of HP. There was significant variability between centres, but
even within centres, content and emphasis could vary from day to day or from patient to patient,
and even between children with the same condition. Some specialist centres had developed bespoke
leaflets in-house, whereas others used those generated by charities, including the British Heart Foundation
or Little Hearts Matter. HPs varied in their views about the quality of information and training given to
families, noting difficulties in prioritising the information most crucial to an individual patient.
TABLE 22 Summary of HPs interviewed. Reproduced from Tregay et al., 2016.145 This is an Open Access article
distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative
works on different terms, provided the original work is properly cited and the use is non-commercial.
See: http://creativecommons.org/licenses/by-nc/4.0/
HPs interviewed Number
Tertiary centres
Cardiologists 14
Specialist cardiac nursesa 10
Allied HPs 1
Total 25
Non-tertiary
PECs 3
General paediatricians 2
GPs 2
HVs 2
Community nurses 2
Total 11
a For example cardiac liaison nurses, nurse practitioners.
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BOX 17 Selected quotations illustrating preparation for discharge. Reproduced from Tregay et al., 2016.145 This is
an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial
(CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
They’re sometimes given so much stuff that it’s just chucked in a bag and never got out.
Q031; GP
Everything was such a blur really . . . it was all very, very raw and difficult to understand.
FR01; parent
I often have concerns particularly if it’s the woman who doesn’t speak English, about what they are
translating because you think ‘I don't think you are getting everything I am saying to you’.
HP017; specialist nurse
I don’t get any communication from [tertiary centre] at all . . . Families get paperwork themselves. I’ll read
their paperwork when I go and see them. I don’t get any directed to me.
Q025; HV
It’s not necessarily a ‘one size fits all’ amount of information. That’s possibly where the discharge
procedures can fall down . . . I also think information like that is quite difficult to give in one hit – it needs
to be given more than once for people to really understand.
Q033; GP
Until you’re actually doing it, it doesn’t really mean anything to you.
FR09; parent
I’m not a medical expert, so I’d like to be told in layman’s terms . . . it’s nice to know the long word,
but it’s nice to know what it actually means.
FR07; parent
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BOX 18 Selected quotations illustrating the discharge processes. Reproduced from Tregay et al., 2016.145 This is an
Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC
4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and
license their derivative works on different terms, provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Some units don’t communicate very well. It may be that they’re not in our network and they function differently.
Q030; general paediatrician
It would be nice if there was consistency, but the bottom line is we’re dealing with 6 or 7 local health
boards that will have different priorities and community services may not be a priority for that particular
area . . . we have to adapt what we do according to where they are.
F005; cardiologist
They were hoping my local hospital would give me a paediatrician by the time we left, which didn’t
happen . . . they tried to get me an A&E passport card . . . but unless you have a paediatrician it’s hard for
you to have that.
F04; parent
The patient has gone home and I have no idea who this is. If this patient crashes they will come to my local
hospital and we would have no information at all about this patient and we would be managing them.
Q027; PEC
If they give the information to parents, well give it to us as well. Don’t let us go in blind.
Q026; community nurse
BOX 19 Selected quotations illustrating views about maintenance at home. Reproduced from Tregay et al., 2016.145
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial
(CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is properly cited and the use
is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
There was an element of me having to liaise between the different organisations in order for everybody to
have the information, which didn’t strike me as something I should be doing.
FR08; parent
I think life would be easier [if there were] national standards for the monitoring of babies . . . I do think it
would be much easier if everybody did the same . . . it would make community nurses lives much easier
because some of the community nurses I’ve spoken to they have patients from several different centres . . .
it is really confusing for people.
CLNO017; cardiac liaison nurse
. . . I was more focused on the paperwork than my baby. I couldn't see what else was going on because I
was so worried about every drop of milk.
FB05: parent
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Families remarked that it could be ‘a lot to take on board all at once’, or ‘overwhelming’. Both parents
and professionals felt that information about the signs and symptoms that might warn of a baby’s
deterioration might be missing, vague or not documented in writing. Although several HPs had used
interpreters, both professionals and families noted the adverse impact of language barriers; interpreters
were not always available and information transfer often seemed incomplete. Interestingly, non-tertiary
HPs interviewed rarely knew what information or training families were given before discharge.
Service provision perceived to be effective
Health professionals felt that information and training was best given in chunks when families had the
time and energy to concentrate, that it should be patient specific and that parents should have a chance
to ask questions later. HPs noted that checklists used when a patient was entering a HMP offered
advantages of consistency in terms of practice between professionals (see Box 19). Both HPs and families
valued hands-on training for parents taking responsibility for care involving medical technologies
(sometimes called ‘competencies’). Clear ‘lay terms’ were seen as beneficial by families, as was practical
information about ‘what to look out for’.
Discharge process from the specialist centre
It can be difficult for HPs in tertiary centres to identify the correct secondary and primary HPs to contact
before a patient goes home; this leads to confusion, missed opportunities for communication and wasted
time. Communication works better when clinical networks are well established. Late delivery and
variable quality and content of discharge documents from the tertiary centres compounded difficulties.
Specialist technical terminology and the absence of key basic information rendered discharge documents
less useful to community professionals and indeed families.
Families were aware that crucial opportunities for information handover were sometimes missed and that
co-ordination of care after discharge could be unclear and could delay their accessing help when they
needed it. Community teams noted their scarcity of resources and how rarely individual HPs see babies
with CHD in their practice. This meant HPs valued clear, regular and consistent guidance, which was not
always provided.
Service provision perceived to be effective
Some respondents felt that transition was more effective when the network for a specialist centre was
clearly defined, and a paediatrician, particularly a PEC, co-ordinated postdischarge care. ‘Network days’
held by the tertiary centre for HPs in their linked network and a policy of early notice for HPs before
If local services aren’t familiar with CHD then they can miss the opportunity to intervene before that child
crashes a day later.
E008; cardiologist
That’s one of the more difficult things to get right I think – who to call and when.
D007; cardiologist
[The CLN] was the main point of contact really . . . she was like a lifeline. I don’t know how we would have
been [if they didn’t have a CLN].
FB03; parent
BOX 19 Selected quotations illustrating views about maintenance at home. Reproduced from Tregay et al.,
2016.145 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non
Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work
non-commercially, and license their derivative works on different terms, provided the original work is properly
cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
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a complex baby is discharged were advocated by some. Various HPs expressed the view that ‘step-down
care’, achieved by discharging potentially precarious babies from the tertiary centre to their local hospital
before going home, helped make this transition safer and improved communication. Early contact with
their particular GP was valued, even if the child seemed stable. Non-specialist HPs and parents appreciated
clear discharge documents written in non-technical language.
Maintenance at home
The default arrangements for follow-up and routine surveillance varied; who next sees the patient
and when and where they are reviewed differ enormously between diagnoses and between services.
Problems about information sharing undermined the confidence that some families had in local services
and presented challenges to HPs responsible for patient care at home.
Professionals varied in their identification of patients as ‘high risk’. This could impact their subsequent
management, for example whether or not they were flagged as having ‘open access’ to paediatric wards
rather than having to attend A&E departments. Many HPs view babies with palliated or uncorrected heart
defects and those with comorbidities or feeding difficulties as ‘high risk’. Family characteristics including
poor English, recent migration, cultural pressures and chaotic or difficult economic circumstances could
also impair communication or challenge a family’s ability to cope, adding to a child’s risk. Table 23
summarises the responses of interviewees asked about the current provision of HMPs at their centre,
which suggest there is considerable variation across the UK. Importantly, HPs and some families expressed
concern over the pressure of complying with the requirements of HMPs for multiple measurements
and documentation.
When a baby becomes unwell, it may be challenging for the families to adequately articulate their
concerns (discussed in more detail elsewhere136). Both families and HPs noted difficulties encountered by
non-specialists as they triaged babies who presented to primary or secondary care. Lack of confidence
about the need for specialist input meant that action could be either over-zealous (‘calling for everything’)
or initiated ‘too late’.
Service provision perceived to be effective
Families valued the role of the CLNs, who act to mitigate some of the difficulties previously described with
telephone calls to/from parents and relevant HPs. PECs were reported by some as able to bridge some of
the information gaps between tertiary and secondary care; however, this role is not universally available.
‘Open access’ to general paediatric wards for complex babies was viewed as beneficial by both parents
and HPs. Standardised follow-up with explicit triggers for action (known as ‘breach criteria’) were viewed
by some HPs as helpful.
Non-medical support
Families may face practical difficulties after their baby’s discharge (child care, transport or financial) but,
unless there are safeguarding or significant psychological issues, psychosocial support is unlikely to be
provided. Parents struggle with the demands of caring for their baby, including maintaining complex
regimens of medication or measurements, with some reporting difficulties obtaining repeat prescriptions
from their GP. The words ‘fear’ and ‘scary’ recurred when parents and HPs described their emotions
dealing with a sick baby in the home.
In practice, opting out of the role of being an ‘expert parent’ may not be an option for parents.
One thing [tertiary centre] said is you will become the expert as a parent. I didn’t believe that at the
start but then . . . the moment you start going into the community you realise you’re telling people
what to do, rather than them telling you.
FB04; parent
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Service provision perceived to be effective
Although not universally available, non-medical support was obtained from individual HPs in primary and
secondary care with particularly strong approval expressed in respect of support provided by tertiary CLNs.
The potential of the internet as a means of keeping in touch with HPs or accessing specialist charity
helplines was noted.
Discussion
This study is a qualitative appraisal of discharge and postdischarge care for babies undergoing intervention
for CHD within the UK. The data are informed by professionals from secondary, primary and community
care and every UK specialist centre, and by families who had first-hand experience of ‘testing the systems’:
all had either lost a baby or their baby had needed emergency readmission to PICU.
Limitations
The study has several limitations. The parents approached were already known to the specialist nurses assisting
with recruitment so potentially represent those with a good relationship to the local team. Despite our attempts
to achieve ethnic diversity, three-quarters of our sample were ‘white British’ families. Professionals approached
were purposively sampled so may not be typical of all clinicians involved in the care of cardiac infants;
furthermore, we were limited to one or two professionals per centre. Although we interviewed professionals
from secondary and primary care and from rural and urban settings, given the small number of subjects and
the large extent of the services they represent, we may not have captured a complete range of views.
Implications of our findings
Our study demonstrates certain ‘system problems’ within the discharge and follow-up pathways for infants
going home following cardiac interventions.
Paediatric cardiac network services incorporate multiple team interfaces with corresponding steep
knowledge gradients and opportunities for information loss. Infants with CHD may be medically fragile
and subject to dangerous deterioration; many non-specialist HPs and parents find this responsibility
challenging and extremely stressful. The pressures resulting from the system problems that our study
identified fall particularly on parents, CLNs and PECs.
Our study suggests that implementation of HMP (see Chapter 3) in the UK is variable and the complex
regimens of feeding, medications, weights and saturation monitoring with ‘breach criteria’ place
considerable burdens on those responsible for them.
In practice, infants with heart disease who become acutely unwell at home are likely to present to a GP,
to a local hospital via A&E or through ‘open access’ to the paediatric department. Our study identified
problems with correct identification of the deteriorating child, and difficulties determining what
appropriate steps to take from the perspective of both primary and secondary health-care professionals.
Within this context, interview participants reported the potential benefit to both parents and local medical
personnel of local ‘step-down’ care before an infant’s final discharge home after cardiac surgery, such that
the child is known when in a stable condition.
Our findings also highlighted the effective role that named and informed PECs with responsibility for local
children with heart disease could play in strengthening networks. PECs are well placed to recognise
postpericardiotomy syndrome or discriminate a respiratory infection from decompensated ventricular
function, perhaps with support from a regional cardiologist. PECs are also well placed to address the less
acute but nevertheless important aspects of managing the postoperative infant, particularly other
comorbidities and dealing with feeding difficulties, reflux or lung disease in context.
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Paediatricians with expertise in cardiology, however, may not be the first point of contact for the
deteriorating infant with CHD, and there may be potential for learning from related secondary care
examples, such as scoring tools that have been deployed in A&E and utilised by non-specialist HPs to
detect signs of deterioration in presenting children.146
Finally, at present the focus of national and international audit remains on 30-day mortality rates for
paediatric cardiac surgery68,69,147 and we note that additional audit metrics focusing on the postdischarge
stage of the patient journey may be a useful lever for quality improvement in the future.
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Chapter 9 Congenital heart charity helpline
staff viewpoints: a qualitative study
Introduction
Charities have a key role to play in providing support, information and practical assistance to patients with
health conditions. Many charities run a telephone helpline, usually staffed by volunteers, and there is
evidence (predominantly in the field of cancer) that patients and their carers/families rate these helplines
positively in terms of information provision and reducing anxiety.148 Furthermore, it has been suggested
that helplines fulfil a different function to websites, with website users less likely to request information on
sensitive topics but more likely to request factual information than helpline users.149 Helplines offer callers
anonymity, convenience, time to discuss their concerns and are also an outlet for other people indirectly
affected by a condition, such as family members and friends.150 However, previous research into the role of
helplines in health care, including those staffed by HPs, has focused on the user perspective, involving
interviews or surveys with callers rather than with the helpline staff.151,152
The CHF is a parent-led national charity that acts as the umbrella organisation for more than 20 other
organisations and charities providing support to children with heart conditions and their families in the UK.
The CHF has links to more than 12,000 families of children with CHD and provides support via its website,
e-mail and a telephone helpline. Three of the charities affiliated to the CHF are Little Hearts Matter, which
specifically supports children with SV conditions and their families; the Down’s Heart Group, which offers
support and information relating to heart conditions associated with Down syndrome; and Max Appeal!,
which supports families affected by DiGeorge syndrome/VCFS/22q11.2 deletion (which may be associated
with a congenital heart lesion).
In view of the unique perspective that helpline staff have of the issues faced by families of children with
CHD, we wanted to interview helpline staff from a number of charities to understand their experiences of
talking to families whose baby had recently been discharged after infant cardiac surgery. We also wanted
to elicit their perceptions of the key reasons/issues/concerns that families called the helpline to discuss in
relation to their baby’s cardiac surgery.
Our aims were to:
l access information about parents’ experiences with services/trying to access support (as reported
to helpline staff)
l elicit helpline staff’s perceptions about the key issues that parents call the helpline to discuss.
Methods
The CHF and three other UK charities that support families of children with CHD were approached about
participation. Each charity was provided with written information about the project and asked to provide
contact details for any helpline staff willing to participate in a short interview. All participants were assured
of anonymity in the reporting of anything they told us and it was made explicit that we were not asking
them about their responses to any issues raised by families but rather were interested in what the families
told them.
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All interviews were semistructured and followed a topic guide. Interviews focused on the following areas:
l families’ concerns when the child is initially discharged
l the information families are given about their child’s condition, what to look for and who to contact
if they are worried
l support that families access in the community
l barriers to families getting the support they need.
Participants were asked to provide either written or verbal consent concerning their participation in the
study. All interviews were tape-recorded (with participants’ agreement) and transcribed verbatim
(with all identifying information removed). Framework analysis was used to process the transcripts.
Results
Key findings from the helpline interviews
The core theme identified from the helpline interviews was communication and knowledge (Figure 9),
which was described in terms of patient and family factors, sources of support and systems. Quotes for
each theme are presented in Boxes 20–29.
Non-medical support
As well as discussing support provided by HPs and the patterns of communication between professionals
and charities in different health-care sectors, the importance of other heart families, patient support
groups and social media was identified by helpline staff.
Patient and family
Communication
and knowledge
Sources of
support
Systems
Systems/processes
Health-care professionals
Community-based support
Socioeconomic and
cultural risk factors
Single parents
Child care
Other
Other
Financial
pressures
Educational level
Cardiologists
Cardiac liaison
nurses
A and E
Politics
Timing and readiness
for discharge
Content, format and quantity of
information provided
Barriers to 
accessing support
Discharge
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‘Slipping through
the net’
Knowledge (i.e. knowing
the people/networks)
Consistency – systems,
advice, follow-up
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Health visitors and
community nursing
GPs
Communication 
with support 
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Charity support
Online support
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FIGURE 9 Themes from the helpline interviews.
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BOX 20 Selected quotations about socioeconomic and cultural risk factors
Discharge information needs to be given in the language that they understand otherwise they’re never
going to get it are they?
06
They get there where they’re 100 miles from home. What do they do? . . . But I think it’s assumed that
once you’re on your way home, then you’re on your way home and that’s your problem.
07
They couldn’t afford to get from A to B and going back for their follow-up appointments. Subsequently
they weren’t able to make the appointments . . . It does tend to be the less educated end that manages it
worse because they don’t think ahead, generally, to write things down or write questions down in
advance or write what they have been told. Because people don’t absorb information straight away.
02
And the ethnic communities like that can be quite difficult – they are really hard to reach. There are a lot
of pressures . . . we have a mum who had a child with a very complex heart defect who for a number of
years . . . her family . . . really almost banned her from taking any outside help. And it’s the cultural barriers
that’s probably the greater issue (rather than language barriers).
07
You get people from minority backgrounds who will I guess in their communities will hold back from
accessing support so perhaps wouldn’t necessarily phone a charity, wouldn’t go to find a support group.
They wouldn’t feel that that is acceptable in their own community. We have people we are in contact with
who have a child with an illness and they are disowned from their community and find it very difficult to know
where to go. It all comes down to when they are leaving the hospital, if they aren’t given the information then
they may never find it . . . so yes, there is definitely a big gap depending on their background.
01
We do get calls, especially single families, who have other siblings, who are very worried about how to
cope with child care arrangements and financially when they are taking time off work to care for their
child, especially if they are in more isolated communities and don’t necessarily have any kind of support.
03
BOX 21 Selected quotations about practical support
We have them phoning up about feeding – feeding is a VERY big issue. It is incredibly stressful and
families feel very responsible.
06
We have in the past supplied pulse oximeters because bizarrely the hospitals like the families to look at the
child and see how the child is looking. So ‘look at your baby and learn to know your baby, are they blue
around the lips are they sweaty on the head, are they breathless, is their pulse racing?’ Whereas if you’re a
qualified nurse or a consultant cardiologist then you use a pulse oximeter, but parents are encouraged not
to do so – ironic isn’t it? But the parents are supposed to look at their baby and know them from their
colour and behaviour.
07
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BOX 22 Selected quotations about signs and symptoms
We also get a lot of calls from people who have had recent discharges and they are very worried about
even the slightest thing so they are not sure– I don’t want to say they are paranoid because that sounds
negative . . . Totally understandably but they are like ‘Like oh my god I don’t know if my child’s lips are
blue. How blue is blue. I don’t know what you are talking about’.
03
A lot of them are concerned about symptoms to look out for. So we get lots of calls from specifically
mums or dads who’ve got home from the hospital who have been given lots of information but feel very
lost so their questions is usually ‘what should I do if’, ‘What should I look out for’.
04
Things that parents sometimes say ‘I don’t know if this is normal or not’ something I hear a lot ‘Is this
normal?’ and of course you can’t answer that. You don’t want to say ‘oh that’s fine’ because something
might happen to them and you don’t want to panic them and say ‘Go to A&E’. When I try and say take
them to A&E you have to say it so calmly. There are certain times that you think why are the parents
phoning a charity when they should be phoning a medical professional. That’s what worries me. Why are
they phoning us they should be phoning . . . or taking their child to a doctor?
01
They’ll go home with all the information about the medication for their children and they know exactly
when they should be giving them and how much but they don’t know why. They don’t understand that if
a child vomits what their next action should be regarding the medication they’ve given. They don’t
understand the signs and symptoms they need to be looking for so that they can trigger a concern with
someone else – they don’t understand about the respirations, they don’t understand about the colour,
the way the baby feeds, because we all know that feeding for cardiac babies gives you a whole history.
06
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BOX 24 Selected quotations about sources of support
The ones that had clear access to a CLN or something similar seemed to do best because at least they
could go back and ask.
02
What a lot of parents find very useful is where . . . the CLN has been able to talk and support the parent in
the handover to the community team – and some are better at that than others.
05
What I’m always shocked at is that some of them aren’t even aware they have the CLN as that point of
contact . . . When I contact the nurses on behalf of the family they’re amazing – they give a lot of their
time, they will speak for a long, long time and give me a very detailed response, but I just think that
families aren’t aware of them being there.
01
BOX 23 Selected quotes about emotional support
It’s when people don’t have the confidence to communicate what they need and they end up getting
intimidated or think ‘oh I must be wrong’. That’s the single most vulnerable thing and I think that can
happen to anybody.
03
I think it depends a lot on how they are coping themselves, what family support network they have
because obviously if you have got a good supportive family that are all rallying around . . . you know if you
are a single family with no support then you have complete isolation.
08
I think [they need] the acceptance that it’s ok for them to get support as well, so breaking that barrier . . .
For me the hardest helpline calls to answer are the ones where the Dad is in absolute bits saying ‘I need to
fix this – my son’s got this condition and we are out of hospital but my wife’s had to leave work and she is
in a real emotional state and I’ve got to fix this because I’m the dad’ . . . But I think something around
making it ok or making it the normal for people to ask for help. This is the helpline number whenever you
have problems, contact the [organisation] . . .
04
They [parents] are very overly aware, highly vigilant and very anxious . . . I think what people really want
when they phone us up is support, they want help, they want a face, they want somebody who can tell
them it’s going to be ok or can tell them this is what is going to happen, this is what you can expect,
or even just somebody to say ‘I understand, I will listen to you’ or ‘I don’t understand, but tell me.’
They just want someone to talk to.
03
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BOX 25 Selected quotations about helpline staff’s perceptions about knowledge of HPs in the community
You might get luck and have a GP that is tuned in, switched on, proactive, or you might get one that isn’t
really bothered. Sometimes you’re at the mercy of a belligerent receptionist . . . It would be really nice if
you could have your GP out without having to go through 2 hours of NHS phone triage and take them
out to somebody else in a community centre 5 miles up the road. So lack of personalised GP support is
so poor.
07
They [HV] ask the parent to check this and the parent comes to us and that really diminishes the trust and
faith that the parent has in the people that are supposed to be caring for their child.
03
There is the occasional fantastic HV and the occasional fantastic GP and it would be terrible to tar
them all with the same brush. But in most cases they are out of their league with knowledge base.
They don’t understand.
06
If they’ve [the family] been granted open access to the ward then that makes them feel so secure because
they’re not required to go through A&E. They can just pop up onto the ward.
07
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BOX 26 Selected quotations about patterns of communication
We work as hard as we can to make links really firm with centres because that really helps us. A lot of
times we might ring cardiac liaison nurses or doctors ourselves and ask them about helpline calls if we had
a particularly difficult one come in and we feel the parents won’t make that contact themselves. It will
depend on the unit, how easy that is. Some of the communication of some units is absolutely amazing
and we [are] very confident referring families to those units and other times the after care of some units
are very questionable.
04
We’re often giving people advice on how to speak to their cardiologists because more often than not,
and I completely understand, you go in to speak to someone and just sit there and get completely
overwhelmed by what you’re listening to and not understanding what they’re saying and then leave with
more questions . . . So what we try and do is prepare people before they see the cardiologists – try and get
them to write down all the questions they’re asking us, try and get them to write down all of those
questions because again we can’t answer them.
01
Quite a bit of my time on the phone is spent helping people to see that to get what they want they are
going to have to stamp their feet and make a nuisance of themselves because it won’t be offered up
on a plate.
02
They need to feel that confidence that the person that they are ringing won’t go oh for goodness sake
how stupid are you. Sometimes . . . the staff . . . can be a little bit condescending and expect that the
family really ought to know this now and the attitude is a little bit like what on earth are you asking me
this for again.
08
When I take those types of calls I view that as a way of giving parents . . . the permission or confidence if
you like to go back and ask questions . . . They’re not stupid questions and how about raising it like this,
this and this.
05
And also somebody communicating with their community team because if you don’t build that then the
community team don’t know what they’re doing and either avoid the family like the plague or they give
them all the wrong information.
06
What I would really like is if there was a much closer link between the clinical team . . . with a parent
support group and there is almost an automatic referral.
05
It’s that hand-over. It may well be that the community team themselves, they may not see many children
with . . . any of these conditions. So it’s outside of their experience and then you’ve got a worried mother
that’s when it can become quite difficult.
04
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BOX 27 Selected quotations about non-medical support
So to meet another Mum, to be given those opportunities, to be one on one or in a group. I think it’s just
invaluable. Just talking it through with someone.
01
They wanted to chat to families that would get the worries that they were going through and maybe see
people that had already been through that and were already on to the next stage and how you can come
through that and any tips they had to help each other.
10
I think a lot of the parents are quite lonely . . . So they feel quite alone and that’s where social media has
come in because you often see things posted on Facebook and so on . . . you see questions and that sort
of thing so they get support that way. They can build up friendships. Sometimes you are a bit worried
about the information that is given and we try to step in. So we try to monitor that.
05
BOX 28 Selected quotations about systems and processes
I don’t know how that information is given in all centres. So that might vary. I think it’s been varied . . .
some people come out feeling quite informed and others don’t . . .
09
Inconsistent provisions . . . some areas are better than others and have support while other don’t.
02
I think the quality of the CLN team and the quality of their relationships with external care providers . . .
that really fuels whether somebody will receive that support.
03
We get some patients who go into their GPs a couple of weeks later and the GP hasn’t even got a letter
so they don’t even know what surgery the child has had. I think that can just send parents into a real
panic mode because they feel like there should be joined-up information.
04
If they are seen at a local centre not at a specialist unit then you might have someone who doesn’t
specialise in cardiology. So again, they might not understand the full extent. So that’s the kind of barriers
I see.
01
[We need to] get a point of contact. Someone who can guide them at least – whether they stick with the
CLN or somebody that can guide them through the right paths to get to the point where they need to be.
Possibly on discharge some mechanism for connecting people to more local support and indeed local after
care services and local hospital and whether their care is provided because that seems to be a gap.
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Patient and family factors
Socioeconomic and cultural risk factors
Helpline staff discussed knowledge and communication in relation to characteristics of the patient
and family, in terms of socioeconomic and cultural risk factors such as language barriers, ethnicity,
financial difficulties and the problems associated with being so far from the tertiary centre.
Practical support
Staff described calls they received requesting direct support or advice about accessing support in relation
to practical topics such as feeding and the requirement for specific equipment. The CHF provides some
funding for small grants to purchase particular pieces of equipment such as INR machines, and some of
the participants talked about receiving a lot of requests for financial help, both from families and from
nurses on behalf of families. In relation to support with equipment, one helpline staff member specifically
talked about the advice that some parents were given about looking out for signs and symptoms in their
baby but not necessarily knowing how to do so.
BOX 29 Selected quotations about discharge planning and follow-up
. . . the last call I had from a family couldn’t be worse. Because they were suddenly discharged. They didn’t
think they were going for another 3 days, and they suddenly went and they didn’t have any mechanisms
in place at all at that point in time. There’s a newborn baby . . . and they had to travel so they weren’t
where their family were. So I would suggest that that one failed miserably . . . and they were really upset,
I mean REALLY upset. Nobody knew that they were going home, they didn’t know they were going home
and it was all rushed and they were frightened.
06
We have the horror stories of children who have just had open heart surgery being sent home on the tube
and getting home and the parents feeling completely let down because the treatment and the care have
been amazing and then it’s almost like ‘ok you’re done, goodbye.
04
. . . when people make the effort to put in phone calls to patients periodically, keep that communication
going which happens in some centres. I think that’s really important, that the whole of the community
involved with that child are on board with the support and the advice and the care . . . in vulnerable
situations that relinquishes some of the pressure on the parent and I think that opens up the opportunities
for the vulnerable person to access support for themselves as well as for their child . . . I think when people
have got it right is when people actively, really actively, follow-up ‘do not attends’ so when people haven’t
gone to their appointments for various reasons . . . we do often get calls from people saying ‘my
appointment is in three days and I haven’t got any money to get the train’ . . . If somebody phoned the
family before (follow-up appointment) saying ‘How are you going to get there? What’s your plan? . . .
Have you thoughts about childcare?’ I think there should be really consistent questions which are being
asked everywhere . . . We have heard of people being discharged from hospital . . . but then they are
bunged on the tube or they are doing a two and a half hour journey home on the train . . . Consideration
for that family, if you want the family to remain engaged with the services in accessing the right support.
It has to start from day dot [because] if they feel abandoned, kicked out of hospital . . .
03
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Signs and symptoms
Parents frequently used the helpline as a means of accessing support about specific signs and symptoms
they were concerned about, particularly soon after hospital discharge. Furthermore, some of the
participants mentioned calls from parents unsure about what to look for which were not in response to a
particular situation but were reflecting their more general anxiety about caring for their baby after being
discharged from hospital. Helpline staff also talked about the difficulty they have when parents call seeking
medical advice when they are not in a position to provide that advice and their own anxieties around that.
They described the tension they experience between wanting to reassure parents but at the same time not
giving them false assurances. Some helpline staff also expressed their concerns about parents’ lack of
knowledge about signs and symptoms and what to look for.
Emotional support
As well as receiving calls about particular queries and concerns, helpline staff discussed calls that they
received that were about the support needs of the family related to more general issues such as
confidence and isolation. A number of participants also talked about the psychological and emotional
impact of CHD and subsequent treatment on parents of affected children and the need for parents to feel
able to access support for themselves.
Sources of support
Participants discussed the individual sources of support that families access or call about, such as HPs in
primary, secondary and tertiary care as well as non-professional support such as social media, other
families and charities. Most of the participants talked specifically about the role of the CLN, with both
good and poor examples of how the role worked in practice.
Staff also commented on the varying levels of knowledge of, and support provided by, HPs in the
community and at the local hospital.
Communication
As well as describing sources of support, helpline staff also talked about how links were made between
professionals and families. For example, one participant described their own role, as one of the charity
helpline staff, in developing links with centres, sometimes with a view to giving more specific information
to families (see Box 26, participant 4a). Others talked about the advice they provide to parents to enable
them to talk to HPs, recognising that as helpline staff they are not able to provide the answers to parents’
medical questions but that they can have a role in facilitating communication. The level of confidence of
parents was also mentioned by some of the participants in relation to how parents interacted with HPs and
the role of the helpline staff in empowering parents. Finally, helpline staff described the importance of the
communication between the different sources of support, such as between HPs and charities or between
community and hospital professionals, and how they thought this could work more effectively.
Systems and processes
The third component of knowledge and communication focused on the systems and processes, in terms of
the content, format and quantity of information provided, knowing the network and people who should
be providing support to parents, together with barriers to obtaining support and the consequences of that.
The overarching theme was consistency and continuity – or, conversely, the individual approaches in each
centre, each community and of each professional, with the result that helpline staff perceived families to
have very different experiences of ‘the system’ and how it works. This lack of consistency was perceived
to extend across the network, from the tertiary centres and into primary and secondary care, and staff
identified the need for a more joined-up and co-ordinated approach to care for individual families.
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Participants also talked about their perceptions of what happens to families at discharge, in terms of the
planning that happens prior to discharge, the practicalities at the time of discharge and communication
with local HPs. In particular, staff described the lack of consistency and the impact on families of a poorly
planned discharge. A number of staff identified processes that they thought worked and did not work for
families once they were back home, which were primarily focused on the processes of communication and
keeping the family engaged with services.
Discussion
Helpline staff provided a unique perspective on the issues faced by parents taking children home after
cardiac surgery and identified a number of examples of when things work and do not work for families.
Knowledge and communication are clearly key elements for the families and those working with them,
and the insights of the helpline staff provide evidence to inform the development of more structured
interventions to optimise outcomes for children and their parents.
Although the core theme from the data was knowledge and communication, the overarching factor
described throughout all of the interviews was a lack of consistency in the way that families are supported
after discharge from hospital, both in terms of their information and psychosocial needs. Families
themselves clearly have different needs but the ways in which support was provided and their needs
addressed varied enormously, despite many similarities in the patient journey for infants undergoing
cardiac surgery. This variability in response was perceived to exist in all areas of care, in terms of both the
place of care (tertiary, secondary or primary) and the professionals providing it (with respect to both
individuals and generic professional groups). Helpline staff articulated many examples of good
communication and provision of knowledge by HPs but also identified many examples where families had
been failed or support had been less than optimal, however unintentional that might have been.
Limitations and strengths of the study
There are some limitations to this part of the overall study. First, although CHF and the three affiliated
charities providing support to families were involved, the overall number of participants was small. The
three organisations provide support in different ways and their access to specialised medical knowledge
varies. Participants from three of the groups provide support to specific patient groups, whereas the
remainder are there for a generic heart population covering the whole CHD spectrum. Participants could
also comment only on the support and information needs of families who contacted the helpline, which
is likely to result in the needs of some parents not being represented, such as those of parents from
non-English-speaking populations or parents who were less able, for financial, social or other reasons,
to contact the helpline. A further limitation was that not every participant had experience in each of the
areas covered by the interview; for example, one helpline staff member had not taken any calls in relation
to discharge after surgery. Finally, parents invariably call a helpline because they have a problem so the
views expressed by the helpline staff are inevitably skewed towards the things that do not work or have
gone wrong for families, rather than reflecting a more balanced view.
Despite these limitations, there are a number of unique elements with the approach adopted in this part of
the study. The helpline staff are part of national charities and are therefore in contact with families from
all over the UK, rather than only being exposed to families from a limited number of specialist centres.
They do not have affiliations with any individual centre and, although individual helpline staff will
inevitably hold opinions about aspects of care in specific centres, they were providing us with a national
overview. Furthermore, charities do not provide clinical care and in most cases helpline staff are not
medically trained, thus reducing the likelihood of medical or clinical bias influencing their responses.
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Previous research into the role of helplines in health care has focused on the user perspective, involving
interviews or surveys with callers rather than with the helpline staff.151,152 We focused instead on accessing
information about families’ needs and their experiences of using services by tapping into the staff’s body
of experience. In common with studies of cancer patients’ use of helplines,150 interviews with helpline staff
in our study indicated that parents’ reasons for calling charity helplines were multifaceted, with their
psychosocial needs being intertwined with their needs for information and advice. Thus helplines clearly
have a unique and important role in the support of families of children with CHD. Furthermore, the views
of the helpline staff we interviewed provided important and previously uncaptured evidence to help inform
and develop interventions to better support children and families after hospital discharge following infant
cardiac surgery.
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Chapter 10 Intervention development:
suggestions for health care, proposed metrics for
future monitoring and recommendations for future
research directions
Introduction
The overarching aim for this study was:
To use a mixed methods approach including quantitative analyses of national audit data and
qualitative approaches to gather information from key individuals, in order to establish an evidence
based and realistic guideline for community based surveillance of fragile infants with congenital
heart disease.153
With the specific study objective:
To combine the data and information acquired to generate the evidence based protocol or guideline
for surveillance of infants with CHD, including the ‘who’, ‘when’ and ‘how’ this should best be
delivered. The ultimate objective is to produce a workable and effective follow-up surveillance protocol
for infants discharged into the community after cardiac surgery, with appropriate targeting of higher
risk patients and consideration of measures that will be acceptable and useful to parents and
community based health care professionals. Intervention development will include consideration of
measures of success.153
This chapter discusses the development of our suggestions for service improvement in respect of
the postdischarge management of fragile infants with CHD, which represent the main deliverable of the
project, fulfilling the overarching study aim and objective. The evidence that was collected and analysed in
each phase of the study over the course of 2 years, including the two systematic reviews of the literature
(objective 1), the national audit data that generated a risk model for our outcomes of interest and CART
risk groups (objective 2), and our interviews and other qualitative explorations (objective 3), were
presented and discussed in an iterative fashion to a multidisciplinary group, over the course of the entire
study. Each of these elements of research evidence informed and fed into subsequent stages of work,
ultimately generating our final suggestions for service improvement (objective 4) and informing the
implications for future practice and research that are discussed in this chapter.
Methods
To the end of fulfilling the above stated aim and objective, an expert advisory group to IHS was established
to review the emerging evidence generated from the systematic reviews, quantitative analyses and
qualitative analyses relating to the outcomes and discharge/postdischarge management of neonates and
infants undergoing intervention for CHD and propose candidate suggestions for improving services based
on that evidence. This multidisciplinary group comprised professionals (with a diverse skill set) from the
three tertiary cardiac centres involved in the study (K Brown, K Bull, D Barron, R Franklin and P Daubeney),
representatives from primary (S Hull) and secondary care (N Barnes), patient group representatives
(R Simbodyal) and academics from the disciplines of psychology (J Tregay and J Wray), statistics (D Ridout),
epidemiology (R Knowles) and operational research (S Crowe).
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The group met on five occasions (each lasting 2–3 hours) between March 2013 and June 2014
to consider:
1. the results of mixed-methods research regarding UK service provision and outcomes specifically in this
patient population as discussed in Chapters 2 and 3 (systematic reviews), Chapters 4 and 5 (quantitative
analyses of national audit data) and Chapters 6–9 (qualitative analyses of OF data, as well as family,
professional and charity helpline views)
2. quality improvement initiatives in related areas such as the discharge of premature and high-risk infants.
In July 2014, these candidate suggestions and a summary of the evidence were shared at a facilitated
workshop with parents of infants who had undergone surgery for CHD and subsequently either died
after discharge or required emergency readmission to intensive care (10 parents representing five babies).
Their views on the acceptability of the candidate suggestions and additional ones were captured
(notes from the meeting are included in full in Appendix 9).
This phase of the project drew upon the skills and input of an operational researcher trained in quality
improvement methods (S Crowe) who was funded by the Health Foundation and joined the study team
with the express purpose of bringing operational research expertise to bear upon this phase of the study.
Establishing the final set of suggestions for health care
A working group comprising selected members of the expert advisory group and invited additional
representatives from the community and charitable sector was convened to assess the draft suggestions for
health care and propose a final set for endorsement by the IHS expert advisory group (see Appendix 10
for the working group’s terms of reference and list of members). A facilitated all-day workshop was held in
September 2014 (tape-recorded and with live minutes), in which the group was tasked with:
l reviewing the draft suggestions for health care: assessing the feasibility and acceptability of each for
service improvement
l assessing the set of draft suggestions for health care as a whole within the context of patient risk
groups and targeting these (setting priorities)
l agreeing a final set of suggestions for health-care improvement to circulate among the IHS expert
advisory group for comments and endorsement.
On the second point, the working group explicitly considered both the size and nature of the risk
associated with each of the patient groups identified in our analysis of national audit data reported in
Chapter 4 (summarised in Table 24). The groups are characterised by patient risk factors and stratified by
occurrence of outcome 2 (death or emergency readmission to paediatric intensive care within the first year
post discharge from infant cardiac surgery). Any decision about the types of interventions supported for
different patient groups will have implications for resource use. Given the limited resources available for
providing these services, the working group therefore agreed that it was important to consider the relative
size of the patient groups alongside their relative risks and the nature of those risks when thinking about
how limited resources might be targeted most effectively.
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Results
The proposals for service improvement that represent the main output of the project are set out in
Table 25. The table is structured to show the aspects of the service that might benefit from improvement
alongside the source of the evidence on which each individual statement is based, as collected over the
various phases of the study in the left-hand column. The proposals put forward by the intervention
development group, which are linked to each individual area for improvement, are listed in the right-hand
column. The elements of the patient journey that are covered within Table 25 are training and information
for families predischarge, discharge and transferring to non-specialist services, medical follow-up services,
non-medical support, provision of patient information, accessing support when a baby is sick and
knowledge gaps, weak links and poor communication between HPs.
It is worth noting that the original overarching study objective was focused on the community-based
surveillance of fragile infants with CHD, and as listed in Table 25, this area has been covered in detail in our
suggestions for service improvement (see the sections on medical follow-up services, non-medical support,
provision of patient information and accessing support when a baby is sick). In undertaking the iterative
series of reviews of the emerging evidence from the study it became apparent that optimal community-
based surveillance of these infants necessitates further inter-related improvements to additional elements of
the patient journey (see sections on training and information for families predischarge and discharge and
transferring to non-specialist services). Hence our focus widened somewhat to incorporate aspects of the
patient journey that start in the tertiary centre (including training of families and communication between
professionals in different sectors) and these additional aspects are discussed in detail in Table 25.
TABLE 24 Patient risk groups
Patient group Group characteristics
Occurrence
of adverse
events (%)a
% overall
patient
population
% overall
adverse
eventsa
1 Neurodevelopmental condition(s). May also have:
congenital anomalies (52%); HLHS, functionally UVH
or PA+ IVS (17%); LOS > 1 month (26%)
24 4 15
2 No neurodevelopmental conditions; VSD/other;
congenital anomalies; LOS > 1 month
24 2 8
3 No neurodevelopmental conditions; HLHS,
functionally UVH or PA. May also have: congenital
anomalies (10%); LOS > 1 month (20%)
15 11 26
4 No neurodevelopmental conditions; VSD/other;
no congenital anomalies; LOS > 1 month
9 4 6
5 No neurodevelopmental conditions; VSD/other;
congenital anomalies; LOS < 1 month
8 16 20
6 No neurodevelopmental conditions; VSD/other;
no congenital anomalies; LOS < 1 month
3 63 26
a Adverse event (outcome 2) is death (occurring outside a planned readmission) or emergency readmission to PICU within
the first year post discharge from infant cardiac surgery.
Congenital anomalies are a range of major anomalies (some requiring neonatal surgery) with an impact that is likely to be
life-long, for example Downs syndrome, DiGeorge syndrome, urogenital/renal malformations, tracheal/tracheoesophageal
malformations, vision/hearing deficits and exomphalos/gastrointestinal malformations.
See Appendix 7 for further details.
Neurodevelopmental conditions are a range of conditions that are likely to have lifelong impact, for example epilepsy/
seizures, developmental delay, sleep apnoea, hydrocephalus, retinopathy of prematurity, stroke, hemiparesis/hemiplegia,
anoxic encephalopathy, cerebral venous sinus thrombosis and cerebral palsy. See Appendix 7 for further details.
The six mutually exclusive patients groups identified in the analysis of national audit data (reported in full in Chapter 4). For
each group we present: the defining patient characteristics of the group; the occurrence of adverse event (outcome 2) in
the group; the percentage of the overall patient population within the group; the percentage of overall adverse events
(outcome 2) accounted for by the group.
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TABLE 25 Endorsed suggestions for service improvements
Identified service challenges and barriers to
support Suggestions and comments from the IHS
1. Training and information for families predischarge
Information overload: lots of information,
some of which families find difficult to
understand and absorb [FI, OF]
Poor timing: information is often rushed before
discharge [FI, HPI]
Insufficient training on ‘signs, symptoms,
responses’: often missed, vague or unstructured,
and no written material to take away [FI, HPI]
Barriers for non-English speakers: limited
funding and/or access to interpreters and most
resources only available in English [HPI]
Some families miss out: ‘hit and miss’ which
families are offered what information and
training, depending on the HP at bedside and
resource shortages [HPI]
1.1 For all patients, training and information should start as early as
possible, (antenatal if this is applicable) repeating as necessary and
checking that families have taken it on board
1.2 For all patients, information should be targeted towards the
individual child, for example through hands-on demonstrations with
their baby and involvement in the baby’s care while in hospital.
Nationally standardised generic information should also be provided,
for example in written form and as a web-based resource
1.3 For all patients, training and information should be provided as
far as possible in the format most helpful for the family and should
therefore be available in a range of formats (e.g. verbal, written,
visual and digital). Video and other visual information was
considered easier to understand, particularly for non-English
speakers. For example, mobile phone videos recorded at discharge of
the ‘normal’ status of the child could be used by families as a
comparison when child is unwell
1.4 For all patients, HPs should use a nationally standardised
checklist in order to plan, deliver and audit the provision of training
and information for families prior to discharge. The IHS will propose
a checklist (based on the evidence gathered in the IHS), which they
recommend for piloting and evaluation
1.5 The IHS notes that the following patient/family groups would
benefit from more frequent/intensive provision of suggestions
1.1–1.4:
l non-English-speaking families
l families with learning difficulties
l families with psychosocial concerns.
1.6 For these patient/family groups, the IHS also recommends
referral to a HV/social work team to assist in ongoing training
support (in their own home)
1.7 For non-English speakers, the IHS recommends interpreters and
translations of written material where this is feasible and appropriate
for the family but notes that where this is not possible visual
information (e.g. videos of their own child; see suggestion 3) should
be used
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TABLE 25 Endorsed suggestions for service improvements (continued )
Identified service challenges and barriers to
support Suggestions and comments from the IHS
2. Discharge and transferring to non-specialist services
Poor access to local support services: it is
difficult for specialist centres to know which local
and community services are available and how to
contact them (e.g. named individuals rather than
teams), particularly when links are not well
established. Community teams are often short of
resources and it’s harder to get support for social
(rather than medical) issues [HPI]
Inadequate planning: can be ad hoc and
strongly influenced by the availability and
accessibility of local resources, leading to
variation across the country in terms of who is
offered what follow-up care. Contact with local
services is often made on the day of discharge,
at which point it is difficult to organise
appropriate, timely support [HPI]
Poor-quality discharge letters/summaries:
letters are often very delayed, do not go to all
HPs, contain too much specialist information and
terminology and often do not include basic
information (e.g. wound care, immunisations),
what training families have received, details on
what needs to be monitored and any associated
breach criteria, what to look out for and how to
respond [HPI]
Ad-hoc planning for high-risk patients: there
is often no protocol in place for identifying high-
risk babies and the (extra) care that is offered to
them – large variability across the country [HPI]
2.1 At discharge from the specialist centre, all patients should have a
named cardiologist, named paediatrician (with expertise in
cardiology when possible) and named specialist nurse (e.g. cardiac
liaison role or equivalent). When it is not possible to allocate a
named specialist nurse, there should be a named specialist nursing
team. Responsibility for ensuring this lies with the specialist centre
2.2 At discharge home, either the specialist centre or the local
hospital if step-down, all patients should also have a named GP and
a named pharmacy (if discharged with a long-term prescription)
2.3 For all patients, responsibility for care co-ordination should be
transferred to the named paediatrician at discharge from the
specialist centre. The named paediatrician and GP are responsible for
referring to local services and maintaining effective communication
between HPs
2.4 A multidisciplinary team should be established as early as
possible (2–3 days prior to discharge or earlier) for the following
groups:
l patient groups 1, 2, 5 (and 4 when appropriate) (see Table 54
for details of groups) [multisystem]
l families with psychosocial issues (across all patient groups)
[psychosocial involvement]
This should involve phoning the HV and community nursing teams
prior to discharge and, when appropriate, inviting them to discharge
planning meetings
2.5 All patients should have a nationally standardised structured
discharge document that is distributed electronically to all relevant
HPs. The IHS will propose the minimum content for this discharge
document (based on the evidence gathered in the IHS), which they
recommend should be piloted and evaluated
2.6 For all patients, the structured discharge document should be
used for:
l developing a child-specific care plan
l discharge planning with the family, with discussions starting as
early as possible (at admission)
2.7 Weekend discharge without appropriate support or sharing of
information should be avoided for all patients
2.8 Patient groups 1–4 should receive ‘step-down’ care, that is
discharge via their local hospital. Ideally this should be as an
in-patient (even if just for 24 hours). If this is infeasible because of
the lack of bed space they should be admitted as a day case. At a
minimum (given resource constraints) they should be seen as an
outpatient as soon as possible (e.g. within 48 hours)
continued
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TABLE 25 Endorsed suggestions for service improvements (continued )
Identified service challenges and barriers to
support Suggestions and comments from the IHS
3. Medical follow-up services
Problems with clinics: clinics are often full and
running late. Specialist centre outpatient clinics
can be difficult for families to get to and are not
always attended by specialist nurses. Not all
outreach clinics are jointly run with paediatricians
or attended by specialist nurses and, in general,
there is no multiprofessional follow-up [FI, HPI]
Inconsistent specialist support between
clinics: many families (particularly ‘high risk’) get
regular calls from CLNs/CNSs, but some do not
and can find it hard to get in touch with them.
Families often do not speak with the same nurse
each time [FI, HPI]
Variability and resource challenges: the use of
local services is not standardised, the support
available varies across the country and there are
often insufficient resources. In particular, there are
not enough PEC (or out-of hours/annual leave
cover) and often newly trained or less-experienced
community nurses/HVs attend visits (sometimes
from a pooled resource so there is a lack
consistency of care). Babies must have a medical
need to get a community nurse but it can be
difficult to maintain regular home visits from HV,
as the baby may not be considered high priority
(i.e. child protection) [HPI]
No protocol for home monitoring: large
variation between centres in the provision of
HMPs (which babies and what it consists of) and
generally no clear protocol. Often a lack of clarity
among community nurses/HVs/families as to what
to do with the information monitored. Some
families find it helpful, others a distraction or too
complicated [FI, HPI]
Feeding/weight gain: very stressful aspect
of care for many families, who often feel
unsupported and receive conflicting advice
from the specialist centre, local hospital and HV.
Replacing nasogastric tubes out of hours is
particularly stressful [FI]
3.1 All patients should be seen by their named paediatrician and
named cardiologist at joint outreach clinics. A specialist nurse should
attend all outpatient clinics and outreach clinics
3.2 All families should receive ‘check-in’ telephone calls from their
named specialist nurse (team), the frequency of which should be
determined by their needs
3.3 All families should have access to a telephone support service led
by specialist nurses
The IHS notes that recommendations 3.1–3.3 are broadly in line with
the proposed standards from the NHS England Congenital Heart
Disease review. The IHS further note that in order to meet these
recommendations, additional resources may be required in some areas
3.4 All patients with a medical need (such as weight gain/feeding
difficulties) should have access to community nursing and all patients
should be referred to a HV team (via the GP or through community
child health services). It is important that the community nurses/HVs
are supported by the specialist centre (see 7.1–7.3)
3.5 Home monitoring should be provided for all patients with a
primary diagnosis of HLHS, functionally univentricular heart or PA
(including PA+ IVS). This will include all patients in CART group 3 and
some in group 1 (see above and Chapter 3)
3.6 There should be a nationally agreed protocol for home monitoring
of these patients, based on the best available evidence. The IHS
recommends that further research is conducted on the effectiveness
of constituent components of home monitoring. The IHS notes that in
order to meet the needs of a larger number of home monitoring
patients, community nurses may need to run clinics or video and voice
call clinics rather than provide home visits
3.7 The structured discharge document that is shared electronically
with all HPs should contain:
l the home monitoring protocol (with criteria specific to the
individual child) (patient group 3 and, when appropriate,
group 1)
l clear guidelines on feeding requirements, including what is
normal and expected for the individual child (patients with
weight gain/feeding difficulties)
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TABLE 25 Endorsed suggestions for service improvements (continued )
Identified service challenges and barriers to
support Suggestions and comments from the IHS
4. Non-medical support
Practical difficulties: families sometimes
experience practical difficulties in the community
that may not have been identified prior to
discharge. These include child care for siblings,
access to transport to get to follow-up
appointments, financial difficulties due to long
hospital stays, debts, loss of earnings and inability
to return to work. Some families struggle to
adhere to medication regimes and can
experience difficultly getting prescriptions
because GPs are not always clear what has been
prescribed or what to do about off-licence
medications [FI, HLI, OF]
Fear and isolation: parents often live in fear of
an emergency and the worry of infection isolates
them from other parents and support groups in
their community [FI, OF]
Families lack confidence: some families lack the
confidence to approach or challenge HPs, fail to
ask questions during appointments for fear of
appearing ignorant or incapable, or lack the
ability to articulate their concerns (particularly
non-English speakers) [HLI, HPI, OF]
The strain of ‘expert parenting’/lack of
confidence in local services: many families
have to explain/pass on information about their
child’s condition to HPs that do not have
specialist knowledge and sometimes (as the
holders of knowledge) feel they are battling with
local services. Many families take on an ‘expert
parent’ role, which can be alienating and
frightening [FI, HPI, OF]
Insufficient psychosocial support: the support
offered to families is often purely related to the
medical needs of their child with no specific
protocol for assessing their psychosocial needs
and resources harder to get for social (rather
than medical) support unless they meet criteria
for safeguarding [FI, HPI, OF]
4.1 All families should have a named GP and named pharmacy prior
to discharge. Changes to medication in hospital or as an outpatient
should be sent electronically (e-mail/fax) to the named GP and
pharmacy within an agreed timeframe (e.g. 72 hours)
4.2 Families with non-medical needs should be guided by their local
HPs (e.g. GP, HV or community nurse) towards local support services
appropriate to their needs (e.g. charity support or a family support
worker). The IHS notes that statutory services for non-medical
support are limited and declining and that this role is increasingly
met by non-statutory services. The IHS recommends that further
information is established regarding:
l The range of support services available from non-statutory
groups and how HPs can keep up to date with this (e.g.
establishing a directory that is available to families and HPs)
l The proportion (and range) of families that currently seek
support from such services and their experiences in doing so
4.3 All families should be offered an opportunity to connect with
other families (e.g. through social media and charity support groups)
and those families more likely to experience language/cultural
barriers to accessing support should be offered buddying. The IHS
noted that there would need to be appropriate infrastructure to
support this (e.g. training for buddies) and that this may be best
facilitated through the charity sector. Ideally, families with learning
difficulties or non-English-speaking families should be offered more
intensive help and encouragement to access support networks and
group 3 patients should be offered buddying with other group 3
patients specifically
4.4 All patients should be referred to a HV (via the GP or through
community child health services), who can act as an advocate for
them, for example in helping them to articulate concerns/questions
at appointments
4.5 All patients should be provided with information regarding
patient support groups, both by the specialist centre (in particular
cardiac support groups) and local HPs (local support services that
may be more generic such as child development clinics)
4.6 For all patients, the named GP and named paediatrician should
act as consistent points of contact in their locality
4.7 As part of the discharge planning process, families’ expectations
of local/community health services should be managed, with
relationships established as early as possible. Specifically, all patients
should see their named GP within 2 weeks of discharge
4.8 Psychosocial meetings should be held after ward rounds in the
specialist centre (led by the lead specialist nurse and psychologist)
in order to determine needs and liaise with local or referral services
as appropriate
4.9 Families with psychosocial needs should receive more frequent
telephone calls (‘checking in’) from their named specialist nurse
(team) and additional visits from a HV who is able to provide support
and refer on to a psychologist if necessary
continued
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TABLE 25 Endorsed suggestions for service improvements (continued )
Identified service challenges and barriers to
support Suggestions and comments from the IHS
5. Patient information
Poor sharing of patient information: there are
very few shared electronic patient record systems
across services and notes from clinics/visits are
often not sent to the other HPs involved (often
assuming that they will be forwarded on by
someone else, e.g. GP). Information is often
relayed through the families, although there is
inconsistency in the extent to which HPs use red
books, hand-held records, health booklets, etc.
[FI, HPI]
Not flagged or fast-tracked: there is often no
formal system for flagging (high-risk) babies to
local HPs or for enabling them to have quick
access to services [FI, HPI]
5.1 For all patients, every HP involved in their care should receive
electronic versions of:
l The structured discharge document (see 2.4)
l Patient-specific information about signs, symptoms and
guidance on what to do (see 6.1)
5.2 All families should have handheld notes (written and/or
electronic). The format and content of these should ideally follow a
national standard and is likely to include the structured discharge
document (see 2.4)
5.3 For all families, their clinic letters should be sent electronically to
the entire multidisciplinary team within a nationally agree standard
timeframe (e.g. 72 hours)
5.4 The postdischarge death of any patient outside a specialist centre
should be reported to the specialist centre and reviewed at a Network
Mortality and Morbidity meeting for quality improvement purposes
5.5 All patients should have open access to their local hospital
children’s ward
5.6 All patients should be flagged on their local hospital A&E system
(e.g. using flags on electronic patient records or patient management
systems), with fast-track referral to a secondary care paediatrician
5.7 All patients should be flagged on their GP practice system with
clear instructions for receptionists/other GPs regarding appropriate
fast-tracking
6. Accessing support when a baby is sick
Not knowing ‘Signs, symptoms, response’:
parents and all local HPs are often unclear
on what signs and symptoms to look for
(or threshold criteria) and how to respond, with
insufficient guidance from specialist centres
[FI, HPI]
Families not taken seriously: families
sometimes find it difficult to verbalise their
concerns, lack the confidence to seek help or do
not feel listened to by HPs when they do [FI, OF]
Failing to seek specialist advice: sometimes
local HPs fail to notify the PEC or specialist centre
of an incident (e.g. A&E visit) or contact them
when there is a concern even when they lack the
specialist knowledge they need (particularly out
of hours) [FI, HPI]
6.1 All families and all of the HPs involved in their support should
receive the same clear guidance on ‘what is normal’ for that child,
signs and symptoms to look for, how to respond and important
contact numbers, for example in the form of a traffic-light tool.
Ideally the format and content of this guidance should be
standardised nationally, with scope for tailoring to local areas/
networks as appropriate
6.2 The IHS agreed that there is an urgent need for such guidance
(e.g. traffic-light tool) to be developed, that it should be evidence
based as far as possible and that its implementation should be
formally evaluated (i.e. its effectiveness and impact on families and
HPs should be monitored)
6.3 The IHS recommends that guidance addresses out-of-hours
procedures and specifies that the named specialist nurse or
cardiologist must be informed if any patient attends hospital (for any
reason). The IHS also recommends that guidance is short and
self-contained (e.g. a sheet in the red book, fridge magnet, credit
card for wallet or telephone application) and notes that it is likely to
require different content for the following four sets of patients:
l group 1
l groups 2 and 4
l patients with a primary diagnosis of HLHS, functionally
univentricular heart or PA (including PA+ IVS). This includes all
of group 3 and some patients in group 1
l groups 5 and 6
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TABLE 25 Endorsed suggestions for service improvements (continued )
Identified service challenges and barriers to
support Suggestions and comments from the IHS
Each version of the guidance should have the scope for
customisation to the individual needs of the patient
6.4 All families should receive hands-on training in the guidance
prior to discharge. The IHS suggests that the guidance (e.g. traffic-
light tool) is also made available to families in a diary format, as this
may empower them to seek help and articulate their concerns with
HPs in a timely fashion
Note that some of the recommendations in sections 4 and 7 are also
relevant here
7. Knowledge gaps, weak links and poor communication between HPs
Qualitative evidence of knowledge gaps: all
strands of the qualitative evidence highlighted
the existence (across the entire patient journey)
of large knowledge gaps between specialist and
non-specialist HPs, weak links across different
sectors and poor communication between HPs,
identifying these as major potential or actual
causes of failures in care. Examples reported in
the data include:
l absence of anyone to co-ordinate
across specialties
l difficulty knowing who is taking responsibility
for what
l unclear who to contact and when
l information lost between hospitals/HPs
l Family communication: families are relied
upon to transfer information/knowledge
between HPs
l Between-HP communication: the
communication between HPs is hierarchical
Gaps in existing networks: these issues were
related particularly to care that did not fall within
existing ‘networks’ or well-establish personal links
between professionals (that had built a rapport
and trust over time) [FI, HLI, HPI, OF]
Effective communication and co-ordination:
examples of effective communication and
co-ordination were also reported, typically when
there was a PEC running joint clinics with the
cardiologist who was familiar with the specialist
centre processes and had direct contact with
individuals there. Often CLNs/CNSs provided the
link and point of contact between local and
specialist centres and this was reported to work
particularly well when they attended local clinics
and/or trained key link nurses in the local team
[FI, HPI]
7.1 The IHS highlights the importance of strengthening networks
and building local capacity in order to address the large knowledge
gaps between specialist and non-specialist HPs, weak links across
different sectors and poor communication between HPs, which the
IHS identified as major potential or actual causes of failures in care
7.2 In particular, the IHS recommends that all HPs involved in caring
for any patient should have the direct contact number and e-mail for
the lead clinician co-ordinating care, that is the named paediatrician,
in order to ask questions or raise concerns. They should additionally
have the contact number/e-mail for the named specialist nurse and
cardiologist at the specialist centre. This contact information will be
contained on the discharge document (see 2.4)
7.3 Further suggestions include:
l deliver an ongoing programme of education/training for local
services, for example specialist centre running study days and
networking days for community HPs
l increase the number of PEC and specialist nurses
l have cardiac-trained nurses in the community (or formal training
once a year for community paediatric nurses)
l train key link nurses in local hospitals to establish direct links and
familiarity with specialist centre protocols
l have a CHD repository at the local hospital as part of the
paediatric team’s knowledge base
l have a named health-care professional (formalised with
protected time) locally that can liaise with the specialist centre
and come to network study days
CNS, cardiac nurse specialist; HLI, helpline staff interview; HPI, health professional interview.
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Many of the service improvements proposed and refined by the working group were suggested for all
infants as they were considered to have lower resource implications and/or to be important for everyone,
irrespective of their risk (e.g. a structured discharge document or standardised training). However,
interventions considered particularly beneficial for certain patient groups were suggested selectively (e.g.
multidisciplinary care teams for children with long term complex needs in addition to their primary cardiac
diagnosis). In addition, given that over half of all adverse events occur in the 21% of patients in risk
groups 1–4 (see Table 24), suggestions regarding some of the potentially higher resource aspects of service
provision were prioritised for these high-risk patient groups (e.g. discharge home via the local hospital).
Finally, on the basis of qualitative evidence (Chapters 7 and 8), suggesting that problems in accessing
support can be exacerbated for families who face cultural or language barriers or have learning difficulties,
and on the basis that National Audit data presented in Chapter 4 indicates that more complex heart
defects, deprivation and higher-risk medical conditions such as neurodevelopmental problems are
over-represented in particular ethnic minority groups, some suggestions were prioritised for these groups
(e.g. offering and supporting family buddying).
The service challenges and barriers identified during the course of the IHS are listed below, accompanied
by the suggestions for service improvements endorsed by the IHS expert advisory group.
Discussion
Over the course of the IHS a set of evidence-informed guidelines were developed for managing the
discharge and postdischarge care of infants undergoing major cardiac intervention, which were directly
aimed at addressing challenges in this previously neglected section of the care pathway. The development
of this guideline was, indeed, the overarching aim of the study, and as stated above in the Introduction
section of this chapter, formed the basis of study objective 4. In the completion of study objectives 1–3
and the gathering of multimethods research evidence that generated information regarding patient risk
characteristics and the challenges encountered in accessing and providing services for this patient
population presented in Chapters 2–9, it became clear that the guideline would need to incorporate a
series of comments and suggestions related to discharge and postdischarge management, including
community-based surveillance of fragile infants with heart disease. These guidelines, which are presented
in full in Table 25, represent the final output of an evidence-informed, multistakeholder process, and go
beyond the original aims of our study in that they are somewhat broader in scope. This was necessary in
order to address comprehensively all of the evidence that came to light over the course of the programme
of research.
Strengths and limitations
A limitation of our research project was that the development of optimal guidelines for services across
sectors is challenging, not least because there is often limited or disparate evidence that is difficult to
synthesise (for example with no established methods equivalent to the meta-analysis of randomised
controlled trials), and inevitably involves an element of subjectivity. In this context, our study had two key
strengths. First, developing and applying a systematic and transparent process for synthesising and
incorporating a broad range of available evidence covering multiple aspects of the problem enhanced the
richness and breadth of the guidelines. For example, the qualitative evidence was very useful in specifying
what the problems in services were and how they might be improved, and the quantitative evidence
enabled prioritisation of patient groups according to their risk. Second, representatives from across the
entire patient pathway critiqued the feasibility and acceptability of the recommendations, and the needs of
service users remained of central importance through incorporating findings from an OF and interviews,
views captured in a family workshop and involving a parent representative on the expert group.
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Implications for practice
Our proposed guidelines for services are of direct relevance to all health-care professionals caring for
infants with CHD including GPs, community nurses, HVs, secondary care paediatricians and clinicians in
specialist surgical centres, as well as patients, their families and support groups. The proposals will resonate
with clinicians, patient families and user groups from other geographical areas when later postdischarge
CHD deaths have been reported as a concern in certain diagnostic groups, for example Germany55 and
the USA.26
As discussed in more detail in Table 25, there is a need for reduced variability and improved overall
standards in respect of the training and information for families with infants affected by CHD predischarge,
the process for discharge and transfer of infants with CHD to non-specialist services and their medical
follow-up services, the non-medical support for patient families, the provision of patient information, the
access to support when a baby is sick, and in reducing knowledge gaps and strengthening communication
between HPs. It is likely that such interventions could have a material impact in terms of reducing
postdischarge deaths and readmissions to intensive care, as well as improving the perceptions and
experiences of services by patients’ families.
There is a role for the relevant professional groups (e.g. the British Congenital Cardiac Association and the
PEC Special Interest Group), research funders, the national audit body and service users in taking forward
certain aspects that require further research and development (see Recommendations for research).
CHD services in the UK are currently under national review by NHS England and the findings and
conclusions reported in this article fed into the review’s public consultation on the care standards and
service specification to be used in commissioning specialist CHD services (see Appendix 11).
Suggestions for audit metrics
The evidence and suggestions from the IHS would support monitoring of the process and outcome
measures, in order to increase the focus on this neglected phase of the patient journey and hence, it is
hoped, to drive up standards of service provision. One potential option for such monitoring is the Quality
Dashboard, which is guided by the Clinical Reference Group. Please note, however, that while the IHS
team suggests the monitoring of out-of-hospital outcomes was highlighted as important within the IHS
data, the analytical steps and processes required to do this are beyond the scope of the IHS team and
would need to be considered further by, for example, the NCHDA steering committee.
The IHS findings would first need to be disseminated more widely within the community and agreement
reached about the steps required for implementing the recommendations; for example, a number of
metrics relate to standardised documents/protocols that would need to be developed and appropriately
piloted beforehand. Others require further consideration as to how the information could be collected
and/or aggregated. Furthermore, some findings may be considered more appropriate for local monitoring
for improvement purposes, rather than for inclusion on the national Quality Dashboard.
The IHS therefore suggests that the feasibility and appropriateness of including any or all of the following
metrics from Box 30 on the Quality Dashboard should be revisited in the next 1 to 2 years and, in the
meantime, steps taken to develop these areas.
Patient-reported experience measures
The IHS supports the monitoring of patient-reported experience measures alongside the process and
outcome measures in Box 30, for example adopting a similar approach to the specialist Quality Dashboards
(e.g. heart transplant and ECMO) that include three questions relating to patient-reported experience
measures. This area would require further development work.
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The importance of joined-up service specifications/commissioning across
specialist, local and community services
We emphasise that the IHS findings demonstrate the need and potential for improvements across the
entire patient journey spanning community, primary, secondary and specialist services. This would require
service specifications and commissioning to be addressed not only for the specialist services commissioned
by the Congenital Heart Services clinical reference group, but for all of these sectors. The IHS’s evidence
of weak links across sectors and poor communication between different HPs further suggests the need for
joined-up service specifications and models of commissioning across the whole patient journey, including
local and community settings.
BOX 30 Metrics proposed for use in audit
Outcome measures
Emergency unplanned readmissions to PICU within 1 year following infant heart surgery (for all infants).
Process measures
Percentage of infants with HLHS/UVH/PA/neurodevelopmental conditions/LOS in the specialist centre > 1 month
that receive ‘step-down’ care (i.e. discharge via their local hospital).
Percentage of infant deaths outside the specialist hospital that are discussed at a Network Mortality and
Morbidity conference, with details recorded on a nationally standardised pro forma.
Percentage of infants for whom a nationally standardised structured discharge document is completed prior to
discharge and distributed electronically to all of the HPs involved in their care.
Percentage of infants with HLHS/UVH/PA who are following a nationally agreed protocol for home monitoring.
Percentage of families that receive nationally agreed guidance on ‘what is normal’ for that child, signs and
symptoms to look for, how to respond and important contact numbers (e.g. in the form of a traffic-light tool).
Percentage of infants for whom all of the HPs involved in their care receive nationally agreed guidance on
‘what is normal’ for that child, signs and symptoms to look for, how to respond and important contact
numbers (e.g. in the form of a traffic-light tool).
Percentage of families that receive all required training and information prior to discharge (facilitated using a
nationally standardised checklist).
Percentage of infants who, at discharge home (either from specialist or local hospital), have a named GP.
Percentage of infants who, at discharge home (either from specialist or local hospital), have a named
pharmacist (if discharged with a long-term prescription).
Percentage of families offered an opportunity to connect with other families (e.g. through social media or
charity support groups).
Percentage of families more likely to experience language/cultural barriers to accessing support that are
offered buddying.
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Recommendations for research
The study highlighted areas where further specific research is needed, these being as follows.
Home monitoring programmes
The systematic review (see Chapter 3) revealed that data on the effectiveness of HMPs are limited: most of
the data originate from the USA (where health systems differ), with only one study available from
Germany; in addition, the data’s effectiveness is not completely certain as control patients were based on
historic data, which means that resultant biases should be considered, such as the role of other changes in
the patient journey apart from HMPs contributing to improvements. The qualitative data in our study from
the family and professional interviews reported in Chapters 7 and 8 indicated that although many
informants thought that HMPs were beneficial because they helped everyone to follow consistent
standards and increased awareness across various HP groups of high-risk patients, some parents found
HMPs burdensome. The studies in the systematic review did not contain user viewpoints, so we cannot
ascertain what these were. Furthermore, current practice across the UK in respect of HMP protocols varies
widely (see Chapter 8). Overall, the studies in the systematic review support the hypothesis that HMP are
effective (with some remaining doubts and caveats), and our study findings support the use of HMP for
HLHS, UVH and PA patients with shunt dependence. However, further national consensus building and
research is required to establish the optimal protocol and components of HMP incorporating specific
consideration of user views and cultural or language barriers before taking these forward. Additional work
is also needed to review the inclusion criteria for HMP, particularly when these necessitate additional
patients being monitored over current practice, including an assessment of resource implications. As HMP
are implemented more uniformly within UK centres, it will be vital to collect prospective information
about effectiveness.
Development and evaluation of proposed tools for improvement
Additional health-care evaluation is required of the best format, applications and effectiveness of the
proposed traffic-light tool to detect early warning signs of deterioration, as well as health-care evaluation
of the proposed structured discharge document, discharge checklist and step-down care. Cultural and
language barriers should form part of this evaluation.
Metrics for national audit
The study working group has clearly endorsed the need to include metrics for national audit and
benchmarking, which go beyond 30-day mortality rates and address the need to monitor postdischarge
outcomes for infant CHD. Given the availability of life status tracking to the national audit (NCHDA) and
the possibility being open for record linkage to occur between NCHDA and PICANet as a means to
underpin future audit (this would enable the audit of postdischarge emergency readmissions to PICU),
this is technically feasible. That said, a series of analytical steps would need to be undertaken for this to
occur, which are not insignificant.
Another important issue to consider, which is likely to require further research, is adjustment for case mix
when monitoring postdischarge outcomes. The first step that the working group proposed, of auditing
postdischarge interstage deaths in infants with HLHS, UVH and PA, incorporates case mix adjustment, as
these diagnoses represent a high-risk group as determined by our analyses. However, we note that the
risks of adverse outcome differ even between HLHS (odds ratio of outcome 1 : 7.4) and UVH–PA (odds
ratio of outcome 1 : 4.4). In this example, the national distribution of children with HLHS across specialist
centres is uneven in the UK with certain centres taking care of the majority of patients with HLHS.
If outcome is audited for HLHS together with UVH and PA, then there is the potential for an unfairly
negative assessment of outcome in a centre with a large number of patients that have HLHS. Hence,
finally, we note that further analytical and statistical steps are required in order to adequately address case
mix complexity, building upon the work we have set out in Chapter 4, such that these outcomes and
further postdischarge outcome measures proposed above for future audit, may effectively form part of the
portfolio of metrics subjected to national audit.
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Appendix 1 Electronic search strategy for risk
factors systematic review
The Cochrane Library (1999 to present), MEDLINE (1980 to present), EMBASE (1980 to present), CINAHL(1981 to present), Web of Knowledge (1980 to present) and PsycINFO (1980 to present) databases will
be searched using the following search strategy (MEDLINE search strategy):
1. neonate OR newborn OR child* OR infant* OR baby OR babies OR pediatric* OR paediatric*.ti,ab,sh
2. exp. CONGENITAL ABNORMALITIES
3. ‘congenital abnormalit*’ OR ‘birth defect*’ OR ‘congenital malformation*’ OR ‘congenital anomal*’
4. 2 OR 3
5. 1 AND 4
6. exp SURGICAL PROCEDURES, OPERATIVE
7. surgery OR ‘surgical procedure*’ OR ‘surgical intervention’ OR operation* OR ‘shunt’ OR ‘arterial
shunt’ OR Norwood OR ‘arterial switch’ OR ‘truncus repair’ OR ‘interrupted adj3 arch repair’ OR
‘complete adj3 atrioventricular septal defect repair’ OR ‘complete AVSD repair’ OR ‘pulmonary artery
band’ OR ‘total anomalous pulmonary venous adj2 repair’ OR ‘tetralogy adj3 fallot repair’ OR
‘coarctation repair’ OR ‘ventricular septal defect repair’ OR ‘VSD repair’ OR ‘diaphragmatic hernia
repair’ OR ‘pulmonary adj5 lobectomy’ OR ‘tracheal resection’ OR ‘tracheal stenosis repair’ OR
‘oesophageal atresia repair’ OR ‘esophageal atresia repair’ OR ‘duodenal atresia repair’ OR ‘anal
atresia repair’ OR ‘Ladd* procedure’ OR ‘malrotation adj5 repair’ OR ‘omphalocoele repair’ OR
‘omphalocele repair’ OR ‘gastroschisis repair’ OR ‘spina bifida adj2 repair’ OR ‘Myelomeningocele adj2
repair’ OR ‘Kasai procedure’ OR ‘Kasai portoenterostomy’.ti,ab,sh
8. 6 OR 7
9. 5 AND 8
10. community OR home OR discharge*.ti,ab,sh
11. 9 AND 10
12. morbidity OR mortality OR death OR ‘adverse outcome’ OR readmi*.ti,ab,sh
13. 11 AND 12
14. exp. AMBULATORY SURGICAL PROCEDURES
15. ‘minor surgery’ OR ‘day surgery’ OR ‘day case’.ti,ab,sh
16. 14 OR 15
17. 13 NOT 16
18. ‘injury’.ti,ab
19. 17 NOT 18
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Appendix 2 Evidence quality assessment
framework
This appendix has been reproduced from Morley PT. Quality Assessment For Individual Studies To BeUsed For The Review Of Resuscitation Science For 2010. American Heart Association International
Liaison Committee on Resuscitation (ILCOR), 2008. URL: www.heart.org/idc/groups/heart-public/@wcm/
@private/@ecc/documents/downloadable/ucm_308201.pdf (accessed 29 August 2014). Reproduced
with permission.
TABLE 26 Evidence quality assessment framework
LOEs in order of strength:
LOE P1: inception (prospective) cohort studies (or meta-analyses of inception cohort studies), or validation of a Clinical
Decision Rule (CDR)
At study inception, the cohort is either non-diseased or all at the same stage of the disease or where groups of people
(cohorts) are observed at a point in time to be exposed or not exposed to an intervention (or the factor under study) and
then are followed prospectively with further outcomes recorded as they happen
LOE P2: follow-up of untreated control groups in RCTs (or meta-analyses of follow-up studies), or derivation of CDR, or
validated on split-sample only
LOE P3: retrospective cohort studies
Where the cohorts (groups of people exposed and not exposed-including surgical case series) are defined at a point of time
in the past and information collected on subsequent outcomes
LOE P4: studies without a control group (e.g. case series)
A single group of people exposed to the intervention (factor under study). Only outcomes after the intervention
(factor under study) are recorded in the series of people, so no comparisons can be made
After being categorised according to the levels of evidence above, studies were assessed for methodological
quality according to the presence of particular quality items relevant to that particular level of evidence:
(a) the study has most/all of the relevant quality items
(b) the study has some of the relevant quality items
(c) the study has few of the relevant quality items (but is of sufficient value to include in the review).
Level of evidence P1
Level of evidence P1: quality assessment for inception (prospective) cohort
studies (or meta-analyses of inception cohort studies), or validation of a
Clinical Decision Rule (CDR)
Were comparison groups clearly defined? Yes/no
Were outcomes measured in the same (preferably blinded), objective way in both groups? Yes/no
Were known confounders identified and appropriately controlled for? Yes/no
Was follow-up of patients sufficiently long and complete (e.g. > 80%) Yes/no
Quality of evidence (please circle) A (4 factors) B (3 factors) C (≤ 2 factors)
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Level of evidence P1: quality assessment for meta-analyses of inception/
prospective cohort studies
A meta-analyses of these types of studies is also allocated a LOE P1.
Were specific objectives of the review stated (based on a specific clinical question in which patient, intervention,
comparator, outcome (PICO) were specified)
Yes/no
Was the study design defined? Yes/no
Were selection criteria stated for studies to be included (based on trial design and methodological quality)? Yes/no
Were inclusive searches undertaken (using appropriately crafted search strategies)? Yes/no
Were characteristics and methodological quality of each trial identified? Yes/no
Were selection criteria applied and a log of excluded studies with reasons for exclusion reported? Yes/no
Quality of evidence (please
circle)
A (most of/all relevant quality
items)
B (some relevant quality
items)
C (few/no relevant
quality items)
Level of evidence P2
Level of evidence P2: quality assessment for studies involving follow-up of
untreated control groups in randomised controlled trials (or meta-analyses
of follow-up studies), or derivation of Clinical Decision Rule, or validated on
split-sample only
Were comparison groups clearly defined? Yes/no
Were outcomes measured in the same (preferably blinded), objective way in both groups? Yes/no
Were known confounders identified and appropriately controlled for? Yes/no
Was follow-up of patients sufficiently long and complete (e.g. > 80%) Yes/no
Quality of evidence (please
circle)
A (4 factors) B (3 factors) C (≤ 2 factors)
Level of evidence P2: quality assessment for meta-analyses of
follow-up studies
A meta-analyses of these types of studies is also allocated a level of
evidence P2
Were specific objectives of the review stated (based on a specific clinical question in which patient, intervention,
comparator, outcome (PICO) were specified)
Yes/no
Was the study design defined? Yes/No
Were selection criteria stated for studies to be included (based on trial design and methodological quality)? Yes/No
Were inclusive searches undertaken (using appropriately crafted search strategies)? Yes/NO
Were characteristics and methodological quality of each trial identified? Yes/NO
Were selection criteria applied and a log of excluded studies with reasons for exclusion reported? YES/NO
Quality of evidence (please
circle)
A (most/all relevant quality
items)
B (some relevant quality
items)
C (few/no relevant
quality items)
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Level of evidence P3
Level of evidence P3: quality assessment for retrospective cohort studies
Were comparison groups clearly defined? Yes/no
Were outcomes measured in the same (preferably blinded), objective way in both groups? Yes/no
Were known confounders identified and appropriately controlled for? Yes/no
Was follow-up of patients sufficiently long and complete? Yes/no
Quality of evidence (please circle) A (4 factors) B (3 factors) C (≤ 2 factors)
Level of evidence P4
Level of evidence P4: quality assessment for case series
Were outcomes measured in an objective way? Yes/no
Were known confounders identified and appropriately controlled for? Yes/no
Was follow-up of patients sufficiently long and complete (e.g. > 80%)? Yes/no
Quality of evidence (please circle) A (3 factors) B (2 factors) C (≤ 1 factors)
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Appendix 3 Electronic search strategy for
interventions systematic review
The Cochrane Library (1999 to present), MEDLINE (1980 to present), EMBASE (1980 to present), CINAHL(1981 to present), Web of Knowledge (dates 1980 to present) and PsycINFO (1980 to present)
databases will be searched using the following search strategy (in MEDLINE format):
1. neonate OR newborn OR child* OR infant* OR baby OR babies OR pediatric* OR paediatric*.ti,ab,sh
2. exp. CONGENITAL ABNORMALITIES
3. ‘congenital abnormalit*’ OR ‘birth defect*’ OR ‘congenital malformation*’ OR ‘congenital anomal*’.ti,
ab,sh
4. 2 OR 3
5. 1 AND 4
6. exp HOME CARE
7. exp TELEMEDICINE
8. ‘community intervention’ OR ‘monitoring’ OR ‘outreach’ OR ‘surveillance’ OR ‘telemedicine’ OR
‘tele-medicine’ OR ‘telecare’ OR ‘tele-care’ OR ‘telehealth’.ti,ab,sh
9. 6 OR 7 OR 8
10. morbidity OR mortality OR death OR ‘adverse outcome’ OR readmi*.ti,ab,sh
11. 9 AND 10
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Appendix 4 Record of data search carried out
within NCHDA and the trusted third-party site
All records in 
CCAD Congenital
(n = 107,929)
Include only non-missing 
NHS numbers
(n = 86,871)
Include only valid NHS numbers
(numeric, length= 10)
(n = 86,807)
Include procedures 
1 January 2005–31 December 2010
(n = 50,053)
Include age at
operation < 1 year
(n = 17,151)
Include only open, closed
and catheter 12,497 patients
(n = 16,655)
Exclude ‘trivial’-specific procedures
12,450 patients
(n = 16,369)
Match with PICANet list
9455 patients
(n = 13,022)
FIGURE 10 Record of data search carried out within NCHDA and the trusted third-party site (final step) in order to
generate the data set sent to the research team. CCAD, Central Cardiac Audit Database. n denotes the number
of procedures.
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Appendix 5 Specific procedure hierarchy and
groupings used for risk model and CART analyses in
Chapter 4
Reproduced from Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American HeartAssociation, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution‐Non Commercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
TABLE 27 Specific procedure hierarchy and groupings used for risk model and CART analyses in Chapter 4
Specific procedurea NCHDA hierarchyb Procedure groupc
Norwood 1 Palliative
Heart transplant 2 Palliative
TAPVC repair+ arterial shunt 3 Palliative
Fontan procedure 4 Palliative
Bidirectional cavopulmonary shunt 5 Palliative
Senning or Mustard procedure 6 Palliative
Truncus and interruption repair 7 Corrective
Truncus arteriosus repair 8 Corrective
Tricuspid valve replacement 9 Ungrouped
Interrupted aortic arch repair 10 Corrective
Multiple VSD closure 11 Corrective
Mitral valve replacement 12 Corrective
Repair of TAPVC 13 Corrective
AVSD and tetralogy repair 14 Corrective
AVSD (complete) repair 15 Corrective
AVSD (partial) repair 16 Corrective
Aortic valvotomy (surgical) 17 Corrective
Aortic valvoplasty 18 Corrective
Anomalous coronary artery repair 19 Corrective
Cor triatriatum repair 20 Corrective
Arterial switch+VSD closure 21 Corrective
Arterial switch (for isolated transposition) 22 Corrective
PA VSD repair 23 Corrective
Pulmonary valve replacement 24 Corrective
Tetralogy with absent pulmonary valve repair 25 Corrective
Tetralogy repair 26 Corrective
Isolated coarctation repair 27 Corrective
Aortic valve replacement – non-Ross 28 Corrective
Supravalvar aortic stenosis repair 29 Corrective
continued
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TABLE 27 Specific procedure hierarchy and groupings used for risk model and CART analyses in
Chapter 4 (continued )
Specific procedurea NCHDA hierarchyb Procedure groupc
Rastelli procedure 30 Corrective
Aortic valve replacement – Ross 31 Corrective
Aortic root replacement (not Ross) 32 Corrective
Subvalvar aortic stenosis repair 33 Corrective
Aortopulmonary window repair 34 Corrective
ASD repair 35 Corrective
VSD repair 36 Corrective
Arterial shunt 37 Palliative
Isolated pulmonary artery band 38 Palliative
PDA ligation (surgical) 39 Corrective
Transcatheter pulmonary valve replacementd 40 Excluded
VSD closure (catheter)d 41 Excluded
Aortic balloon valvotomy 42 Corrective
Coarctation angioplasty 43 Corrective
Pulmonary artery stentingd 44 Excluded
ASD closure (catheter)d 45 Excluded
PDA closure (catheter) 46 Corrective
Recoarctation angioplastyd 47 Excluded
Pulmonary balloon valvoplasty 48 Corrective
Blade atrial septostomyd 49 Excluded
Coarctation stenting 50 Corrective
PFO closure (catheter)d 51 Excluded
Pulmonary valvotomy (radiofrequency) 52 Corrective
Duct stenting 53 Palliative
RVOT stenting 54 Palliative
Radiofrequency ablation for supraventricular tachycardiad 55 Excluded
Implantable cardioverter defibrillatord 56 Excluded
Minor and excluded proceduresd 57 Excluded
Not a specific procedure: surgicale 58 Ungrouped
Not a specific procedure: catheterd 59 Excluded
PFO, patent foramen ovale; RVOT, right ventricular outflow tract.
a Within the NCHDA data set, each interventional procedure can be described by a combination of up to eight individual
procedural IPCCCs.73 A specific procedure algorithm developed by the NCHDA Steering Committee links the individual
IPCCCs for a given record to 1 of 57 specific procedures, that is recognisable surgical operations or catheter procedures.
b The NCHDA algorithm imposes a hierarchy with the record assigned the most complex specific procedure consistent
with the collection of codes recorded. Approximately 85% of procedures fall into one of these 57 specific procedures.
c For reasons of model reliability and validity of predictive discrimination, the index specific procedures were aggregated
into three procedural groups considered clinically meaningful to the study focus (palliative, corrective, ungrouped).
d Catheter procedure excluded from analysis.
e Note that n= 53 out of 231 children with a cardiac diagnosis of aortic arch obstruction ±VSD/ASD and no index specific
procedure had either a banding of pulmonary trunk or pulmonary trunk band removal and were therefore classified as a
‘palliative’ procedure group rather than ‘ungrouped’.
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Appendix 6 Cardiac diagnosis hierarchy and
groupings used for risk model and CART analyses in
Chapter 4
Reproduced from Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American HeartAssociation, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution‐Non Commercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
Within the NCHDA data set, each interventional procedure can be described by up to six individual
diagnostic International Paediatric and Congenital Cardiac Codes (IPCCCs). The combination of
these can be mapped to 1 of 24 primary cardiac diagnoses using a hierarchical scheme developed by
Brown et al.75 For the purposes of this study, this mapping scheme was implemented with two minor
adjustments: a new category of ‘arrhythmia’ was created (ranked 24th in the modified hierarchy) and the
‘miscellaneous congenital’ diagnostic category was split into ‘major miscellaneous diagnoses’ (ranked ninth
in the modified hierarchy) and ‘minor miscellaneous diagnoses’ (ranked 25th in the modified hierarchy).
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TABLE 28 Cardiac diagnosis hierarchy and groupings used for risk model and CART analyses in Chapter 4
Primary cardiac diagnosis category Hierarchy ranka Cardiac diagnosis groupb
HLHS 1 HLHS
Functionally univentricular heart 2 UVH or PA+ IVS
Common arterial trunk (truncus arteriosus) 3 Other
TGA+VSD/DORV-TGA type 4 Other
Interrupted aortic arch 5 Other
TGA (concordant AV and discordant VA connections) and intact
ventricular septum
6 Other
PA with an intact ventricular septum 7 UVH or PA+ IVS
PA+VSD (including Fallot type) 8 Other
Miscellaneous congenital primary diagnoses 9 Other
AVSD 10 Other
Fallot/DORV-Fallot type 11 Other
Aortic valve stenosis (isolated) 12 Other
Tricuspid valve abnormality (including Ebstein’s) 13 Other
Mitral valve abnormality (including supravalvar, subvalvar) 14 Other
TAPVC 15 Other
Aortic arch obstruction±VSD/ASD 16 Other
Pulmonary stenosis 17 Other
Subaortic stenosis (isolated) 18 Other
Aortic regurgitation 19 Other
VSD 20 VSD
Interatrial communication (ASD) 21 Other
Patent ductus arteriosus 22 Other
Acquired 23 Other
Arrhythmia 24 Other
Miscellaneous congenital terms 25 Other
Non-cardiac or uncoded diagnosis 26 Other
AV, atrioventricular; DORV, double outlet right ventricle; VA, ventriculoarterial.
a The hierarchical scheme developed by Brown et al.,75 modified for the purposes of this study with two minor
adjustments: creating a new category of ‘arrhythmia’ and splitting the original ‘miscellaneous congenital’ diagnostic
category into ‘major miscellaneous diagnoses’ and ‘minor miscellaneous diagnoses’.
b For reasons of model reliability and validity of predictive discrimination, we grouped the diagnostic categories into four
cardiac diagnosis groups considered clinically meaningful to the study focus: HLHS; functionally UVH or PA, including PA
with an intact ventricular septum; VSD; ‘other’.
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Appendix 7 Non-cardiac diagnosis and
comorbidity information used for risk model and
CART analyses in Chapter 4
Reproduced from Crowe et al., 2016.67 © 2016 The Authors. Published on behalf of the American HeartAssociation, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution‐Non Commercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
TABLE 29 Non-cardiac diagnosis and comorbidity information used for risk model and CART analyses in Chapter 4
Category
number Category
Number
of codes Examples of included clinical conditions
1 Acquired endocrine, nutritional and
metabolic conditions
82 Diabetes mellitus, alpha-1-antitrypsin disorder,
rickets, failure to thrive
2 Acquired gastrointestinal (digestive system)
conditions
166 Gastritis, constipation, liver failure, hernia,
jaundice, perianal fistula
3 Acquired infections (in any system except
respiratory infections which are included
within the category for acquired respiratory
system conditions)
144 Cytomegalovirus, Escherichia coli infection,
MRSA, meningitis, otitis media, wound abscess
4 Conditions related to haematology, oncology
or immunology, which may be acquired or
congenital
97 Acute myeloid leukaemia, factor VIII
deficiency, teratoma, sickle cell anaemia
5 Acquired musculoskeletal, connective tissue
or skin conditions
29 Atopic dermatitis, scoliosis, systemic onset
juvenile chronic arthritis
6 Acquired genitourinary system conditions 42 Acute renal failure, hydronephrosis,
rectovaginal fistula
7 Acquired respiratory system conditions 229 Stridor, asthma, bronchiolitis, pulmonary
oedema, pneumonia, haemothorax
8 Conditions originating in, or specific to, the
perinatal period
109 Birth asphyxia, gestational diabetes, meconium
ileus, shoulder dystocia
9 Non-cardiac intervention or operation,
excluding procedures that are part of routine
intensive care
478 Adenoidectomy, bone marrow transplant,
splenectomy, plication of diaphragm
10 Collapse or cardiac arrest 14 Cardiac arrest, hypovolaemic shock, fainting,
respiratory arrest
11 Acquired injury or complication of
surgery/other condition
145 Brain injury, anaesthetic shock, closed rib
fracture, vocal cord palsy, limb ischaemia
12 Congenital heart disease or cardiac
procedures
875 Heart transplant, cardiac pacemaker, catheter
procedure, Ebstein’s anomaly
13 Congenital anomalies (all severity) 342 Trisomy 18, Pierre Robin syndrome, cleft
palate, club foot, oesophageal atresia
14 Neurological or neurodevelopmental
conditions – may be congenital or acquired
126 Cataract, cerebral palsy, autistic spectrum
disorder, epilepsy, optic atrophy
15 Additional codes which are non-specific or
do not have standardised coding
429 Family history of hypothyroidism, child in
foster care, central line feeding
16 Premature birth (< 37 completed weeks’
gestation)
11 Baby born premature/very premature
17 Supportive procedures 7 ECMO, ventricular assist device
MRSA, meticillin-resistant Staphylococcus aureus.
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Non-cardiac diagnosis and comorbidity information was primarily sourced from PICANet, in which any
given PICU admission can record up to 24 Read Codes (a clinical coding system used as standard in
general practice in the UK and maintained by the Health and Social care Information Centre). In total,
3325 discrete Read Codes were present in the data set and so to explore the potential for this information
to add discriminatory power to the risk model, we developed a new scheme linking each code to at most
1 of 17 system-based categories (see Appendix 6).
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Appendix 8 Incidence of individual CHD
subgroups by ethnic group (infants operated between
2006 and 2009)
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Appendix 9 Notes from the ‘Infant Heart Study
Parent Workshop’ (19 July 2014)
Flip chart 1: what do parents want information about?
(partial list)
l Diagnosis.
l Surgery.
l Feeding.
l How is the condition going to affect normal life?
l Access to knowledge/troubleshooting [e.g. who to ask (named person)]; someone who can act as
‘back up’ both in and out of hospital and help parents to feel empowered.
l Education for the local team.
l Having criteria milestones to aim for.
l Specialists focusing only on the heart – need to share information with the appropriate teams if they
pick up something else.
Flip chart 2: how do parents decide who to contact when they
have a problem?
l Depends on the problem (e.g. if think it’s cardiac – CLN or if not then the community nurse).
l Knowledge – someone they have confidence in and believe has the knowledge needed to deal with
the problem and advise them appropriately.
l Someone who is going to act in the best interests of their child and who can connect them to the
right person.
l Someone they believe in.
l A&E – not valuable/helpful, but sometimes is the only choice.
l Did not know who to contact (lost link with CLN team due to problems with handover).
l Open access at local hospital – very helpful.
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Flip chart 3: seeking help and feedback about the
traffic-light system
l What is normal for your child? – liked this.
l Need someone refreshing your memory about symptoms on a regular basis – can be easy to forget.
l Checklist as a ‘passport’ to getting access to the right support.
l Scary time and worry that you are not going to notice the signs – good to have a list/guide.
l Good to have something more structured to give credibility to what parents say about symptoms (e.g.
‘I know something is wrong but I’m not quite sure what it is – the chart says I needed to bring him to
see you . . .’)
l Need to make the top line re: ‘what to do’ look different from the symptoms – break this up from
the rest.
l Have a sheet in the red book with info about the condition and signs/symptoms/traffic light, etc.
(like there is for Down Syndrome).
l Give traffic lights to GP.
l Good to have something separate from the rest of the information – self-contained info just about
what to look for and what to do – just the information that is REALLY important.
l Would need someone to go over it a week/few days before discharge and repeated several times –
not just before when parents just want to get home.
l Could give them a chance to practice with the traffic-light system while still in hospital.
l Could bring it to appointments to help review how baby has been and document any deterioration.
l Portable sats machine at home –? Different opinions among parents re: helpful/not helpful.
l Could be bound together as a diary.
l Traffic lights as a magnet for the fridge?
l One parent had something very similar from the Lullaby Trust – bound diary and sheet for red book –
very easy to use and reassuring.
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Appendix 10 Terms of reference and composition
of the final intervention development meeting as
referred to in Chapter 10
Composition of the subgroup
The composition of the subgroup was designed to reflect the range of professions and sectors that provide
support to babies and their families following discharge from heart surgery in the first year of life, including
specialist centres, primary and secondary care providers, community health services and charitable organisations.
The subgroup consists of selected members of the Intervention Development Group, co-applicants on the IHS
and invited representatives from other professions who have had previous involvement in IHS.
l Dr Nick Barnes, Consultant PEC (Northampton General Hospital).
l Hannah Charrot, Community Children’s Nurse (Cambridgeshire Community Services NHS Trust).
l Jan Pennington, HV (Barts Health NHS Trust).
l Sally Hull, GP and Reader in Primary Care (Jubilee Street Practice, NHS East London and the City).
l Rodney Franklin, Consultant Paediatric Cardiologist (The Royal Brompton Hospital).
l Liz Smith, Lead Advanced Nurse Practitioner (Great Ormond Street Hospital for Children NHS Trust).
l Suzie Hutchinson, Parent/Patient Representative (Chief Executive, Little Heart Matter).
l Kate Bull, Acting Principal Investigator on the Infant Heart Project (Great Ormond Street Hospital for
Children NHS Trust).
Facilitator
Sonya Crowe, Operational Researcher (University College London).
Minutes
Rachel Knowles, Paediatric Epidemiologist (UCL Institute of Child Health).
Observers
Jo Wray, Health Psychologist (Great Ormond Street Hospital); Simon Turner, Health Services Researcher
(University College London).
Background to the subgroup
Over the last 2 years, the IHS [funded by the National Institute for Health Research (NIHR), NIHR project
number 10/2002/29] has been gathering evidence about the barriers to accessing, and challenges to
providing, support for infants and their families following discharge from cardiac surgery in the first year of
life. It has also generated evidence to inform the identification of high risk infants based on factors available
to clinicians at the time of discharge. This evidence base was intended to inform recommendations for
service improvements aimed at reducing adverse events (death in the community or emergency readmission
within the first year post discharge) in this patient population.
The Intervention Development Group has met on five occasions to review and critique the evidence
gathered from the study and to propose service improvements to address the challenges and barriers
identified in the data. Subsequently, a workshop was held for families of babies that had experienced an
adverse event in order to elicit their suggestions for service improvements to address these challenges too.
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The study research team has drafted a set of data-driven ‘service challenges’ linked to ‘recommended
service improvements’ using the gathered evidence and proposals from the Family Workshop and
Intervention Development Group.
The subgroup’s responsibilities
Building on the previous work of the Intervention Development Group and the IHS research team, the
subgroup has been convened in order to assess the draft recommendations for service improvements and
agree upon a final set that they will propose to the wider Intervention Development Group for endorsement.
More specifically, the subgroup is tasked with the following:
l to review the draft recommendations – assess the feasibility and acceptability of each draft
recommendation for service improvement
l to assess the set of draft recommendations as a whole within the context of patient risk groups and
targeting recommendations (setting priorities)
l to agree a final set of recommendations to circulate amongst the wider Intervention Development
Group for comments and endorsement
l to develop a strategy for wider engagement and dissemination of the agreed recommendations (within
the context of the NHS England CHD Review).
These terms of reference were reviewed and agreed by the subgroup in their meeting on Monday
29 September 2014.
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Appendix 11 Infant Heart Study:
recommendations and suggested metrics
Document containing main recommendations of the
intervention development group and suggested metrics from
the Infant Heart Study as circulated to the Clinical Reference
Group prior to their meeting on 26 March 2015
This document is based on the headline findings of IHS, a 2-year multicentre multidisciplinary research study
funded by the NIHR with additional support from the Health Foundation. The primary funding for the IHS
was from the NIHR Health Services and Delivery Research programme (project number 10/2002/29). The
views and opinions expressed therein are those of the authors and do not necessarily reflect those of the
NIHR Health Services and Delivery Research programme or the Department of Health. Please note that these
are emerging findings, since the underpinning research data will be peer reviewed in 2015 within the grant
report for this project.
Main suggestions
Structured discharge and transfer of care
l All infants should eventually have a nationally standardised structured discharge document that is
distributed electronically to all of the health professionals involved in their care. The IHS has proposed
the minimum content for this discharge document based on the evidence gathered. A national
template would need to be appropriately reviewed, piloted and evaluated. Meanwhile, the following
recommendations are all amenable to auditing within the current disparate discharge documents:
l At discharge from the specialist centre, all infants should have a named cardiologist, named
paediatrician (with expertise in cardiology where possible) and named specialist nurse (e.g. cardiac
liaison role or equivalent). Where it is not possible to allocate a named specialist nurse, there should be
a named specialist nursing team. Responsibility for ensuring this lies with the specialist centre.
¢ This should be documented in the discharge summary. The use of a template would facilitate local
provision of audit data but in principle a template is not absolutely necessary. However,
responsibility for providing audit figures for the proportions of discharge summaries containing this
information should lie with the specialist centre.
l Infants in the following groups should receive ‘step-down’ care, that is discharge via their local hospital:
¢ all infants with HLHS, UVH or PA
¢ all infants with neurodevelopmental conditions
¢ all infants with length of stay in the specialist centre > 1 month.
¢ Ideally this ‘step-down’ should be as an in-patient transfer (even if just for 24 hours). If this is
infeasible owing to bed shortages then they should be admitted as a day case. At a minimum
(given severe resource constraints) they should be seen as an outpatient as soon as possible
(e.g. within 48 hours). In principle this can be audited using returns from the specialist centres.
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l At discharge home, either from the specialist centre or local hospital if step-down, all patients should
also have a named GP and a named pharmacist (if discharged with a long-term prescription). It is more
difficult to aggregate audit data for this recommendation for patients who have ‘stepped down’,
although it is identified as an important aim. Pending better information exchange, it should still be
possible for specialist centres to report the proportion of patients discharged without a named GP.
Home monitoring
l Home monitoring should be provided for all infants with a primary diagnosis of HLHS, functionally
univentricular heart or pulmonary atresia (including PA+ intact ventricular septum). There should be a
nationally agreed protocol for home monitoring of these patients that is based on the best available
evidence; this may take some time to achieve. The IHS recommends that further research is conducted
on the effectiveness of constituent components of home monitoring. However, in the meantime, it
should be possible for specialist centres to provide audit data showing the proportion of patients
in these categories who are on home monitoring pathways, however defined locally.
Guidance on signs, symptoms and response (e.g. a traffic-light tool)
1. All families and all of the health professionals involved in their support should receive the same clear
guidance on ‘what is normal’ for that child, signs and symptoms to look for, how to respond and
important contact numbers, for example in the form of a traffic-light tool. Ideally the format and
content of this guidance should be standardised nationally, with scope for tailoring to local areas/
networks as appropriate. This may take some time and cannot be implemented immediately, although
it will be worth considering how best to take this recommendation forward nationally.
2. The IHS demonstrated that there is an urgent need for such guidance (e.g. traffic-light tool) to be
developed and recommends that it should be evidence-based as far as possible and that its
implementation should be evaluated (i.e. its impact on families and health professionals monitored).
Information and training for families prior to discharge
l Health professionals should use a nationally standardised checklist in order to plan, deliver and audit
the provision of training and information for all families prior to discharge. The IHS will propose the
content of a checklist based on the evidence gathered. A national checklist would need to be
appropriately reviewed, piloted and evaluated. Again, this may take some time to agree nationally and
it will be worth considering how best to take this recommendation forward.
Network review of deaths outside specialist centre
l The post discharge death of any infant outside a specialist centre should be reported to the specialist
centre and reviewed at a Network Mortality and Morbidity meeting attended in person, by teleconference
or at least a written summary be distributed for quality improvement purposes. In principle, the paediatric
team with a relationship to the deceased patient should perform the fact-checking and lead the discussion.
Looking ahead, every death outside the specialist hospital should be recorded on a standard pro forma
documenting the antecedents of every death. This could potentially be aggregated nationally, although
further discussion about how this could be done is required.
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Family buddying
l All families should be offered an opportunity to connect with other families (e.g. through social media
or charity support groups) and those families more likely to experience language/cultural barriers to
accessing support should be offered buddying. The IHS notes that there would need to be appropriate
infrastructure to support this (e.g. training for buddies) and that it may be best facilitated through the
charity sector.
This is not easily audited in the first instance, but if the charity sector is prepared to evolve such a facility,
it may be possible eventually to provide information about the beneficiaries.
Suggested metrics: for immediate consideration for the
Quality Dashboard
The evidence and suggestions from IHS would support inclusion of the following process and outcome
measures on the Quality Dashboard.
Please note, however, that while IHS suggests the monitoring of out-of-hospital outcomes, the analytical
steps and processes required to do this are beyond the scope of IHS and would need to be considered
by the National Congenital Heart Diseases Audit [at National Institute for Cardiovascular Outcomes
Research (NICOR)].
BOX 31 Outcome measures 1
Outcome measuresa
Deaths outside a specialist centre within 1 year following infant heart surgery.
Emergency unplanned readmissions to PICU within 1 year following infant heart surgery for children with a
primary diagnosis of HLHS, functionally univentricular heart or pulmonary atresia (including PA+ IVS).b
Process measures
Percentage of infants who, at discharge from the specialist centre, have a named cardiologist.
Percentage of infants who, at discharge from the specialist centre, have a named paediatrician (with expertise
in cardiology where possible).
Percentage of infants who, at discharge from the specialist centre, have a named specialist nurse (e.g. cardiac
liaison role or equivalent) or named specialist nursing team.
Percentage of infants who, at discharge from the specialist centre, have a named cardiologist.
Percentage of infants who do not have a named GP at discharge from specialist centre.
Percentage of infants with a primary diagnosis of HLHS, functionally univentricular heart or pulmonary atresia
(including PA+ IVS) who are on home monitoring pathways, however defined locally.
a Although IHS strongly recommends the monitoring of out-of-hospital outcomes, the analytical steps and
processes required to do this are beyond the scope of the Study and would need to be considered by the
National Congenital Heart Diseases Audit (at NICOR).
b This is the patient subgroup for which home monitoring is recommended.
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Suggested metrics: to revisit next year for the
Quality Dashboard
The IHS surfaced a number of important and potentially problematic service areas for which there is
considerable variability across the country and for which there are currently no guidelines or protocols.
Evidence from the IHS supports the monitoring of metrics relating to these, but acknowledges that it
would not be feasible to include them on the Quality Dashboard without some further work, and that
indeed it may not be feasible to include all of them. The IHS findings would first need to be disseminated
more widely within the community and agreement reached about the steps required for implementing the
recommendations. For example, a number of metrics relate to standardised documents/protocols that
would need to be developed and appropriately piloted beforehand. Others require further consideration as
to how the information could be collected and/or aggregated. Furthermore, some may be considered
more appropriate for local monitoring for improvement purposes, or linked into a CQUIN, rather than for
inclusion on the national Quality Dashboard.
The IHS therefore suggests that the feasibility and appropriateness of including any or all of the following
metrics on the Quality Dashboard should be revisited in the next 1 to 2 years and, in the meantime,
steps taken to develop these areas.
BOX 32 Outcome measures 2
Outcome measuresa
Emergency unplanned readmissions to PICU within 1 year following infant heart surgery (for all infants).
Process measures
Percentage of infants with HLHS/UVH/PA/neurodevelopmental conditions/length of stay in the specialist centre
> 1 month that receive ‘step-down’ care (i.e. discharge via their local hospital).
Percentage of infant deaths outside the specialist hospital that are discussed at a Network Mortality and
Morbidity meeting, with details recorded on a nationally standardised pro forma.
Percentage of infants for whom a nationally standardised structured discharge document is completed prior to
discharge and distributed electronically to all of the health professionals involved in their care.
Percentage of infants with HLHS/UVH/PA who are following a nationally agreed protocol for home monitoring.
Percentage of families that receive nationally agreed guidance on ‘what is normal’ for that child, signs and
symptoms to look for, how to respond and important contact numbers (e.g. in the form of a traffic-light tool).
Percentage of infants for whom all of the health professionals involved in their care receive nationally agreed
guidance on ‘what is normal’ for that child, signs and symptoms to look for, how to respond and important
contact numbers (e.g. in the form of a traffic-light tool).
Percentage of families that receive all required training and information prior to discharge (facilitated using a
nationally standardised checklist).
Percentage of infants who, at discharge home (either from specialist or local hospital), have a named GP.
Percentage of infants who, at discharge home (either from specialist or local hospital), have a named
pharmacist (if discharged with a long-term prescription).
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Percentage of families offered an opportunity to connect with other families (e.g. through social media or
charity support groups).
Percentage of families more likely to experience language/cultural barriers to accessing support that are
offered buddying.
a Although IHS strongly recommends the monitoring of out-of-hospital outcomes, the analytical steps and
processes required to do this are beyond the scope of the IHS and would need to be considered by the
National Congenital Heart Diseases Audit (at NICOR).
Patient-Reported Experience Measures
The IHS supports the monitoring of patient reported experience measures alongside the process and
outcome measures above, for example adopting a similar approach to the specialist Quality Dashboards
(heart transplant, ECMO), which include three questions relating to patient-reported experience measures.
This area would require further development work.
The importance of joined up service specifications/commissioning across
specialist, local and community services
We emphasise that IHS findings demonstrate the need and potential for improvements across the entire
patient journey spanning community, primary, secondary and specialist services. This would require service
specifications and commissioning to be addressed not only for the specialist services commissioned by the
Congenital Heart Services clinical reference group, but for all of these sectors. The IHS’s evidence of weak
links across sectors and poor communication between different health professionals further suggests the
need for joined-up service specifications and models of commissioning across the whole patient journey,
including local and community settings.
Further information about the IHS is available from:
Sonya Crowe: xxxx
Kate Brown: xxxx
Kate Bull: xxxxx
BOX 32 Outcome measures 2 (continued)
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Appendix 12 NHS England congenital heart
disease review consultation report: references to the
Infant Heart Study
Quotations in this appendix have been reproduced from: NHS England. Consultation on Draft Standardsand Service Specifications for Congenital Heart Disease Services: Final Report. Dialogue by
Design. 2015.
Page 59: suggestions on the proposed standards for nursing
One organisation makes a list of specific suggestions based on the findings of a recent two-year
multicentre multidisciplinary research study. The study found that specialist nurses provide essential
support and are often the link between local and specialist centres. This link was best demonstrated in
cases where specialist nurses attended local clinics or trained key link nurses in local teams. The study
makes a list of recommendations, some of which are already included in the draft standards:
at discharge from the specialist centre, all infants should have a named specialist nurse (e.g. cardiac
liaison role or equivalent). Where it is not possible to allocate a named specialist nurse, there should be
a named specialist nursing team;
all families should receive ‘check-in’ telephone calls from their named specialist nurse (team), the
frequency of which should be determined by their needs;
a specialist nurse should attend all outpatient clinics and outreach clinics;
all families should have access to a telephone support service led by specialist nurses;
having cardiac trained nurses in the community (or formal training once a year for community
paediatric nurses); and
training key link nurses in local hospitals to establish direct links and familiarity with specialist
centre protocols.
The same organisation makes recommendations on how to improve the community nursing service,
which the study found to be inconsistent:
all patients with a medical need should have access to community nursing which should be supported
by the specialist centre; and
home monitoring should be provided for all patients with a primary diagnosis of HLHS5, functionally
univentricular heart or pulmonary atresia; community nurses may need to run Skype clinics (or just
clinics) rather than provide home visits.
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Page 60: suggestions on the proposed standards
for psychologists
The organisation drawing on the study mentioned above makes a number of recommendations for
psychological support. The study found that psychological support was insufficient and focused mainly
on patients’ medical rather than psychological needs. The recommendations are:
l psychosocial meetings should be held after ward rounds in the specialist centre (led by the lead
specialist nurse and psychologist) in order to determine needs and liaise with local or referral
services as appropriate;
l for families identified to have psychosocial needs, a multidisciplinary team including psychosocial
involvement should be established as early as possible (2–3 days prior to discharge or earlier) with
all team members invited to a discharge planning meeting (either in person or via teleconference/Skype);
l families with psychosocial needs should receive more frequent phone calls (‘checking in’) from their
named specialist nurse (team) and additional visits from a health visitor who is able to provide
support and refer on to a psychologist if necessary; and
l for families with psychosocial concerns, learning difficulties or difficulty communicating in English,
the Study recommended referral to a health visitor/social work team to assist in ongoing training
support (in their own home).
Page 61: suggestions on the proposed standards for
cardiologists and paediatricians
The study mentioned above identified knowledge gaps between specialists and non-specialists as well
as poor communication between health professionals, which could result in specialist centres not
knowing what local and community services are available. The findings also showed that the level of
local support across the country varied and that the number of available Paediatricians with Expertise
in Cardiology was often insufficient. The positive counterexamples were cases where a Paediatrician
with Expertise in Cardiology had links with the specialist centres and often ran joint outreach clinics
with cardiologists. Drawing on this study, the organisation makes the following recommendations:
all patients should have a named paediatrician (with expertise in cardiology where possible);
for all patients, responsibility for care co-ordination should be transferred to the named paediatrician
at discharge from the specialist centre. The named paediatrician and GP are responsible for referring
to local services and maintaining effective communication between health professionals and should act
as a consistent point of contact in their locality; and all patients should be seen by their named
paediatrician and named cardiologist at joint outreach clinics.
Page 116: information sharing
Another refers to a research suggesting that referral processes and sharing of patient information
between different professionals involved in CHD care are inconsistent and often poorly coordinated.
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Page 118: organisation, governance and audit
One respondent makes a specific suggestion relating to audit. They suggest a number of data fields
should be added to routine cardiac audit including birth gestation and birth weight.
Page 119: home monitoring
One research team makes specific reference to their study which recommends that further research is
conducted on the effectiveness of the constituent components of home monitoring.
Page 122: information for patients
Respondents believe patients/parents/carers should be given clear guidance about what to expect with
a diagnosis of CHD. Information provided should include comprehensive material about the signs and
symptoms that are considered ‘normal’ and how to cope in unfamiliar situations, with the inclusion of
important contact numbers and helpful advice.
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